Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+

  Bladder Cancer, January 2019

Free Subscription


Retrieve all available abstracts of the following 924 articles:
HTML format


Single Articles

  1. PRENDEVILLE S, Berney DM, Bubendorf L, Comperat E, et al
    Handling and Reporting of Pelvic Lymphadenectomy Specimens in Prostate and Bladder Cancer: A Web-based Survey by the European Network of Uropathologists (ENUP).
    Histopathology. 2019 Jan 3. doi: 10.1111/his.13818.
    Abstract     Related articles   

  2. SJODAHL G, Jackson Chelsea L, Bartlett J, Robert SD, et al
    Molecular Profiling In Muscle Invasive Bladder Cancer: More Than The Sum Of Its Parts.
    J Pathol. 2019 Jan 2. doi: 10.1002/path.5230.
    Abstract     Related articles   

  3. STUBENDORFF B, Wilhelm K, Posselt K, Catto J, et al
    A three-gene methylation marker panel for the nodal metastatic risk assessment of muscle-invasive bladder cancer.
    J Cancer Res Clin Oncol. 2019 Jan 2. pii: 10.1007/s00432-018-02829.
    Abstract     Related articles   

  4. VAN OSCH FHM, Vlaanderen J, Jochems SHJ, Bosetti C, et al
    Modeling the complex exposure history of smoking in predicting bladder cancer: a pooled analysis of 15 case-control studies.
    Epidemiology. 2018 Dec 26. doi: 10.1097/EDE.0000000000000964.
    Abstract     Related articles   

  5. TOKUNAGA K, Furuta A, Arizono S, Teramoto Y, et al
    Duodenal obstruction induced by retroperitoneal progression of bladder cancer: a report of two cases.
    Abdom Radiol (NY). 2019 Jan 1. pii: 10.1007/s00261-018-1874.
    Abstract     Related articles   

  6. GALLIOLI A, Boissier R, Territo A, Breda A, et al
    Towards the future of upper tract urothelial carcinoma surveillance: lessons learnt from bladder cancer urinary biomarkers.
    World J Urol. 2019 Jan 2. pii: 10.1007/s00345-018-2611.
    Abstract     Related articles   

  7. ZHANG W, Zhang J, Zhang Z, Guo Y, et al
    Overexpression of Indoleamine 2,3-Dioxygenase 1 Promotes Epithelial-Mesenchymal Transition by Activation of the IL-6/STAT3/PD-L1 Pathway in Bladder Cancer.
    Transl Oncol. 2018;12:485-492.
    Abstract     Related articles   

  8. SMAL MP, Kuzhir TD, Savina NV, Nikitchenko NV, et al
    BER gene polymorphisms associated with key molecular events in bladder cancer.
    Exp Oncol. 2018;40:288-298.
    Abstract     Related articles   

  9. WU CH, Silvers CR, Messing EM, Lee YF, et al
    Bladder cancer extracellular vesicles drive tumorigenesis by inducing the unfolded protein response in endoplasmic reticulum of non-malignant cells.
    J Biol Chem. 2018 Dec 28. pii: RA118.006682. doi: 10.1074/jbc.RA118.006682.
    Abstract     Related articles   

  10. SALMASI A, Elashoff DA, Guo R, Upfill-Brown A, et al
    Urinary cytokine profile to predict response to intravesical BCG with or without HS-410 therapy in patients with non-muscle invasive bladder cancer.
    Cancer Epidemiol Biomarkers Prev. 2018 Dec 28. pii: 1055-9965.EPI-18-0893.
    Abstract     Related articles   

  11. TRIPATHI A, Plimack ER
    Immunotherapy for Urothelial Carcinoma: Current Evidence and Future Directions.
    Curr Urol Rep. 2018;19:109.
    Abstract     Related articles   

  12. CEANGA AI, Ceanga M, Eveslage M, Herrmann E, et al
    Preoperative anemia and extensive transfusion during stay-in-hospital are critical for patient`s mortality: A retrospective multicenter cohort study of oncological patients undergoing radical cystectomy.
    Transfus Apher Sci. 2018;57:739-745.
    Abstract     Related articles   

  13. RODRIGUEZ-VIDA A, Bellmunt J
    Avelumab for the treatment of urothelial cancer.
    Expert Rev Anticancer Ther. 2018;18:421-429.
    Abstract     Related articles   

  14. CHEN A, Chong J, Si Q, Haines K, et al
    Robotic approach to resection of villous adenoma of the urachus: a case report and literature review.
    J Robot Surg. 2018;12:567-570.
    Abstract     Related articles   

  15. HUANG CJ, Lee CH, Chang YH, Won JG, et al
    Paravesical (urachal) paraganglioma (PGL) presenting as hypertensive crisis during micturition, mimicking bladder PGL.
    J Formos Med Assoc. 2018;117:247-249.
    Abstract     Related articles   

  16. ONISHI T, Sekito S, Shibahara T, Uchida K, et al
    The role of continuous saline bladder irrigation after transurethral resection in patients with high-grade non-muscle-invasive bladder cancer.
    Scand J Urol. 2019 Jan 10:1-4. doi: 10.1080/21681805.2018.1548502.
    Abstract     Related articles   

  17. CHEN R, Zhou X, Liu J, Huang G, et al
    Relationship between the expression of PD-1/PD-L1 and (18)F-FDG uptake in bladder cancer.
    Eur J Nucl Med Mol Imaging. 2019 Jan 9. pii: 10.1007/s00259-018-4208.
    Abstract     Related articles   

  18. MATUSZEWSKI M, Szymanska B, Dlugosz A, Malkiewicz B, et al
    Preliminary Evaluation of the Diagnostic Usefulness of Uroplakin 2 with an Assessment of the Antioxidant Potential of Patients with Bladder Cancer.
    Biomed Res Int. 2018;2018:8693297.
    Abstract     Related articles   

  19. ELMUSSAREH M, Simonsen PC, Young M, Kingo PS, et al
    Correlation between organ-specific co-morbidities and complications in bladder cancer patients undergoing radical cystectomy.
    Scand J Urol. 2019 Jan 9:1-6. doi: 10.1080/21681805.2018.1531921.
    Abstract     Related articles   

    Population-based validation of the National Comprehensive Cancer Network recommendations for baseline imaging for bladder cancer: a case for routine baseline bone scan?
    J Comp Eff Res. 2019 Jan 9. doi: 10.2217/cer-2018-0113.
    Abstract     Related articles   

  21. NASRAZADANI M, Maracy MR, Dreassi E, Mahaki B, et al
    Mapping of Stomach, Colorectal, and Bladder Cancers in Iran, 2004-2009: Applying Bayesian Polytomous Logit Model.
    Int J Prev Med. 2018;9:104.
    Abstract     Related articles   

  22. DANIELSSON G, Malmstrom PU, Jahnson S, Wijkstrom H, et al
    Bladder health in patients treated with BCG instillations for T1G2-G3 bladder cancer - a follow-up five years after the start of treatment.
    Scand J Urol. 2019 Jan 8:1-8. doi: 10.1080/21681805.2018.1538162.
    Abstract     Related articles   

  23. WANG JR, Liu B, Zhou L, Huang YX, et al
    MicroRNA-124-3p suppresses cell migration and invasion by targeting ITGA3 signaling in bladder cancer.
    Cancer Biomark. 2018 Dec 27. pii: CBM182000. doi: 10.3233/CBM-182000.
    Abstract     Related articles   

  24. ZHANG LF, Ren KW, Zuo L, Zou JG, et al
    VEGF gene rs3025039C/T and rs833052C/A variants are associated with bladder cancer risk in Asian descendants.
    J Cell Biochem. 2019 Jan 4. doi: 10.1002/jcb.28324.
    Abstract     Related articles   

  25. CHEN JB, Zhu YW, Guo X, Yu C, et al
    Microarray expression profiles analysis revealed lncRNA OXCT1-AS1 promoted bladder cancer cell aggressiveness via miR-455-5p/JAK1 signaling.
    J Cell Physiol. 2019 Jan 4. doi: 10.1002/jcp.28037.
    Abstract     Related articles   

  26. RYU H, Jin H, Ho JN, Bae J, et al
    Suberoylanilide Hydroxamic Acid Can Re-sensitize a Cisplatin-Resistant Human Bladder Cancer.
    Biol Pharm Bull. 2019;42:66-72.
    Abstract     Related articles   

  27. WANG L, Xin F, Lin N, Wang Y, et al
    Metallothioneins may be a potential prognostic biomarker for tumors: A Prisma-compliant meta-analysis.
    Medicine (Baltimore). 2018;97:e13786.
    Abstract     Related articles   

  28. WANG K, Zhou H, Lu Y, Lu Q, et al
    ALK-negative urachal inflammatory myofibroblastic tumor in an elderly female: A case report.
    Medicine (Baltimore). 2018;97:e13619.
    Abstract     Related articles   

  29. ZHOU Y, Guan H, Fu Y, Mao L, et al
    The impact of pre-existing cancer on survival of prostate cancer patients: A population-based study.
    Medicine (Baltimore). 2018;97:e13479.
    Abstract     Related articles   

  30. YUK HD, Kim JK, Jeong CW, Kwak C, et al
    Differences in Pathologic Results of Repeat Transurethral Resection of Bladder Tumor (TURBT) according to Institution Performing the Initial TURBT: Comparative Analyses between Referred and Nonreferred Group.
    Biomed Res Int. 2018;2018:9432606.
    Abstract     Related articles   

  31. TUNG MC, Wen YC, Wang SS, Lin YW, et al
    Dopamine receptor D2 genetic variations is associated with the risk and clinicopathological variables of urothelial cell carcinoma in a Taiwanese population.
    Int J Med Sci. 2018;15:1187-1193.
    Abstract     Related articles   

  32. PAVONE C, Candela L, Fontana D, Simonato A, et al
    Postoperative complications and 90-day mortality in radical cystectomy in high-risk patients: A monocentric retrospective observational study.
    Urologia. 2018;85:111-117.
    Abstract     Related articles   

  33. FANG T, Liu DD, Ning HM, Dan Liu, et al
    Modified citrus pectin inhibited bladder tumor growth through downregulation of galectin-3.
    Acta Pharmacol Sin. 2018;39:1885-1893.
    Abstract     Related articles   

  34. MCGRATH JS, Daneshmand S
    Readmission Following Radical Cystectomy: A Ray of Light in the "Black Box"?
    Eur Urol Focus. 2018;4:718-719.
    Abstract     Related articles   

  35. SILVA-SMITH R, Sussman DA
    Co-occurrence of Lynch syndrome and juvenile polyposis syndrome confirmed by multigene panel testing.
    Fam Cancer. 2018;17:87-90.
    Abstract     Related articles   

  36. BAO F, Deng Y, Dai Q
    ACID: Association Correction for Imbalanced Data in GWAS.
    IEEE/ACM Trans Comput Biol Bioinform. 2018;15:316-322.
    Abstract     Related articles   

  37. PALMISANO F, Gadda F, Spinelli MG, Maggioni M, et al
    Symplastic glomus tumor of the urinary bladder treated by robot-assisted partial cystectomy: a case report and literature review.
    Urologia. 2018;85:130-132.
    Abstract     Related articles   

  38. AMARA CS, Ambati CR, Vantaku V, Piyarathna DWB, et al
    Serum metabolic profiling identified a distinct metabolic signature in Bladder Cancer Smokers: A key metabolic enzymes associated with patient survival.
    Cancer Epidemiol Biomarkers Prev. 2019 Jan 14. pii: 1055-9965.EPI-18-0936.
    Abstract     Related articles   

  39. MONTEIRO-REIS S, Lobo J, Henrique R, Jeronimo C, et al
    Epigenetic Mechanisms Influencing Epithelial to Mesenchymal Transition in Bladder Cancer.
    Int J Mol Sci. 2019;20.
    Abstract     Related articles   

  40. XIE X, Pan J, Han X, Chen W, et al
    Downregulation of microRNA-532-5p promotes the proliferation and invasion of bladder cancer cells through promotion of HMGB3/Wnt/beta-catenin signaling.
    Chem Biol Interact. 2019 Jan 10. pii: S0009-2797(18)31262.
    Abstract     Related articles   

  41. MOROZUMI K, Mitsuzuka K, Takai Y, Katsumata Y, et al
    Intraoperative hypothermia is a significant prognostic predictor of radical cystectomy especially for stage II muscle-invasive bladder cancer.
    Medicine (Baltimore). 2019;98:e13962.
    Abstract     Related articles   

  42. LIU Y, Wu X, Wang G, Hu S, et al
    CALD1, CNN1, and TAGLN identified as potential prognostic molecular markers of bladder cancer by bioinformatics analysis.
    Medicine (Baltimore). 2019;98:e13847.
    Abstract     Related articles   

  43. CRITSELIS E, Rava M, Marquez M, Lygirou V, et al
    Diagnostic and prognostic performance of Secreted Protein Acidic and Rich in Cysteine (SPARC) assay for detecting primary and recurrent urinary bladder cancer.
    Proteomics Clin Appl. 2019 Jan 11:e1800148. doi: 10.1002/prca.201800148.
    Abstract     Related articles   

  44. WUJANTO C, Tey J, Chia D, Ho F, et al
    Radical radiotherapy in older patients with muscle invasive bladder cancer.
    J Geriatr Oncol. 2019 Jan 7. pii: S1879-4068(18)30302.
    Abstract     Related articles   

  45. NIWA N, Matsumoto K, Ide H
    The clinical implication of gamma globulin levels in patients with nonmuscle-invasive bladder cancer.
    Urol Oncol. 2019 Jan 7. pii: S1078-1439(18)30552.
    Abstract     Related articles   

  46. SONG D, Jiao W, Gao Z, Liu N, et al
    Inflammatory myofibroblastic tumor of urinary bladder with severe hematuria: A Case report and literature review.
    Medicine (Baltimore). 2019;98:e13987.
    Abstract     Related articles   

    Bladder Cancer Treatment (PDQ(R)): Patient Version
    Bull Cancer. 2018;105 Suppl 1:S43-S49.
    Abstract     Related articles   

  48. HUANG Z, Xiao H, Lu X, Yan W, et al
    Enhanced photo/chemo combination efficiency against bladder tumor by encapsulation of DOX and ZnPC into in situ-formed thermosensitive polymer hydrogel.
    Int J Nanomedicine. 2018;13:7623-7631.
    Abstract     Related articles   

  49. KHAN FM, Gupta SK, Wolkenhauer O
    Integrative workflows for network analysis.
    Essays Biochem. 2018;62:549-561.
    Abstract     Related articles   

  50. DENG J, Peng M, Wang Z, Zhou S, et al
    Novel application of metformin combined with targeted drugs on anticancer treatment.
    Cancer Sci. 2019;110:23-30.
    Abstract     Related articles   

  51. BOSSERMAN AJ, Dai D, Lu Y
    Imaging Characteristics of a Bladder Wall Paraganglioma.
    Clin Nucl Med. 2019;44:66-67.
    Abstract     Related articles   

  52. DELAUNE T, Bernard F, Matres-Lorenzo L, Bernarde A, et al
    Radical cystectomy and subsequent ureterohysterostomy in a bitch.
    Vet Surg. 2018;47:1106-1111.
    Abstract     Related articles   

  53. ELAWDY MM, Osman Y, Taha DE, El-Halwagy S, et al
    Coincidental Bladder Cuff Transitional Cell Carcinoma in Nephroureterectomy Specimens: Risk Factors, Prognosis and Clinical Implementation.
    Urol J. 2018;15:256-260.
    Abstract     Related articles   

  54. XU Z, Zhang Q, Luh F, Jin B, et al
    Overexpression of the ASPM gene is associated with aggressiveness and poor outcome in bladder cancer.
    Oncol Lett. 2019;17:1865-1876.
    Abstract     Related articles   

  55. LU JJ, Su YW, Wang CJ, Li DF, et al
    Semaphorin 4D promotes the proliferation and metastasis of bladder cancer by activating the PI3K/AKT pathway.
    Tumori. 2019 Jan 24:300891618811280. doi: 10.1177/0300891618811280.
    Abstract     Related articles   

  56. RAJA SA, Abbas S, Shah STA, Tariq A, et al
    Increased expression levels of Syntaxin 1A and Synaptobrevin 2/Vesicle-Associated Membrane Protein-2 are associated with the progression of bladder cancer.
    Genet Mol Biol. 2019 Jan 21:0. doi: 10.1590/1678-4685-GMB-2017-0339.
    Abstract     Related articles   

  57. GUO CC, Czerniak B
    Bladder Cancer in the Genomic Era.
    Arch Pathol Lab Med. 2019 Jan 23. doi: 10.5858/arpa.2018-0329.
    Abstract     Related articles   

  58. QIU F, Zhang MR, Zhou Z, Pu JX, et al
    lncRNA MIR503HG functioned as a tumor suppressor and inhibited cell proliferation, metastasis and epithelial-mesenchymal transition in bladder cancer.
    J Cell Biochem. 2019 Jan 22. doi: 10.1002/jcb.28373.
    Abstract     Related articles   

  59. GUPTA M, Milbar N, Tema G, Pederzoli F, et al
    Impact of intravesical therapy for non-muscle invasive bladder cancer on the accuracy of urine cytology.
    World J Urol. 2019 Jan 23. pii: 10.1007/s00345-018-02624.
    Abstract     Related articles   

  60. YEE CH, Zheng Z, Shuman L, Yamashita H, et al
    Maintenance of the bladder cancer precursor urothelial hyperplasia requires FOXA1 and persistent expression of oncogenic HRAS.
    Sci Rep. 2019;9:270.
    Abstract     Related articles   

  61. TAARNHOJ GA, Johansen C, Pappot H
    Quality of life in bladder cancer patients receiving medical oncological treatment; a systematic review of the literature.
    Health Qual Life Outcomes. 2019;17:20.
    Abstract     Related articles   

  62. RODRIGUES D, Pinto J, Araujo AM, Jeronimo C, et al
    GC-MS Metabolomics Reveals Distinct Profiles of Low- and High-Grade Bladder Cancer Cultured Cells.
    Metabolites. 2019;9.
    Abstract     Related articles   

  63. DAGA M, Pizzimenti S, Dianzani C, Cucci MA, et al
    Ailanthone inhibits cell growth and migration of cisplatin resistant bladder cancer cells through down-regulation of Nrf2, YAP, and c-Myc expression.
    Phytomedicine. 2018;56:156-164.
    Abstract     Related articles   

  64. AMR S, Wolpert BJ, St George DM, James I, et al
    Body mass index modifies bladder cancer risk associated with low estrogen exposure among Egyptian women after menopause.
    Cancer Causes Control. 2019 Jan 21. pii: 10.1007/s10552-019-1131.
    Abstract     Related articles   

  65. WANG F, Chen HG, Zhang RY, Jin D, et al
    Diffusion kurtosis imaging to assess correlations with clinicopathologic factors for bladder cancer: a comparison between the multi-b value method and the tensor method.
    Eur Radiol. 2019 Jan 21. pii: 10.1007/s00330-018-5977.
    Abstract     Related articles   

  66. GIRARD A, Rouanne M, Taconet S, Radulescu C, et al
    Integrated analysis of (18)F-FDG PET/CT improves preoperative lymph node staging for patients with invasive bladder cancer.
    Eur Radiol. 2019 Jan 21. pii: 10.1007/s00330-018-5959.
    Abstract     Related articles   

  67. BLACK P, Gontero P
    SIU-ICUD consultation on bladder cancer 2018.
    World J Urol. 2019 Jan 21. pii: 10.1007/s00345-018-2601.
    Abstract     Related articles   

  68. ZHAO S, Xie Q, Yang R, Wang J, et al
    High prevalence of secondary bladder cancer in men on radiotherapy for prostate cancer: evidence from a meta-analysis.
    Cancer Manag Res. 2019;11:587-598.
    Abstract     Related articles   

  69. WU J, Li W, Ning J, Yu W, et al
    Long noncoding RNA UCA1 targets miR-582-5p and contributes to the progression and drug resistance of bladder cancer cells through ATG7-mediated autophagy inhibition.
    Onco Targets Ther. 2019;12:495-508.
    Abstract     Related articles   

  70. MIERZEJEWSKA P, Gawlik-Jakubczak T, Jablonska P, Czajkowski M, et al
    Nicotinamide metabolism alterations in bladder cancer: Preliminary studies.
    Nucleosides Nucleotides Nucleic Acids. 2019.
    Abstract     Related articles   

  71. JIN S, Wang B, Zhu Y, Dai W, et al
    Log Odds Could Better Predict Survival in Muscle-Invasive Bladder Cancer Patients Compared with pN and Lymph Node Ratio.
    J Cancer. 2019;10:249-256.
    Abstract     Related articles   

  72. CHEN Z, Chen X, Xie R, Huang M, et al
    DANCR Promotes Metastasis and Proliferation in Bladder Cancer Cells by Enhancing IL-11-STAT3 Signaling and CCND1 Expression.
    Mol Ther. 2019 Jan 9. pii: S1525-0016(19)30004.
    Abstract     Related articles   

  73. FU YR, Chen F, Luo Y, Yi YF, et al
    Nanoscale bubble ultrasound contrast agents-mediated suicide gene therapy system, Nanoscale bubble-LV5-YCD-TK/GCV/5-FC, effectively inhibits bladder cancer cell growth.
    Eur Rev Med Pharmacol Sci. 2019;23:75-86.
    Abstract     Related articles   

  74. KWAN ML, Kushi LH, Danforth KN, Roh JM, et al
    The Be-Well Study: a prospective cohort study of lifestyle and genetic factors to reduce the risk of recurrence and progression of non-muscle-invasive bladder cancer.
    Cancer Causes Control. 2019 Jan 17. pii: 10.1007/s10552-019-1130.
    Abstract     Related articles   

  75. WANG X, Wang H, Song Y
    Clinical efficacy and mechanism of Pralatrexate combined with Palbociclib Isethionate in treatment of bladder cancer patients.
    Oncol Lett. 2019;17:201-208.
    Abstract     Related articles   

  76. YE G, Kan S, Chen J, Lu X, et al
    Puerarin in inducing apoptosis of bladder cancer cells through inhibiting SIRT1/p53 pathway.
    Oncol Lett. 2019;17:195-200.
    Abstract     Related articles   

  77. HOU Y
    MiR-506 inhibits cell proliferation, invasion, migration and epithelial-to-mesenchymal transition through targeting RWDD4 in human bladder cancer.
    Oncol Lett. 2019;17:73-78.
    Abstract     Related articles   

  78. EISSA S, Safwat M, Matboli M, Zaghloul A, et al
    Measurement of Urinary Level of a Specific Competing endogenous RNA network (FOS and RCAN mRNA/ miR-324-5p, miR-4738-3p, /lncRNA miR-497-HG) Enables Diagnosis of Bladder Cancer.
    Urol Oncol. 2019 Jan 14. pii: S1078-1439(18)30518.
    Abstract     Related articles   

  79. FURUYA H, Chan OTM, Pagano I, Zhu C, et al
    Effectiveness of two different dose administration regimens of an IL-15 superagonist complex (ALT-803) in an orthotopic bladder cancer mouse model.
    J Transl Med. 2019;17:29.
    Abstract     Related articles   

  80. MISTRETTA FA, Carrion DM, Nazzani S, Vasquez JL, et al
    Bladder recurrence of primary upper tract urinary carcinoma following nephro-ureterectomy, and risk of upper urinary tract recurrence after ureteral stent positioning in patients with primary bladder cancer: a contemporary non-systematic review of the
    Minerva Urol Nefrol. 2019 Jan 17. pii: S0393-2249.19.03311.
    Abstract     Related articles   

  81. DUNN JA, Jefferson K, MacDonald D, Iqbal G, et al
    J Steroid Biochem Mol Biol. 2019 Jan 14. pii: S0960-0760(18)30620.
    Abstract     Related articles   

  82. RUSSO V, Roperto F, Taulescu M, De Falco F, et al
    Expression of the feline leukemia virus subgroup C receptors in normal and neoplastic urothelium of the urinary bladder of cattle associated with bovine papillomavirus infection.
    Vet Microbiol. 2019;229:147-152.
    Abstract     Related articles   

  83. KRASNOW RE, Rodriguez D, Nagle RT, Mossanen M, et al
    The impact of age at the time of radiotherapy for localized prostate cancer on the development of second primary malignancies.
    Urol Oncol. 2018;36:500.
    Abstract     Related articles   

  84. YAP SA, Brunson A, Pugashetti N, M P H RDC, et al
    Immediate intravesical chemotherapy for low-grade bladder tumors in California: An underutilized practice and its impact on recurrence.
    Urol Oncol. 2018;36:498.
    Abstract     Related articles   

  85. COX RM, Magi-Galluzzi C, McKenney JK
    Immunohistochemical Pitfalls in Genitourinary Pathology: 2018 Update.
    Adv Anat Pathol. 2018;25:387-399.
    Abstract     Related articles   

  86. WHONGSIRI P, Pimratana C, Wijitsettakul U, Sanpavat A, et al
    Oxidative stress and LINE-1 reactivation in bladder cancer are epigenetically linked through active chromatin formation.
    Free Radic Biol Med. 2019 Jan 28. pii: S0891-5849(18)32321.
    Abstract     Related articles   

  87. ANDREW AS, Karagas MR, Schroeck FR, Marsit CJ, et al
    MicroRNA dysregulation and non-muscle invasive bladder cancer prognosis.
    Cancer Epidemiol Biomarkers Prev. 2019 Jan 30. pii: 1055-9965.EPI-18-0884.
    Abstract     Related articles   

  88. RAVEN PA, D'Costa NM, Moskalev I, Tan Z, et al
    Development of a murine intravesical orthotopic human bladder cancer (mio-hBC) model.
    Am J Clin Exp Urol. 2018;6:245-259.
    Abstract     Related articles   

  89. MENG XY, Shi MJ, Zeng ZH, Chen C, et al
    The Role of COL5A2 in Patients With Muscle-Invasive Bladder Cancer: A Bioinformatics Analysis of Public Datasets Involving 787 Subjects and 29 Cell Lines.
    Front Oncol. 2019;8:659.
    Abstract     Related articles   

  90. DOMINGOS-PEREIRA S, Sathiyanadan K, La Rosa S, Polak L, et al
    Intravesical Ty21a vaccine promotes dendritic cells and T cell-mediated tumor regression in the MB49 bladder cancer model.
    Cancer Immunol Res. 2019 Jan 29. pii: 2326-6066.CIR-18-0671.
    Abstract     Related articles   

  91. FONT A, Luque R, Villa JC, Domenech M, et al
    The Challenge of Managing Bladder Cancer and Upper Tract Urothelial Carcinoma: A Review with Treatment Recommendations from the Spanish Oncology Genitourinary Group (SOGUG).
    Target Oncol. 2019 Jan 29. pii: 10.1007/s11523-019-00619.
    Abstract     Related articles   

  92. RAMAKRISHNAN S, Granger V, Rak M, Hu Q, et al
    Inhibition of EZH2 induces NK cell-mediated differentiation and death in muscle-invasive bladder cancer.
    Cell Death Differ. 2019 Jan 28. pii: 10.1038/s41418-019-0278.
    Abstract     Related articles   

  93. VISNJAR T, Romih R, Zupancic D
    Lectins as possible tools for improved urinary bladder cancer management.
    Glycobiology. 2019 Jan 25. pii: 5301307. doi: 10.1093.
    Abstract     Related articles   

  94. SHI S, Tian B
    Identification of biomarkers associated with progression and prognosis in bladder cancer via co-expression analysis.
    Cancer Biomark. 2019 Jan 18. pii: CBM181940. doi: 10.3233/CBM-181940.
    Abstract     Related articles   

    Penile Implant Considerations in the Bladder Cancer Survivor.
    Curr Urol Rep. 2019;20:7.
    Abstract     Related articles   

  96. BIELLI P, Di Stasi SM, Sette C
    The emerging role of PTBP1 in human cancer: novel prognostic factor in non-muscle invasive bladder cancer.
    Transl Androl Urol. 2018;7.
    Abstract     Related articles   

  97. PATHAK RA, Hemal AK
    Frailty and sarcopenia impact surgical and oncologic outcomes after radical cystectomy in patients with bladder cancer.
    Transl Androl Urol. 2018;7.
    Abstract     Related articles   

  98. SORIA F, Shariat SF
    Biomarkers for the prediction of oncologic outcomes in non-muscle invasive bladder cancer: state of affairs and new frontiers.
    Transl Androl Urol. 2018;7.
    Abstract     Related articles   

    Does robotic radical cystectomy impede oncological outcome in bladder cancer patients?
    Transl Androl Urol. 2018;7.
    Abstract     Related articles   

  100. PICHLER R, Loidl W, Pichler M
    High economic burden of immunotherapy underlines the need of predictive biomarkers for the individual therapy algorithm in metastatic bladder cancer.
    Transl Androl Urol. 2018;7.
    Abstract     Related articles   

  101. KAAG MG, Raman JD
    Sarcopenia is a reliable predictor of outcomes following radical cystectomy for bladder cancer.
    Transl Androl Urol. 2018;7.
    Abstract     Related articles   

  102. BATURA D
    Redefining the role of immediate intravesical instillation of mitomycin C in non-muscle invasive bladder cancer.
    Transl Androl Urol. 2018;7.
    Abstract     Related articles   

  103. AJIB K, Kulkarni GS
    Editorial comment: bladder preservation as a treatment strategy in muscle-invasive bladder cancer.
    Transl Androl Urol. 2018;7.
    Abstract     Related articles   

    Do we have all the facts to determine the impact of bacillus Calmette-Guerin therapy on bladder cancer?
    Transl Androl Urol. 2018;7.
    Abstract     Related articles   

  105. LEE KH, Ku JH
    Targeting splicing factors as molecular non-muscle invasive bladder cancer predictors.
    Transl Androl Urol. 2018;7.
    Abstract     Related articles   

  106. DAL MORO F, Colicchia M
    Does obesity impact bladder cancer prognosis?-a long-lasting debate.
    Transl Androl Urol. 2018;7.
    Abstract     Related articles   

  107. OOSTERLINCK W, Decaestecker K
    An immediate intravesical instillation of mitomycin C is of benefit in all prognostic risk groups with non-muscle-invasive bladder cancers.
    Transl Androl Urol. 2018;7.
    Abstract     Related articles   

    The association of BMI with risk of recurrence and progression in patients with non-muscle-invasive bladder cancer.
    Transl Androl Urol. 2018;7.
    Abstract     Related articles   

  109. BRODIE A, McCauley N, Cresswell J, Vasdev N, et al
    T1G3 bladder cancer, bacillus Calmette-Guerin and radical cystectomy: continued debate.
    Transl Androl Urol. 2018;7.
    Abstract     Related articles   

  110. ROSSER CJ
    Nutritional implications for quality of life in bladder cancer survivors.
    Transl Androl Urol. 2018;7.
    Abstract     Related articles   

  111. JIANG DM, Jiang H, Chung PWM, Zlotta AR, et al
    Neoadjuvant Chemotherapy Before Bladder-Sparing Chemoradiotherapy in Patients With Nonmetastatic Muscle-Invasive Bladder Cancer.
    Clin Genitourin Cancer. 2019;17:38-45.
    Abstract     Related articles   

  112. ABDELRAHMAN AE, Rashed HE, Elkady E, Elsebai EA, et al
    Fatty acid synthase, Her2/neu, and E2F1 as prognostic markers of progression in non-muscle invasive bladder cancer.
    Ann Diagn Pathol. 2019;39:42-52.
    Abstract     Related articles   

  113. LEOW JJ, Bedke J, Chamie K, Collins JW, et al
    SIU-ICUD consultation on bladder cancer: treatment of muscle-invasive bladder cancer.
    World J Urol. 2019 Jan 25. pii: 10.1007/s00345-018-2606.
    Abstract     Related articles   

  114. LORENZATTI HILES G, Cates AL, El-Sawy L, Day KC, et al
    A surgical orthotopic approach for studying the invasive progression of human bladder cancer.
    Nat Protoc. 2019 Jan 25. pii: 10.1038/s41596-018-0112.
    Abstract     Related articles   

  115. BLACK PC, Goebell PJ, Kamat AM, Nawroth R, et al
    Editorial: Basic research in bladder cancer - refining the tools. 3rd IBCN seminars series(1).
    Urol Oncol. 2019 Jan 22. pii: S1078-1439(19)30003.
    Abstract     Related articles   

  116. CHEN L, Long Y, Han Z, Yuan Z, et al
    MicroRNA-101 inhibits cell migration and invasion in bladder cancer via targeting FZD4.
    Exp Ther Med. 2019;17:1476-1485.
    Abstract     Related articles   

  117. WANG Y, Xu Z, Wang X
    miRNA-373 promotes urinary bladder cancer cell proliferation, migration and invasion through upregulating epidermal growth factor receptor.
    Exp Ther Med. 2019;17:1190-1195.
    Abstract     Related articles   

  118. CHO SK, Su LJ, Mao C, Wolenski CD, et al
    Multifunctional nanoclusters of NaYF4:Yb(3+),Er(3+) upconversion nanoparticle and gold nanorod for simultaneous imaging and targeted chemotherapy of bladder cancer.
    Mater Sci Eng C Mater Biol Appl. 2019;97:784-792.
    Abstract     Related articles   

  119. HA YS, Kim SW, Chun SY, Chung JW, et al
    Association between De Ritis ratio (aspartate aminotransferase/alanine aminotransferase) and oncological outcomes in bladder cancer patients after radical cystectomy.
    BMC Urol. 2019;19:10.
    Abstract     Related articles   

  120. [Expert consensus on treatment of intravesical therapy in non-muscle invasive bladder cancer].
    Zhonghua Zhong Liu Za Zhi. 2019;41:42-45.
    Abstract     Related articles   

  121. ZHOU J, Yang C, Lu Z, Zhang L, et al
    Primary urothelial carcinoma of the prostate: A rare case report.
    Medicine (Baltimore). 2019;98:e14155.
    Abstract     Related articles   

  122. TONG S, Yang Z, Zu X, Li Y, et al
    Anterior versus posterior approach laparoscopic radical cystectomy: a retrospective analysis.
    World J Surg Oncol. 2019;17:9.
    Abstract     Related articles   

  123. MARTINI T, Heinkele J, Mayr R, Weis CA, et al
    Predictive value of lymphangiogenesis and proliferation markers on mRNA level in urothelial carcinoma of the bladder after radical cystectomy.
    Urol Oncol. 2018;36:530.
    Abstract     Related articles   

  124. LALANI AA, Sonpavde GP
    Systemic treatments for metastatic urothelial carcinoma.
    Expert Opin Pharmacother. 2019;20:201-208.
    Abstract     Related articles   

  125. GU YQ, Shen WY, Zhou Y, Chen SF, et al
    A pyrazolopyrimidine based fluorescent probe for the detection of Cu(2+) and Ni(2+) and its application in living cells.
    Spectrochim Acta A Mol Biomol Spectrosc. 2019;209:141-149.
    Abstract     Related articles   

  126. RIVA G, Mian C, Luchini C, Girolami I, et al
    Urachal carcinoma: from gross specimen to morphologic, immunohistochemical, and molecular analysis.
    Virchows Arch. 2019;474:13-20.
    Abstract     Related articles   

  127. MILLER R, Heinlen JE
    Reported rates of clostridium difficile following radical cystectomy in national datasets compared to individual institutions.
    Urol Oncol. 2018;36:526.
    Abstract     Related articles   

  128. MURAKAMI M, Kiyota H, Kasai K, Bando S, et al
    Antimicrobial prophylaxis for transurethral resection of bladder tumor: A retrospective comparison of preoperative single-dose administration of piperacillin and tazobactam/piperacillin.
    J Infect Chemother. 2018;24:954-957.
    Abstract     Related articles   

  129. LI CY, Dai YX, Chen YJ, Chu SY, et al
    Cancer Risks in Vitiligo Patients: A Nationwide Population-Based Study in Taiwan.
    Int J Environ Res Public Health. 2018;15.
    Abstract     Related articles   

  130. KONG V, Taylor A, Chung P, Rosewall T, et al
    Evaluation of resource burden for bladder adaptive strategies: A timing study.
    J Med Imaging Radiat Oncol. 2018;62:861-865.
    Abstract     Related articles   

  131. ADHYA AK, Pradhan MR
    Ectopic prostatic tissue presenting as a mucosal tumor in urinary bladder.
    Indian J Pathol Microbiol. 2018;61:452-453.
    Abstract     Related articles   

  132. LEFFLER AJ, Hostnik ET, Warry EE, Habing GG, et al
    Canine urinary bladder transitional cell carcinoma tumor volume is dependent on imaging modality and measurement technique.
    Vet Radiol Ultrasound. 2018;59:767-776.
    Abstract     Related articles   

  133. BURGER M
    Editorial Commentary on Gregers et al.
    Scand J Urol. 2018;52:199.
    Abstract     Related articles   

  134. MARQUEEN KE, Waingankar N, Sfakianos JP, Mehrazin R, et al
    Early Mortality in Patients With Muscle-Invasive Bladder Cancer Undergoing Cystectomy in the United States.
    JNCI Cancer Spectr. 2018;2:pky075.
    Abstract     Related articles   

  135. JORGENSEN MS, Oldenburg WA, Murray PM
    Mycotic Aneurysm of the Ulnar Artery Secondary to Bacillus Calmette-Guerin Therapy for Bladder Cancer: A Rare Presentation of Hypothenar Hammer Syndrome.
    J Hand Surg Am. 2019 Feb 4. pii: S0363-5023(18)31479.
    Abstract     Related articles   

  136. SOUKUPOVA K, Rudolf E
    Suppression of proliferation and activation of cell death by sodium selenite involves mitochondria and lysosomes in chemoresistant bladder cancer cells.
    J Trace Elem Med Biol. 2019;52:58-67.
    Abstract     Related articles   

  137. MARCQ G, Jarry E, Ouzaid I, Hermieu JF, et al
    Contemporary best practice in the use of neoadjuvant chemotherapy in muscle-invasive bladder cancer.
    Ther Adv Urol. 2019;11:1756287218823678.
    Abstract     Related articles   

  138. RAO A, Patel MR
    A review of avelumab in locally advanced and metastatic bladder cancer.
    Ther Adv Urol. 2019;11:1756287218823485.
    Abstract     Related articles   

  139. OSTERMAN CK, Babu DS, Geynisman DM, Lewis B, et al
    Efficacy of Split Schedule Versus Conventional Schedule Neoadjuvant Cisplatin-Based Chemotherapy for Muscle-Invasive Bladder Cancer.
    Oncologist. 2019 Feb 6. pii: theoncologist.2018-0561.
    Abstract     Related articles   

  140. DI Y, Chen D, Yu W, Yan L, et al
    Bladder cancer stage-associated hub genes revealed by WGCNA co-expression network analysis.
    Hereditas. 2019;156:7.
    Abstract     Related articles   

  141. ZHANG X, Liu X, Jing Z, Bi J, et al
    The circINTS4/miR-146b/CARMA3 axis promotes tumorigenesis in bladder cancer.
    Cancer Gene Ther. 2019 Feb 6. pii: 10.1038/s41417-019-0085.
    Abstract     Related articles   

  142. BOC A, Crisan N, Vesa SC, Coman I, et al
    The impact of minimal invasive surgery on early complications and mortality after radical cystectomy for muscle-invasive urothelial bladder cancer.
    J BUON. 2018;23:104-110.
    Abstract     Related articles   

  143. SIGNES-PASTOR AJ, Scot Zens M, Seigne J, Schned A, et al
    Rice Consumption and Incidence of Bladder Cancer in the United States Population.
    Epidemiology. 2019;30:e4-e5.
    Abstract     Related articles   

  144. RAPHAEL MJ, Booth CM
    Neoadjuvant chemotherapy for muscle-invasive bladder cancer: Underused across the 49(th) parallel.
    Can Urol Assoc J. 2019;13:29-31.
    Abstract     Related articles   

  145. OGIHARA K, Kikuchi E, Okazaki S, Hagiwara M, et al
    Sulfasalazine may modulate the CD44v9-xCT system and enhance CDDP-induced cytotoxic effects in metastatic bladder cancer.
    Cancer Sci. 2019 Feb 4. doi: 10.1111/cas.13960.
    Abstract     Related articles   

  146. TSAI YS, Jou YC, Tsai HT, Shiau AL, et al
    Prothymosin-alpha Enhances PTEN Expression and Binds with TRIM21 to Regulate Keap1/Nrf2 Signaling in Human Bladder Cancer.
    Cancer Sci. 2019 Feb 4. doi: 10.1111/cas.13963.
    Abstract     Related articles   

  147. HEIDE T, Maurer A, Eipel M, Knoll K, et al
    Multiregion human bladder cancer sequencing reveals tumour evolution, bladder cancer phenotypes and implications for targeted therapy.
    J Pathol. 2019 Feb 4. doi: 10.1002/path.5250.
    Abstract     Related articles   

  148. LEMKE EA, Shah AY
    Management of Advanced Bladder Cancer: An Update.
    J Adv Pract Oncol. 2018;9:410-416.
    Abstract     Related articles   

  149. XU C, Zhou J, Wang Y, Wang A, et al
    Inhibition of malignant human bladder cancer phenotypes through the down-regulation of the long non-coding RNA SNHG7.
    J Cancer. 2019;10:539-546.
    Abstract     Related articles   

  150. CHEN Y, Liu L, Guo Z, Wang Y, et al
    Lost expression of cell adhesion molecule 1 is associated with bladder cancer progression and recurrence and its overexpression inhibited tumor cell malignant behaviors.
    Oncol Lett. 2019;17:2047-2056.
    Abstract     Related articles   

  151. COTRUVO JA, Amato H
    National Trends of Bladder Cancer and Trihalomethanes in Drinking Water: A Review and Multicountry Ecological Study.
    Dose Response. 2019;17:1559325818807781.
    Abstract     Related articles   

  152. LIU YN, Zhang H, Zhang L, Cai TT, et al
    Sphingosine 1 phosphate receptor-1 (S1P1) promotes tumor-associated regulatory T cell expansion: leading to poor survival in bladder cancer.
    Cell Death Dis. 2019;10:50.
    Abstract     Related articles   

    Editorial comment on: The role of continuous saline bladder irrigation after transurethral resection in patients with high-grade non-muscle-invasive bladder cancer.
    Scand J Urol. 2019 Feb 4:1-2. doi: 10.1080/21681805.2018.1563629.
    Abstract     Related articles   

  154. HU G, Wang X, Han Y, Wang P, et al
    Protein arginine methyltransferase 5 promotes bladder cancer growth through inhibiting NF-kB dependent apoptosis.
    EXCLI J. 2018;17:1157-1166.
    Abstract     Related articles   

  155. PAK S, You D, Jeong IG, Song C, et al
    Induction Chemotherapy Followed by Surgery Versus Upfront Radical Cystectomy in Patients With Clinically Node-positive Muscle-invasive Bladder Cancer.
    Clin Genitourin Cancer. 2019 Jan 9. pii: S1558-7673(19)30008.
    Abstract     Related articles   

  156. AL-DAGHMIN A, Alhamss S, Al-Najjar H, Al-Saidi I, et al
    Survival and metastasis in muscle-invasive bladder cancer patients who present with indeterminate pulmonary nodules before treatment.
    Ann Saudi Med. 2019;39:42-47.
    Abstract     Related articles   

  157. MINA S, Pardo Munevar CA, Osorio D, Garcia-Perdomo HA, et al
    Life quality evaluation in patients with bladder cancer: A systematic review.
    Actas Urol Esp. 2019 Jan 30. pii: S0210-4806(18)30230.
    Abstract     Related articles   

  158. SAFWAT O, Abd-Ellatif RN, Othman TS, Afifi M, et al
    The evolving role of protein disulfide isomerase A3 in Egyptian bladder cancer patients.
    Gene. 2019 Jan 29. pii: S0378-1119(19)30068-X. doi: 10.1016/j.gene.2019.
    Abstract     Related articles   

  159. ISHII A, Tei Y, Murakami T, Notohara K, et al
    An unusual case of Abeta2M amyloid deposition in bladder cancer in a non-dialysis patient.
    Pathol Int. 2019 Feb 1. doi: 10.1111/pin.12770.
    Abstract     Related articles   

  160. BOSSCHIETER J, Nieuwenhuijzen JA, Hentschel A, van Splunter AP, et al
    A two-gene methylation signature for the diagnosis of bladder cancer in urine.
    Epigenomics. 2019 Feb 1. doi: 10.2217/epi-2018-0094.
    Abstract     Related articles   

  161. KATTEPUR AK, Patkar S, Goel M, Ramaswamy A, et al
    Role of Adjuvant Chemotherapy in Resected T2N0 Gall Bladder Cancer.
    J Gastrointest Surg. 2019 Jan 31. pii: 10.1007/s11605-019-04104.
    Abstract     Related articles   

  162. YUK HD, Jeong CW, Kwak C, Kim HH, et al
    Elevated Neutrophil to Lymphocyte Ratio Predicts Poor Prognosis in Non-muscle Invasive Bladder Cancer Patients: Initial Intravesical Bacillus Calmette-Guerin Treatment After Transurethral Resection of Bladder Tumor Setting.
    Front Oncol. 2019;8:642.
    Abstract     Related articles   

  163. YANG X, Zhao L, Zhang T, Xi J, et al
    Protosappanin B promotes apoptosis and causes G1 cell cycle arrest in human bladder cancer cells.
    Sci Rep. 2019;9:1048.
    Abstract     Related articles   

  164. MATULAY JT, Woldu SL, Lim A, Narayan VM, et al
    The impact of squamous histology on survival in patients with muscle-invasive bladder cancer.
    Urol Oncol. 2019 Jan 28. pii: S1078-1439(19)30021.
    Abstract     Related articles   

  165. BURKHARD FC, Thalmann GN
    No survival benefit with extended lymphadenectomy: now what?
    Nat Rev Urol. 2019;16:3-4.
    Abstract     Related articles   

  166. KONG V, Kwan M, Chen S, Chung P, et al
    Quantification of interobserver variability in image registration using conebeam CT for partial bladder radiotherapy - A Comparison between Lipiodol and Bladder Wall Surface.
    Br J Radiol. 2018 Nov 1:20180413. doi: 10.1259/bjr.20180413.
    Abstract     Related articles   

  167. FROEHNER M, Koch R, Hubler M, Heberling U, et al
    Predicting 90-day and long-term mortality in octogenarians undergoing radical cystectomy.
    BMC Urol. 2018;18:91.
    Abstract     Related articles   

  168. ELKADY N, Sultan M, Elkhouly E
    Evaluation of topoisomerase II, ki-67, and P53 expression in non-muscle-invasive urothelial carcinoma and their clinical significance.
    Indian J Pathol Microbiol. 2018;61:526-531.
    Abstract     Related articles   

  169. ADIL K, Popovic M, Cury FL, Faria SL, et al
    Anisotropic Bladder Planning Target Volume in Bladder Radiation Therapy.
    Pract Radiat Oncol. 2019;9:24-28.
    Abstract     Related articles   

  170. REDMAN JM, Madan RA
    Spotlight on atezolizumab and its potential as an oncology agent.
    Expert Rev Anticancer Ther. 2018;18:719-722.
    Abstract     Related articles   

  171. FREIFELD Y, Krabbe LM, Clinton TN, Woldu SL, et al
    Therapeutic strategies for upper tract urothelial carcinoma.
    Expert Rev Anticancer Ther. 2018;18:765-774.
    Abstract     Related articles   

  172. LIU K, Sun E, Lei M, Li L, et al
    BCG-induced formation of neutrophil extracellular traps play an important role in bladder cancer treatment.
    Clin Immunol. 2019 Feb 13. pii: S1521-6616(18)30633.
    Abstract     Related articles   

  173. MONTALBO R, Lozano JJ, Izquierdo L, Ingelmo-Torres M, et al
    Ability of a urine gene expression classifier to reduce the number of follow-up cystoscopies in bladder cancer patients.
    Transl Res. 2019 Feb 7. pii: S1931-5244(19)30025.
    Abstract     Related articles   

  174. WITZKE KE, Grosserueschkamp F, Jutte H, Horn M, et al
    Integrated Fourier Transform Infrared Imaging and Proteomics for Identification of a Candidate Histochemical Biomarker in Bladder Cancer.
    Am J Pathol. 2019 Feb 9. pii: S0002-9440(18)30739.
    Abstract     Related articles   

  175. OEYEN E, Hoekx L, De Wachter S, Baldewijns M, et al
    Bladder Cancer Diagnosis and Follow-Up: The Current Status and Possible Role of Extracellular Vesicles.
    Int J Mol Sci. 2019;20.
    Abstract     Related articles   

  176. CHUNG J, Kulkarni GS, Morash R, Matthew A, et al
    Assessment of quality of life, information, and supportive care needs in patients with muscle and non-muscle invasive bladder cancer across the illness trajectory.
    Support Care Cancer. 2019 Feb 14. pii: 10.1007/s00520-019-4649.
    Abstract     Related articles   

  177. SIDDIQUI MR, Railkar R, Sanford T, Crooks DR, et al
    Targeting Epidermal Growth Factor Receptor (EGFR) and Human Epidermal Growth Factor Receptor 2 (HER2) Expressing Bladder Cancer Using Combination Photoimmunotherapy (PIT).
    Sci Rep. 2019;9:2084.
    Abstract     Related articles   

  178. CAO YP, Sun JY, Li MQ, Dong Y, et al
    Inhibition of G9a by a small molecule inhibitor, UNC0642, induces apoptosis of human bladder cancer cells.
    Acta Pharmacol Sin. 2019 Feb 14. pii: 10.1038/s41401-018-0205.
    Abstract     Related articles   

  179. KULKARNI GS, Black PC, Sridhar SS, Kapoor A, et al
    Canadian Urological Association guideline: Muscle-invasive bladder cancer.
    Can Urol Assoc J. 2019 Jan 31. pii: cuaj.5902. doi: 10.5489/cuaj.5902.
    Abstract     Related articles   

  180. LIN T, Jin H, Gong L, Yu R, et al
    Surveillance of non-muscle invasive bladder cancer using fluorescence in situ hybridization: Protocol for a systematic review and meta-analysis.
    Medicine (Baltimore). 2019;98:e14573.
    Abstract     Related articles   

  181. KISPERT S, Marentette J, McHowat J
    Cigarette smoking promotes bladder cancer via increased platelet-activating factor.
    Physiol Rep. 2019;7:e13981.
    Abstract     Related articles   

  182. WU S, Ou T, Xing N, Lu J, et al
    Whole-genome sequencing identifies ADGRG6 enhancer mutations and FRS2 duplications as angiogenesis-related drivers in bladder cancer.
    Nat Commun. 2019;10:720.
    Abstract     Related articles   

  183. DENG S, He SY, Zhao P, Zhang P, et al
    The role of oncostatin M receptor gene polymorphisms in bladder cancer.
    World J Surg Oncol. 2019;17:30.
    Abstract     Related articles   

  184. MAJ M, Kokocha A, Bajek A, Drewa T, et al
    The effects of adipose-derived stem cells on CD133-expressing bladder cancer cells.
    J Cell Biochem. 2019 Feb 11. doi: 10.1002/jcb.28436.
    Abstract     Related articles   

  185. DENG Y, Bi R, Guo H, Yang J, et al
    Andrographolide Enhances TRAIL-Induced Apoptosis via p53-Mediated Death Receptors Up-Regulation and Suppression of the NF-small ka, CyrillicB Pathway in Bladder Cancer Cells.
    Int J Biol Sci. 2019;15:688-700.
    Abstract     Related articles   

  186. SU Y, Yang W, Jiang N, Shi J, et al
    Hypoxia-elevated circELP3 contributes to bladder cancer progression and cisplatin resistance.
    Int J Biol Sci. 2019;15:441-452.
    Abstract     Related articles   

  187. XIE R, Chen X, Chen Z, Huang M, et al
    Polypyrimidine tract binding protein 1 promotes lymphatic metastasis and proliferation of bladder cancer via alternative splicing of MEIS2 and PKM.
    Cancer Lett. 2019 Feb 8. pii: S0304-3835(19)30071.
    Abstract     Related articles   

  188. KOSOVA IV, Loran OB, Sinyakova LA, Gundorova LV, et al
    [A prognostic value of level of antiviral antibodies in the development of recurrence of bladder cancer].
    Urologiia. 2018;:86-94.
    Abstract     Related articles   

  189. STONE L
    Treatment timing well tolerated in bladder cancer.
    Nat Rev Urol. 2019 Feb 11. pii: 10.1038/s41585-019-0162.
    Abstract     Related articles   

  190. ELIZALDE BENITO FX, Ucar Terren A, Monzon Alebesque F, Urra Palos M, et al
    Bladder cancer with Indian ink.
    Arch Esp Urol. 2019;72:89-90.
    Abstract     Related articles   

  191. GOMEZ RIVAS J, Eguibar Gonzalez A, Tortolero Blanco L, Aguilera Bazan A, et al
    [Usefulness of photodynamic diagnosis in high-grade Bladder Cancer and subsequent BCG failure. Bibliographic review.]
    Arch Esp Urol. 2019;72:2-8.
    Abstract     Related articles   

  192. EINSTEIN DJ, Sonpavde G
    Treatment Approaches for Cisplatin-Ineligible Patients with Invasive Bladder Cancer.
    Curr Treat Options Oncol. 2019;20:12.
    Abstract     Related articles   

  193. WITLOX WJA, van Osch FHM, Brinkman M, Jochems S, et al
    An inverse association between the Mediterranean diet and bladder cancer risk: a pooled analysis of 13 cohort studies.
    Eur J Nutr. 2019 Feb 8. pii: 10.1007/s00394-019-01907.
    Abstract     Related articles   

  194. IMAI Y, Noda S, Matsuyama C, Shimizu A, et al
    Sex steroid hormone receptors in bladder cancer: Usefulness in differential diagnosis and implications in histogenesis of bladder cancer.
    Urol Oncol. 2019 Feb 6. pii: S1078-1439(19)30024.
    Abstract     Related articles   

  195. KRAJEWSKI W, Zdrojowy R, Kolodziej A
    Purified protein derivative skin test-One swallow does not make a summer: Re: Purified protein derivative skin test reactions are associated with clinical outcomes of patients with nonmuscle invasive bladder cancer treated with induction Bacillus Calm
    Urol Oncol. 2019 Feb 5. pii: S1078-1439(19)30025.
    Abstract     Related articles   

  196. OZAWA M, Suenaga S, Ishii T, Suzuki H, et al
    Nihon Hinyokika Gakkai Zasshi. 2018;109:45-49.
    Abstract     Related articles   

  197. ITO A, Takata R, Matsuo T, Kimura T, et al
    Nihon Hinyokika Gakkai Zasshi. 2018;109:35-39.
    Abstract     Related articles   

  198. MITA K, Kobatake K, Ohara S, Kato M, et al
    Nihon Hinyokika Gakkai Zasshi. 2018;109:1-6.
    Abstract     Related articles   

  199. LEE YL, Lai CR, Yen MS
    Recurrent ovarian mixed germ cell tumor with unusual malignant transformation: a case report.
    J Ovarian Res. 2019;12:2.
    Abstract     Related articles   

  200. WANG B, Pan W, Yang M, Yang W, et al
    Programmed death ligand-1 is associated with tumor infiltrating lymphocytes and poorer survival in urothelial cell carcinoma of the bladder.
    Cancer Sci. 2019;110:489-498.
    Abstract     Related articles   

  201. PABO-CARRASCO S, Vallejo-Benitez A, Carmona-Pinelo E, Umbria-Jimenez S, et al
    [Nested variant Transitional Cell Carcinoma. Report of two cases and bibliographic review.]
    Arch Esp Urol. 2018;71:794-799.
    Abstract     Related articles   

  202. KONDO E, Maki S, Nii M, Yoshida K, et al
    Long-term survival of a patient with malignant transformation of extragonadal endometriosis treated solely with chemotherapy: A case report.
    J Obstet Gynaecol Res. 2018;44:2186-2189.
    Abstract     Related articles   

  203. CLEMENTS MB, Krupski TL, Culp SH
    Robotic-Assisted Surgery for Upper Tract Urothelial Carcinoma: A Comparative Survival Analysis.
    Ann Surg Oncol. 2018;25:2550-2562.
    Abstract     Related articles   

  204. CRISCUOLO D, Morra F, Giannella R, Visconti R, et al
    New combinatorial strategies to improve the PARP inhibitors efficacy in the urothelial bladder Cancer treatment.
    J Exp Clin Cancer Res. 2019;38:91.
    Abstract     Related articles   

  205. KUMAR S, Bhoriwal S, Muduly D, Kar M, et al
    Multimodality management of incidentally detected gall bladder cancer: long term results from a tertiary care cancer centre.
    J Gastrointest Oncol. 2019;10:128-133.
    Abstract     Related articles   

  206. KARATZAS A, Tzortzis V
    Lower urinary tract symptoms and bladder cancer in children: The hidden scenario.
    Urol Ann. 2019;11:102-104.
    Abstract     Related articles   

  207. KALLIFATIDIS G, Smith DK, Morera DS, Gao J, et al
    beta-Arrestins regulate stem cell-like phenotype and response to chemotherapy in bladder cancer.
    Mol Cancer Ther. 2019 Feb 20. pii: 1535-7163.MCT-18-1167.
    Abstract     Related articles   

  208. MORRA F, Merolla F, Criscuolo D, Insabato L, et al
    CCDC6 and USP7 expression levels suggest novel treatment options in high-grade urothelial bladder cancer.
    J Exp Clin Cancer Res. 2019;38:90.
    Abstract     Related articles   

  209. YU H, Wang S, Zhu H, Rao D, et al
    LncRNA MT1JP functions as a tumor suppressor via regulating miR-214-3p expression in bladder cancer.
    J Cell Physiol. 2019 Feb 20. doi: 10.1002/jcp.28274.
    Abstract     Related articles   

  210. RACIOPPI M, Di Gianfrancesco L, Ragonese M, Palermo G, et al
    Can Neutrophil-to-Lymphocyte ratio predict the response to BCG in high-risk non muscle invasive bladder cancer?
    Int Braz J Urol. 2018;45.
    Abstract     Related articles   

  211. XU X, You K, Wu B
    Zonula occludens-1 associated nucleic acid binding protein plays an invasion-promoting role in bladder cancer.
    Neoplasma. 2019 Feb 14. pii: 180725N530. doi: 10.4149/neo_2018_180725.
    Abstract     Related articles   

  212. SHADPOUR P, Zamani M, Aghaalikhani N, Rashtchizadeh N, et al
    Inflammatory cytokines in bladder cancer.
    J Cell Physiol. 2019 Feb 18. doi: 10.1002/jcp.28252.
    Abstract     Related articles   

  213. HU J, Zhou L, Song Z, Xiong M, et al
    The identification of new biomarkers for bladder cancer: A study based on TCGA and GEO datasets.
    J Cell Physiol. 2019 Feb 18. doi: 10.1002/jcp.28208.
    Abstract     Related articles   

  214. LI J, Wang AS, Wang S, Wang CY, et al
    LncSNHG14 promotes the development and progression of bladder cancer by targeting miRNA-150-5p.
    Eur Rev Med Pharmacol Sci. 2019;23:1022-1029.
    Abstract     Related articles   

  215. CAO HL, Liu ZJ, Huang PL, Yue YL, et al
    lncRNA-RMRP promotes proliferation, migration and invasion of bladder cancer via miR-206.
    Eur Rev Med Pharmacol Sci. 2019;23:1012-1021.
    Abstract     Related articles   

  216. KRAJEWSKI W, Rodriguez Faba O, Poletajew S, Palou J, et al
    New predictive nomograms for non-muscle-invasive bladder cancer: it is all about the details.
    World J Urol. 2019 Feb 18. pii: 10.1007/s00345-019-02680.
    Abstract     Related articles   

  217. TAN Y, Zhang T, Zhou L, Liu S, et al
    MiR-34b-3p Represses the Multidrug-Chemoresistance of Bladder Cancer Cells by Regulating the CCND2 and P2RY1 Genes.
    Med Sci Monit. 2019;25:1323-1335.
    Abstract     Related articles   

  218. CHERUKU RR, Cacaccio J, Durrani F, Tabaczynski WA, et al
    Epidermal Growth Factor Receptor Targeted Multifunctional Photosensitizers for Bladder Cancer Imaging and Photodynamic Therapy.
    J Med Chem. 2019 Feb 18. doi: 10.1021/acs.jmedchem.8b01927.
    Abstract     Related articles   

  219. LI S, Zhu Y, Liang Z, Wang X, et al
    Correction: Up-regulation of p16 by miR-877-3p inhibits proliferation of bladder cancer.
    Oncotarget. 2019;10:684.
    Abstract     Related articles   

  220. AMARA CS, Vantaku V, Lotan Y, Putluri N, et al
    Recent advances in the metabolomic study of bladder cancer.
    Expert Rev Proteomics. 2019 Feb 16. doi: 10.1080/14789450.2019.1583105.
    Abstract     Related articles   

  221. ZHANG G, Ma F, Li L, Li J, et al
    Palbociclib triggers apoptosis in bladder cancer cells by Cdk2-induced Rad9-mediated reorganization of the Bak.Bcl-xl complex.
    Biochem Pharmacol. 2019;163:133-141.
    Abstract     Related articles   

  222. SORIA F, Pisano F, Gontero P, Palou J, et al
    Predictors of oncological outcomes in T1G3 patients treated with BCG who undergo radical cystectomy.
    World J Urol. 2018;36:1775-1781.
    Abstract     Related articles   

  223. MARGULIS AV, Fortuny J, Kaye JA, Calingaert B, et al
    Value of Free-text Comments for Validating Cancer Cases Using Primary-care Data in the United Kingdom.
    Epidemiology. 2018;29:e41-e42.
    Abstract     Related articles   

  224. SONPAVDE G, Pond GR, Rosenberg JE, Choueiri TK, et al
    Nomogram to Assess the Survival Benefit of New Salvage Agents for Metastatic Urothelial Carcinoma in the Era of Immunotherapy.
    Clin Genitourin Cancer. 2018;16:e961-e967.
    Abstract     Related articles   

  225. HERMANN GG, Mogensen K, Rosthoj S
    Outpatient diode laser treatment of intermediate-risk non-invasive bladder tumors without sedation: efficacy, safety and economic analysis.
    Scand J Urol. 2018;52:194-198.
    Abstract     Related articles   

  226. MENG X, Press B, Renson A, Wysock JS, et al
    Discriminative Ability of Commonly Used Indexes to Predict Adverse Outcomes After Radical Cystectomy: Comparison of Demographic Data, American Society of Anesthesiologists, Modified Charlson Comorbidity Index, and Modified Frailty Index.
    Clin Genitourin Cancer. 2018;16:e843-e850.
    Abstract     Related articles   

  227. HENSLEY PJ, Goodwin J, Davenport DL, Strup SE, et al
    Optimization of Patient Selection for Neoadjuvant Chemotherapy in Muscle-invasive Urothelial Carcinoma of the Bladder.
    Clin Genitourin Cancer. 2018;16:e851-e858.
    Abstract     Related articles   

  228. BREYER J, Wirtz RM, Erben P, Worst TS, et al
    High CDKN2A/p16 and Low FGFR3 Expression Predict Progressive Potential of Stage pT1 Urothelial Bladder Carcinoma.
    Clin Genitourin Cancer. 2018;16:248-256.
    Abstract     Related articles   

  229. LORENTZ CA, Gilbert K, Alemozaffar M, Patil D, et al
    Risk of Readmission After Uncomplicated Hospitalization After Radical Cystectomy.
    Clin Genitourin Cancer. 2018;16:e705-e710.
    Abstract     Related articles   

  230. HEMDAN T, Turker P, Malmstrom PU, Segersten U, et al
    Choline-phosphate cytidylyltransferase-alpha as a possible predictor of survival and response to cisplatin neoadjuvant chemotherapy in urothelial cancer of the bladder.
    Scand J Urol. 2018;52:200-205.
    Abstract     Related articles   

  231. POWLES T, Necchi A, Rosen G, Hariharan S, et al
    Anti-Programmed Cell Death 1/Ligand 1 (PD-1/PD-L1) Antibodies for the Treatment of Urothelial Carcinoma: State of the Art and Future Development.
    Clin Genitourin Cancer. 2018;16:117-129.
    Abstract     Related articles   

  232. LIU ST, Hui G, Mathis C, Chamie K, et al
    The Current Status and Future Role of the Phosphoinositide 3 Kinase/AKT Signaling Pathway in Urothelial Cancer: An Old Pathway in the New Immunotherapy Era.
    Clin Genitourin Cancer. 2018;16:e269-e276.
    Abstract     Related articles   

  233. GUPTA S, Albertson D, Gaston D, Heilbrun ME, et al
    Comprehensive Genomic Sequencing of Urothelial Tumors Identifies Rare SMARCB1 (INI-1)-Deficient Carcinomas of the Urinary System.
    Clin Genitourin Cancer. 2018;16:e373-e382.
    Abstract     Related articles   

  234. MIRSADRAEI L, Hodkoff A, Jones K, Shabaik A, et al
    Serous Carcinoma Mimicking Primary Urothelial Carcinoma on Clinical Evaluation and Pathology: A Potential Diagnostic Pitfall.
    Arch Pathol Lab Med. 2018;142:168-177.
    Abstract     Related articles   

  235. PEDERSEN M, Stafoggia M, Weinmayr G, Andersen ZJ, et al
    Is There an Association Between Ambient Air Pollution and Bladder Cancer Incidence? Analysis of 15 European Cohorts.
    Eur Urol Focus. 2018;4:113-120.
    Abstract     Related articles   

  236. DO NASCIMENTO ALVES SIPM, Lavalhegas Hallack M, Moreira Perez M, da Costa Aguiar Alves B, et al
    Application of the Z-scan technique for the detection of CFCDNA (cell-free circulating DNA) and urine DNA (uDNA) in patients with bladder cancer.
    Photodiagnosis Photodyn Ther. 2019 Feb 26. pii: S1572-1000(18)30338.
    Abstract     Related articles   

  237. JIANG G, Huang C, Liao X, Li J, et al
    The RING domain in the anti-apoptotic protein XIAP stabilizes c-Myc protein and preserves anchorage-independent growth of bladder cancer cells.
    J Biol Chem. 2019 Feb 28. pii: RA118.005621. doi: 10.1074/jbc.RA118.005621.
    Abstract     Related articles   

  238. LIN JJ, Huang CC, Su YL, Luo HL, et al
    Proteomics Analysis of Tangeretin-Induced Apoptosis through Mitochondrial Dysfunction in Bladder Cancer Cells.
    Int J Mol Sci. 2019;20.
    Abstract     Related articles   

  239. WU T, Duan X, Hu C, Wu C, et al
    Synthesis and characterization of gold nanoparticles from Abies spectabilis extract and its anticancer activity on bladder cancer T24 cells.
    Artif Cells Nanomed Biotechnol. 2019;47:512-523.
    Abstract     Related articles   

  240. LAZARO M, Gallardo E, Domenech M, Pinto A, et al
    Correction to: SEOM Clinical Guideline for treatment of muscle-invasive and metastatic urothelial bladder cancer (2016).
    Clin Transl Oncol. 2019 Feb 26. pii: 10.1007/s12094-019-02061.
    Abstract     Related articles   

  241. MATULAY JT, Narayan VM, Kamat AM
    Clinical and Genomic Considerations for Variant Histology in Bladder Cancer.
    Curr Oncol Rep. 2019;21:23.
    Abstract     Related articles   

  242. CHOI JB, Kim JH, Hong SH, Han KD, et al
    Association of body mass index with bladder cancer risk in men depends on abdominal obesity.
    World J Urol. 2019 Feb 26. pii: 10.1007/s00345-019-02690.
    Abstract     Related articles   

  243. LIN JH, Chen SJ, Liu H, Yan Y, et al
    Vitamin E consumption and the risk of bladder cancer.
    Int J Vitam Nutr Res. 2019 Feb 26:1-8. doi: 10.1024/0300-9831/a000553.
    Abstract     Related articles   

  244. TURKER P, Segersten U, Malmstrom PU, Hemdan T, et al
    Is Bcl-2 a predictive marker of neoadjuvant chemotherapy response in patients with urothelial bladder cancer undergoing radical cystectomy?
    Scand J Urol. 2019 Feb 26:1-6. doi: 10.1080/21681805.2019.1575467.
    Abstract     Related articles   

  245. DATOVO JCF, Neto WA, Mendonca GB, Andrade DL, et al
    Prognostic impact of non-adherence to follow-up cystoscopy in non-muscle-invasive bladder cancer (NMIBC).
    World J Urol. 2019 Feb 25. pii: 10.1007/s00345-019-02697.
    Abstract     Related articles   

  246. BOERI L, Soligo M, Frank I, Boorjian SA, et al
    Clinical predictors and survival outcome of patients receiving suboptimal neoadjuvant chemotherapy and radical cystectomy for muscle-invasive bladder cancer: a single-center experience.
    World J Urol. 2019 Feb 25. pii: 10.1007/s00345-019-02689.
    Abstract     Related articles   

  247. GURUNG PMS, Barnett AR, Wilson JS, Hudson J, et al
    Prognostic DNA Methylation Biomarkers in High-risk Non-muscle-invasive Bladder Cancer: A Systematic Review to Identify Loci for Prospective Validation.
    Eur Urol Focus. 2019 Feb 22. pii: S2405-4569(19)30032.
    Abstract     Related articles   

  248. CHIANG CH, Chung JG, Hsu FT
    Regorefenib induces extrinsic/intrinsic apoptosis and inhibits MAPK/NF-kappaB-modulated tumor progression in bladder cancer in vitro and in vivo.
    Environ Toxicol. 2019 Feb 25. doi: 10.1002/tox.22734.
    Abstract     Related articles   

  249. MEHTALA J, Khanfir H, Bennett D, Ye Y, et al
    Pioglitazone use and risk of bladder cancer: a systematic literature review and meta-analysis of observational studies.
    Diabetol Int. 2018;10:24-36.
    Abstract     Related articles   

  250. POLETAJEW S, Fus L, Ilczuk T, Wojcieszak P, et al
    Expression of E-cadherin, beta-catenin, and epithelial membrane antigen does not predict survival in patients with high-risk non-muscle-invasive bladder cancer.
    Cent Eur J Immunol. 2018;43:421-427.
    Abstract     Related articles   

  251. BALAKRISHNAN AS, Washington SL 3rd, Meng MV, Porten SP, et al
    Determinants of Guideline-Based Treatment in Patients With cT1 Bladder Cancer.
    Clin Genitourin Cancer. 2019 Jan 19. pii: S1558-7673(19)30018.
    Abstract     Related articles   

  252. LI Y, Rapkin B, Atkinson TM, Schofield E, et al
    Leveraging Latent Dirichlet Allocation in processing free-text personal goals among patients undergoing bladder cancer surgery.
    Qual Life Res. 2019 Feb 23. pii: 10.1007/s11136-019-02132.
    Abstract     Related articles   

  253. SATHIANATHEN NJ, Fan Y, Jarosek SL, Konety I, et al
    Disparities in Bladder Cancer Treatment and Survival Amongst Elderly Patients with a Pre-existing Mental Illness.
    Eur Urol Focus. 2019 Feb 20. pii: S2405-4569(19)30027.
    Abstract     Related articles   

  254. SHIMIZU N, Hamaide A, Dourcy M, Noel S, et al
    Evaluation of urinary and serum level of chemokine (C-C motif) ligand 2 as a potential biomarker in canine urothelial tumours.
    Vet Comp Oncol. 2019;17:11-20.
    Abstract     Related articles   

  255. AHSAINI M, Ouattar K, Azelmad H, Mellas S, et al
    A rare pure embryonal rhabdomyosarcoma of the urinary bladder in an adult successfully managed with neoadjuvant chemotherapy and surgery: a case report.
    J Med Case Rep. 2018;12:329.
    Abstract     Related articles   

  256. TALAT Z, Onal B, Cetinel B, Demirdag C, et al
    The surgical technique and initial outcomes of Anatolian neobladder: a novel technique of ileal neobladder after radical cystectomy.
    BMC Urol. 2018;18:94.
    Abstract     Related articles   

  257. JIN L, Wang M, Yang F, Niu Y, et al
    Surgical techniques for facilitating laparoscopic intracorporeal orthotopic neobladder: initial experience.
    Int Braz J Urol. 2018;44:1156-1165.
    Abstract     Related articles   

  258. FOGAZZI GB, Delanghe J
    Microscopic examination of urine sediment: Phase contrast versus bright field.
    Clin Chim Acta. 2018;487:168-173.
    Abstract     Related articles   

  259. KALETSCH A, Pinkerneil M, Hoffmann MJ, Jaguva Vasudevan AA, et al
    Effects of novel HDAC inhibitors on urothelial carcinoma cells.
    Clin Epigenetics. 2018;10:100.
    Abstract     Related articles   

  260. FIELDER S, Breshears M
    What is your diagnosis? Bladder mass in a mare.
    Vet Clin Pathol. 2018;47:665-666.
    Abstract     Related articles   

  261. FERSINO S, Arcangeli S, Jereczek-Fossa BA, D'Angelillo R, et al
    GUROPA survey: genito-urinary radiation oncology prescription attitudes.
    Radiol Med. 2018;123:879-884.
    Abstract     Related articles   

  262. JOHANSSON S, Walters R, Mayer K, Shippey S, et al
    Vaginal Myomectomy to Resolve Bladder Outlet Obstruction 50 Years After Hysterectomy.
    Female Pelvic Med Reconstr Surg. 2018;24:e26-e28.
    Abstract     Related articles   

  263. HORI S, Mitsui Y, Suzuki K, Nakajima K, et al
    [Penile Metastasis from Invasive Bladder Carcinoma Diagnosed by Needle Biopsy : A Case Report and Literature Review].
    Hinyokika Kiyo. 2018;64:127-130.
    Abstract     Related articles   

  264. UCHIDA M, Kawai K, Kurobe M, Ikeda A, et al
    [Metastases of Urothelial Carcinoma with Trophoblastic Differentiation that Responded to Combination Chemotherapy with Gemcitabine and Oxaliplatin : A Case Report].
    Hinyokika Kiyo. 2018;64:55-61.
    Abstract     Related articles   

  265. BRETSCHNEIDER CE, Share SM, Paraiso MFR
    Nephrogenic Adenoma in the Setting of Refractory Labial Agglutination in an Elderly Woman.
    Female Pelvic Med Reconstr Surg. 2018;24:e6-e8.
    Abstract     Related articles   

  266. SANFORD T, Meng MV, Railkar R, Agarwal PK, et al
    Integrative analysis of the epigenetic basis of muscle-invasive urothelial carcinoma.
    Clin Epigenetics. 2018;10:19.
    Abstract     Related articles   

  267. BOTELHO F
    Editorial Comment on: Isolated Red Patches Seen During Endoscopic Surveillance of Bladder Cancer: Incidence of Malignancy and When Should We Biopsy? by Nkwam et al.
    J Endourol. 2018;32:328.
    Abstract     Related articles   

  268. HOLSCHER AS, Schulz WA, Pinkerneil M, Niegisch G, et al
    Combined inhibition of BET proteins and class I HDACs synergistically induces apoptosis in urothelial carcinoma cell lines.
    Clin Epigenetics. 2018;10:1.
    Abstract     Related articles   

  269. FERNANDEZ-ACENERO MJ, Perez Alonso P, Diaz Del Arco C
    Histiocytic sarcoma with bladder involvement: Case report and literature review.
    Rev Esp Patol. 2018;51:23-26.
    Abstract     Related articles   

  270. HUANG SY, Chien CC, Hseu RS, Huang VYJ, et al
    Ganoderma microsporum immunomodulatory protein induces apoptosis and potentiates mitomycin C-induced apoptosis in urinary bladder urothelial carcinoma cells.
    J Cell Biochem. 2018;119:4592-4606.
    Abstract     Related articles   

  271. SMITH AH, Marshall G, Roh T, Ferreccio C, et al
    Lung, Bladder, and Kidney Cancer Mortality 40 Years After Arsenic Exposure Reduction.
    J Natl Cancer Inst. 2018;110:241-249.
    Abstract     Related articles   

  272. AFSHARPAD M, Nowroozi MR, Mobasheri MB, Ayati M, et al
    Cancer-Testis Antigens as New Candidate Diagnostic Biomarkers for Transitional Cell Carcinoma of Bladder.
    Pathol Oncol Res. 2019;25:191-199.
    Abstract     Related articles   

  273. MOSCHINI M, Morlacco A, Briganti A, Hu B, et al
    Clinical Lymphadenopathy in Urothelial Cancer: A Transatlantic Collaboration on Performance of Cross-sectional Imaging and Oncologic Outcomes in Patients Treated with Radical Cystectomy Without Neoadjuvant Chemotherapy.
    Eur Urol Focus. 2018;4:245-251.
    Abstract     Related articles   

  274. VETTERLEIN MW, Seisen T, May M, Nuhn P, et al
    Effectiveness of Adjuvant Chemotherapy After Radical Cystectomy for Locally Advanced and/or Pelvic Lymph Node-Positive Muscle-invasive Urothelial Carcinoma of the Bladder: A Propensity Score-Weighted Competing Risks Analysis.
    Eur Urol Focus. 2018;4:252-259.
    Abstract     Related articles   

  275. JOSHI M, Millis SZ, Arguello D, Holder SL, et al
    Molecular Characterization of Bladder Cancer in Smokers versus Nonsmokers.
    Eur Urol Focus. 2018;4:94-97.
    Abstract     Related articles   

  276. COLOMBO R, Hurle R, Moschini M, Freschi M, et al
    Feasibility and Clinical Roles of Different Substaging Systems at First and Second Transurethral Resection in Patients with T1 High-Grade Bladder Cancer.
    Eur Urol Focus. 2018;4:87-93.
    Abstract     Related articles   

  277. OKUBO K, Isono M, Asano T, Sato A, et al
    Metformin Augments Panobinostat's Anti-Bladder Cancer Activity by Activating AMP-Activated Protein Kinase.
    Transl Oncol. 2019;12:669-682.
    Abstract     Related articles   

  278. SONG Y, Yang Y, Liu L, Liu X, et al
    Association between five polymorphisms in vascular endothelial growth factor gene and urinary bladder cancer risk: A systematic review and meta-analysis involving 6671 subjects.
    Gene. 2019 Mar 5. pii: S0378-1119(19)30211-2. doi: 10.1016/j.gene.2019.
    Abstract     Related articles   

  279. ZHANG W, Shi L, Zhao Z, Du P, et al
    Disruption of CTLA-4 expression on peripheral blood CD8 + T cell enhances anti-tumor efficacy in bladder cancer.
    Cancer Chemother Pharmacol. 2019 Mar 8. pii: 10.1007/s00280-019-03800.
    Abstract     Related articles   

  280. HOU T, Zhou L, Wang L, Kazobinka G, et al
    Correction: CLCA4 inhibits bladder cancer cell proliferation, migration, and invasion by suppressing the PI3K/AKT pathway.
    Oncotarget. 2019;10:1010.
    Abstract     Related articles   

  281. FAN J, Wu K, Zhang P, He D, et al
    Green-laser assisted laparoscopic partial cystectomy for selective muscle-invasive bladder cancer: technique and initial outcome.
    World J Urol. 2019 Mar 6. pii: 10.1007/s00345-019-02712.
    Abstract     Related articles   

  282. KONALA VM, Adapa S, Aronow WS
    Immunotherapy in Bladder Cancer.
    Am J Ther. 2019 Feb 28. doi: 10.1097/MJT.0000000000000934.
    Abstract     Related articles   

  283. GOK B, Atmaca AF, Canda AE, Asil E, et al
    Robotic radical cystectomy with intracorporeal Studer pouch formation for bladder cancer: Experience in 98 cases.
    J Endourol. 2019 Mar 6. doi: 10.1089/end.2019.0036.
    Abstract     Related articles   

  284. KIM DK, Lee JY, Jung JH, Hah YS, et al
    Role of adjuvant cisplatin-based chemotherapy following radical cystectomy in locally advanced muscle-invasive bladder cancer: Systematic review and meta-analysis of randomized trials.
    Investig Clin Urol. 2019;60:64-74.
    Abstract     Related articles   

  285. GILD P, Nguyen DD, Fletcher SA, Cole AP, et al
    Contemporary Survival Rates for Muscle-Invasive Bladder Cancer Treated With Definitive or Non-Definitive Therapy.
    Clin Genitourin Cancer. 2019 Jan 29. pii: S1558-7673(19)30036.
    Abstract     Related articles   

  286. TEMRAZ S, Haibe Y, Charafeddine M, Saifi O, et al
    The unveiling of a new risk factor associated with bladder cancer in Lebanon.
    BMC Urol. 2019;19:16.
    Abstract     Related articles   

  287. HUMAYUN-ZAKARIA N, Arnold R, Goel A, Ward D, et al
    Tropomyosins: Potential Biomarkers for Urothelial Bladder Cancer.
    Int J Mol Sci. 2019;20.
    Abstract     Related articles   

  288. BABJUK M
    En-bloc resection of non-muscle invasive bladder cancer: what must be answered in the future?
    World J Urol. 2019 Mar 5. pii: 10.1007/s00345-019-02710.
    Abstract     Related articles   

  289. RODRIGUES D, Pinto J, Araujo AM, Monteiro-Reis S, et al
    Volatile metabolomic signature of bladder cancer cell lines based on gas chromatography-mass spectrometry.
    Metabolomics. 2018;14:62.
    Abstract     Related articles   

  290. LIANG H, Yang T, Wu K, He D, et al
    En bloc resection improves the identification of muscularis mucosae in non-muscle invasive bladder cancer.
    World J Urol. 2019 Mar 4. pii: 10.1007/s00345-019-02672.
    Abstract     Related articles   

  291. SAWICKA E, Kratz EM, Szymanska B, Guzik A, et al
    Preliminary Study on Selected Markers of Oxidative Stress, Inflammation and Angiogenesis in Patients with Bladder Cancer.
    Pathol Oncol Res. 2019 Mar 4. pii: 10.1007/s12253-019-00620.
    Abstract     Related articles   

  292. WANG J, Zhang J, Li T, Shen R, et al
    Strand displacement amplification-coupled dynamic light scattering method to detect urinary telomerase for non-invasive detection of bladder cancer.
    Biosens Bioelectron. 2019;131:143-148.
    Abstract     Related articles   

  293. HUANG C, Liao X, Jin H, Xie F, et al
    MEG3, as a Competing Endogenous RNA, Binds with miR-27a to Promote PHLPP2 Protein Translation and Impairs Bladder Cancer Invasion.
    Mol Ther Nucleic Acids. 2019;16:51-62.
    Abstract     Related articles   

  294. LINDNER AK, Klatte T, Comperat E, Heidegger I, et al
    Therapeutic rationale of targeting BCG and immune checkpoints in non-muscle-invasive bladder cancer: Is this the Future?
    Urol Oncol. 2019 Feb 27. pii: S1078-1439(19)30054.
    Abstract     Related articles   

  295. GIRARD A, Rouanne M
    Comment on: Relationship between the expression of PD-1/PD-L1 and (18)F-FDG uptake in bladder cancer.
    Eur J Nucl Med Mol Imaging. 2019 Mar 1. pii: 10.1007/s00259-019-04296.
    Abstract     Related articles   

  296. BERNDT-PAETZ M, Schulze P, Stenglein PC, Weimann A, et al
    Reduction of muscle-invasive tumors by photodynamic therapy with Tetrahydroporphyrin-Tetratosylat in an orthotopic rat bladder cancer model.
    Mol Cancer Ther. 2019 Mar 1. pii: 1535-7163.MCT-18-1194.
    Abstract     Related articles   

  297. GAO R, Zhang N, Yang J, Zhu Y, et al
    Long non-coding RNA ZEB1-AS1 regulates miR-200b/FSCN1 signaling and enhances migration and invasion induced by TGF-beta1 in bladder cancer cells.
    J Exp Clin Cancer Res. 2019;38:111.
    Abstract     Related articles   

  298. MA Y, Mao G, Zhong Y, Wu G, et al
    Highly sensitive ratiometric fluorescent paper sensor for the urine assay of cancer.
    Talanta. 2019;194:199-204.
    Abstract     Related articles   

  299. MITRA AP, Fairey AS, Skinner EC, Boorjian SA, et al
    Implications of micropapillary urothelial carcinoma variant on prognosis following radical cystectomy: A multi-institutional investigation.
    Urol Oncol. 2019;37:48-56.
    Abstract     Related articles   

  300. SASAHARA T, Sasaki H, Yoshiyama Y, Kimura S, et al
    [A Case of Urachal Carcinoma Treated with Laparoscopic Resection of Urachal Remnants with Partial Cystectomy that was Difficult to Diagnose Preoperatively by Transurethral Biopsy].
    Hinyokika Kiyo. 2018;64:345-348.
    Abstract     Related articles   

  301. BARNES JL, Zubair M, John K, Poirier MC, et al
    Carcinogens and DNA damage.
    Biochem Soc Trans. 2018;46:1213-1224.
    Abstract     Related articles   

  302. PAI A, Mackie S, Watson G
    Novel use of air in laser ablation of bladder transitional cell carcinoma.
    Ann R Coll Surg Engl. 2019;101:227.
    Abstract     Related articles   

  303. DENIZE J, Bugel H, Bou Nasr E, Delcourt C, et al

    Gynecol Obstet Fertil Senol. 2018;46.
    Abstract     Related articles   

  304. QIN ZJ, Bi H, Ma LL, Huang Y, et al
    [A primary intestinal-derived adenocarcinoma in intestine bladder substitutes: a case report].
    Beijing Da Xue Xue Bao Yi Xue Ban. 2018;50:737-739.
    Abstract     Related articles   

  305. TANG XG, Yan Y, Qiu M, Lu J, et al
    [Retrospective study of young bladder urothelial carcinoma from a single center within 16 years].
    Beijing Da Xue Xue Bao Yi Xue Ban. 2018;50:630-633.
    Abstract     Related articles   

  306. AKHTAR S, Al-Shammari A, Al-Abkal J
    Chronic urinary tract infection and bladder carcinoma risk: a meta-analysis of case-control and cohort studies.
    World J Urol. 2018 Feb 5. pii: 10.1007/s00345-018-2206.
    Abstract     Related articles   

  307. KIM BS, Tae BS, Ku JH, Kwak C, et al
    Rate and association of lower urinary tract infection with recurrence after transurethral resection of bladder tumor.
    Investig Clin Urol. 2018;59:10-17.
    Abstract     Related articles   

  308. CENCINI E, Fabbri A, Schiattone L, Gentili F, et al
    Durable response after VNCOP-B and rituximab in an elderly patient with high-grade B-cell lymphoma.
    Acta Clin Belg. 2018;73:408-412.
    Abstract     Related articles   

  309. INOUE S, Mizushima T, Miyamoto H
    Role of the androgen receptor in urothelial cancer.
    Mol Cell Endocrinol. 2018;465:73-81.
    Abstract     Related articles   

  310. GIANNOPOULOU AF, Velentzas AD, Konstantakou EG, Avgeris M, et al
    Revisiting Histone Deacetylases in Human Tumorigenesis: The Paradigm of Urothelial Bladder Cancer.
    Int J Mol Sci. 2019;20.
    Abstract     Related articles   

  311. STEELE TM, Talbott GC, Sam A, Tepper CG, et al
    Obatoclax, a BH3 Mimetic, Enhances Cisplatin-Induced Apoptosis and Decreases the Clonogenicity of Muscle Invasive Bladder Cancer Cells via Mechanisms That Involve the Inhibition of Pro-Survival Molecules as Well as Cell Cycle Regulators.
    Int J Mol Sci. 2019;20.
    Abstract     Related articles   

  312. LUNDBERG E, Hagberg O, Jahnson S, Ljungberg B, et al
    Association between occurrence of urinary bladder cancer and treatment with statin medication.
    Turk J Urol. 2019;45:97-102.
    Abstract     Related articles   

  313. HAIDER M, Ladurner C, Mayr R, Tandogdu Z, et al
    Use and duration of antibiotic prophylaxis and the rate of urinary tract infection after radical cystectomy for bladder cancer: Results of a multicentric series.
    Urol Oncol. 2019 Mar 12. pii: S1078-1439(19)30018.
    Abstract     Related articles   

  314. ZHU J, Li Y, Luo Y, Xu J, et al
    A Feedback Loop Formed by ATG7/Autophagy, FOXO3a/miR-145 and PD-L1 Regulates Stem-Like Properties and Invasion in Human Bladder Cancer.
    Cancers (Basel). 2019;11.
    Abstract     Related articles   

  315. POLETAJEW S, Krajewski W, Adamowicz J, Radziszewski P, et al
    A systematic review of preventive and therapeutic options for symptoms of cystitis in patients with bladder cancer receiving intravesical bacillus Calmette-Guerin immunotherapy.
    Anticancer Drugs. 2019 Mar 11. doi: 10.1097/CAD.0000000000000775.
    Abstract     Related articles   

  316. BAI ZJ, Liu Q, Wang XS, Liu WY, et al
    APC promoter methylation is correlated with development and progression of bladder cancer, but not linked to overall survival: a meta-analysis.
    Neoplasma. 2019 Mar 7. pii: 181009N753. doi: 10.4149/neo_2018_181009.
    Abstract     Related articles   

  317. CHEN J, Cao L, Li Z, Li Y, et al
    SIRT1 promotes GLUT1 expression and bladder cancer progression via regulation of glucose uptake.
    Hum Cell. 2019 Mar 13. pii: 10.1007/s13577-019-00237.
    Abstract     Related articles   

  318. CADIOU S, Al Tabaa O, Nguyen CD, Faccin M, et al
    Back pain following instillations of BCG for superficial bladder cancer is not a reactive complication: review of 30 Mycobacterium bovis BCG vertebral osteomyelitis cases.
    Clin Rheumatol. 2019 Mar 13. pii: 10.1007/s10067-019-04500.
    Abstract     Related articles   

  319. PHILLIPS RM, Loadman PM, Reddy G
    Inactivation of apaziquone by haematuria: implications for the design of phase III clinical trials against non-muscle invasive bladder cancer.
    Cancer Chemother Pharmacol. 2019 Mar 13. pii: 10.1007/s00280-019-03812.
    Abstract     Related articles   

  320. WEN W, Gong J, Wu P, Zhao M, et al
    Mutations in gliclazide-associated genes may predict poor bladder cancer prognosis.
    FEBS Open Bio. 2019;9:457-467.
    Abstract     Related articles   

  321. LIN G, Sheng H, Xie H, Zheng Q, et al
    circLPAR1 is a novel biomarker of prognosis for muscle-invasive bladder cancer with invasion and metastasis by miR-762.
    Oncol Lett. 2019;17:3537-3547.
    Abstract     Related articles   

  322. ALBERTO M, Cuello HA, Gulino CA, Pifano M, et al
    Expression of bladder cancer-associated glycans in murine tumor cell lines.
    Oncol Lett. 2019;17:3141-3150.
    Abstract     Related articles   

  323. WANG Z, Zhou Q, Li A, Huang W, et al
    Extracellular matrix protein 1 (ECM1) is associated with carcinogenesis potential of human bladder cancer.
    Onco Targets Ther. 2019;12:1423-1432.
    Abstract     Related articles   

  324. YANG Y, Wang F, Huang H, Zhang Y, et al
    lncRNA SLCO4A1-AS1 promotes growth and invasion of bladder cancer through sponging miR-335-5p to upregulate OCT4.
    Onco Targets Ther. 2019;12:1351-1358.
    Abstract     Related articles   

  325. SUO N, Wang M, Jin Y, Ding J, et al
    Magnetic multiwalled carbon nanotubes with controlled release of epirubicin: an intravesical instillation system for bladder cancer.
    Int J Nanomedicine. 2019;14:1241-1254.
    Abstract     Related articles   

  326. KLAASSEN Z, Lokeshwar SD, Lowery-Allison A, Wallis CJD, et al
    Mental Illness and Bladder Cancer Patients: The Time for Assertive Intervention Is Now.
    Eur Urol Focus. 2019 Mar 9. pii: S2405-4569(19)30075.
    Abstract     Related articles   

  327. LIM CS, Tirumani S, van der Pol CB, Alessandrino F, et al
    Use of Quantitative T2-Weighted and Apparent Diffusion Coefficient Texture Features of Bladder Cancer and Extravesical Fat for Local Tumor Staging After Transurethral Resection.
    AJR Am J Roentgenol. 2019 Mar 12:1-10. doi: 10.2214/AJR.18.20718.
    Abstract     Related articles   

  328. JOSHUA JM, Vijayan M, Pooleri GK
    A retrospective analysis of patients treated with intravesical BCG for high-risk nonmuscle invasive bladder cancer.
    Ther Adv Urol. 2019;11:1756287219833056.
    Abstract     Related articles   

  329. WANG F, Wu D, Xu Z, Chen J, et al
    miR-182-5p affects human bladder cancer cell proliferation, migration and invasion through regulating Cofilin 1.
    Cancer Cell Int. 2019;19:42.
    Abstract     Related articles   

  330. OUYANG XL, Yang L, Huang L, Pan YM, et al
    Antitumor activity on human bladder cancer T-24 cells and composition analysis of the core of Camellia osmantha fruit.
    Nat Prod Res. 2019 Mar 11:1-5. doi: 10.1080/14786419.2018.1550763.
    Abstract     Related articles   

  331. WU E, Hadjiiski LM, Samala RK, Chan HP, et al
    Deep Learning Approach for Assessment of Bladder Cancer Treatment Response.
    Tomography. 2019;5:201-208.
    Abstract     Related articles   

  332. CHAND D, Dhawan D, Sankin A, Ren X, et al
    Immune Checkpoint B7x (B7-H4/B7S1/VTCN1) is Over Expressed in Spontaneous Canine Bladder Cancer: The First Report and its Implications in a Preclinical Model.
    Bladder Cancer. 2019;5:63-71.
    Abstract     Related articles   

  333. LIU NW, Murray KS, Donat SM, Herr HW, et al
    The Outcome of Post-Chemotherapy Retroperitoneal Lymph Node Dissection in Patients with Metastatic Bladder Cancer in the Retroperitoneum.
    Bladder Cancer. 2019;5:13-19.
    Abstract     Related articles   

  334. AQUILA L, Ohm J, Woloszynska-Read A
    Corrigendum to "The role of STAG2 in bladder cancer" [Pharmacol. Res. 131 (2018) 143-149].
    Pharmacol Res. 2019 Mar 7. pii: S1043-6618(19)30336.
    Abstract     Related articles   

  335. BOORMANS JL, Zwarthoff EC, Black PC, Goebell PJ, et al
    New horizons in bladder cancer research.
    Urol Oncol. 2019 Mar 7. pii: S1078-1439(18)30508.
    Abstract     Related articles   

  336. MARKS P, Gild P, Soave A, Janisch F, et al
    The impact of variant histological differentiation on extranodal extension and survival in node positive bladder cancer treated with radical cystectomy.
    Surg Oncol. 2019;28:208-213.
    Abstract     Related articles   

  337. LI R, Zhang L, Qin Z, Wei Y, et al
    High LINC00536 expression promotes tumor progression and poor prognosis in bladder cancer.
    Exp Cell Res. 2019 Mar 6. pii: S0014-4827(19)30103.
    Abstract     Related articles   

  338. BRANT A, Daniels M, Chappidi MR, Joice GA, et al
    Prognostic implications of prostatic urethral involvement in non-muscle-invasive bladder cancer.
    World J Urol. 2019 Mar 8. pii: 10.1007/s00345-019-02673.
    Abstract     Related articles   

  339. MOSCHINI M, Martini A, Zamboni S, Mattei A, et al
    Evaluation of Cause of Death After Radical Cystectomy for Patients With Bladder Cancer: The Impact of Age at the Time of Surgery.
    Clin Genitourin Cancer. 2019 Feb 13. pii: S1558-7673(19)30045.
    Abstract     Related articles   

  340. SILVERDALE N, Wherry M, Roodhouse A
    Massage and reflexology for post-operative cancer cystectomy patients: Evaluation of a pilot service.
    Complement Ther Clin Pract. 2019;34:109-112.
    Abstract     Related articles   

  341. KIM SC, Park S, Song SH, Kim KS, et al
    Clinicopathological Characteristics of Urinary Bladder Tumors in Korean Patients 20 Years or Younger.
    J Korean Med Sci. 2018;33:e242.
    Abstract     Related articles   

  342. LI P, Ning J, Luo X, Du H, et al
    New method to preserve the original proportion and integrity of urinary cell-free DNA.
    J Clin Lab Anal. 2019;33:e22668.
    Abstract     Related articles   

  343. GE Y, Zhu J, Wang X, Zheng N, et al
    Mapping dynamic histone modification patterns during arsenic-induced malignant transformation of human bladder cells.
    Toxicol Appl Pharmacol. 2018;355:164-173.
    Abstract     Related articles   

  344. SILLS WS, Howerth EW
    Pathology in Practice.
    J Am Vet Med Assoc. 2018;252:1063-1066.
    Abstract     Related articles   

  345. LOERTZER P, Siemer S, Stockle M, Ohlmann CH, et al
    Robot-sewn ileoileal anastomosis during robot-assisted cystectomy.
    World J Urol. 2018;36:1079-1084.
    Abstract     Related articles   

  346. HA YS, Kim SW, Kwon TG, Chung SK, et al
    Decrease in skeletal muscle index 1 year after radical cystectomy as a prognostic indicator in patients with urothelial bladder cancer.
    Int Braz J Urol. 2019;45.
    Abstract     Related articles   

  347. LIAN F, Chen W, Liu Y, Shen L, et al
    Intra-arterial chemotherapy combined with intravesical chemotherapy is effective in preventing recurrence in non-muscle invasive bladder cancer.
    J Cancer Res Clin Oncol. 2019 Mar 21. pii: 10.1007/s00432-019-02900.
    Abstract     Related articles   

  348. FU S, Luan T, Jiang C, Huang Y, et al
    miR-3622a promotes proliferation and invasion of bladder cancer cells by downregulating LASS2.
    Gene. 2019 Mar 18. pii: S0378-1119(19)30247-1. doi: 10.1016/j.gene.2019.
    Abstract     Related articles   

  349. CHEN J, Song B, Kong G
    MicroRNA663b downregulation inhibits proliferation and induces apoptosis in bladder cancer cells by targeting TUSC2.
    Mol Med Rep. 2019 Mar 14. doi: 10.3892/mmr.2019.10023.
    Abstract     Related articles   

  350. BABJUK M
    En-bloc resection of non-muscle invasive bladder cancer: what must be answered in the future?
    World J Urol. 2019 Mar 20. pii: 10.1007/s00345-019-02715.
    Abstract     Related articles   

  351. GUPTA M, Kates M, Bivalacqua TJ
    Immunotherapy in nonmuscle invasive bladder cancer: current and emerging treatments.
    Curr Opin Oncol. 2019 Mar 15. doi: 10.1097/CCO.0000000000000533.
    Abstract     Related articles   

  352. AL KHADER AM, Abu Shahin NI, Obeidat FN, Al-Chalabi MA, et al
    Urinary bladder cancer in Jordanian adults: A histopathological and epidemiological study from a tertiary care center in Amman.
    J Pak Med Assoc. 2019;69:415-417.
    Abstract     Related articles   

  353. YAJIMA S, Yoshida S, Takahara T, Arita Y, et al
    Usefulness of the inchworm sign on DWI for predicting pT1 bladder cancer progression.
    Eur Radiol. 2019 Mar 19. pii: 10.1007/s00330-019-06119.
    Abstract     Related articles   

  354. HAN Y, Zheng Q, Tian Y, Ji Z, et al
    Identification of a nine-gene panel as a prognostic indicator for recurrence with muscle-invasive bladder cancer.
    J Surg Oncol. 2019 Mar 18. doi: 10.1002/jso.25446.
    Abstract     Related articles   

  355. WALKER AK, Karaszi K, Valentine H, Strauss VY, et al
    MRE11 as a predictive biomarker of outcome following radiotherapy in bladder cancer.
    Int J Radiat Oncol Biol Phys. 2019 Mar 15. pii: S0360-3016(19)30371.
    Abstract     Related articles   

  356. SHAKIBAIE M, Vaezjalali M, Rafii-Tabar H, Sasanpour P, et al
    Synergistic effect of phototherapy and chemotherapy on bladder cancer cells.
    J Photochem Photobiol B. 2019;193:148-154.
    Abstract     Related articles   

  357. AMIR H, Khan MA, Feroz S, Bibi N, et al
    CARLo-7-A plausible biomarker for bladder cancer.
    Int J Exp Pathol. 2019 Mar 18. doi: 10.1111/iep.12305.
    Abstract     Related articles   

  358. HUANG D, Jin YH, Weng H, Huang Q, et al
    Combination of Intravesical Bacille Calmette-Guerin and Chemotherapy vs. Bacille Calmette-Guerin Alone in Non-muscle Invasive Bladder Cancer: A Meta-Analysis.
    Front Oncol. 2019;9:121.
    Abstract     Related articles   

  359. MA J, Sun G, Zhu P, Liu S, et al
    Determination of the complexity and diversity of the TCR beta-chain CDR3 repertoire in bladder cancer using high-throughput sequencing.
    Oncol Lett. 2019;17:3808-3816.
    Abstract     Related articles   

  360. ZHAO H, Bo Q, Wu Z, Liu Q, et al
    KIF15 promotes bladder cancer proliferation via the MEK-ERK signaling pathway.
    Cancer Manag Res. 2019;11:1857-1868.
    Abstract     Related articles   

  361. FAN Z, Liang Y, Yang X, Li B, et al
    A meta-analysis of the efficacy and safety of PD-1/PD-L1 immune checkpoint inhibitors as treatments for metastatic bladder cancer.
    Onco Targets Ther. 2019;12:1791-1801.
    Abstract     Related articles   

  362. LEKKA M, Pabijan J, Orzechowska B
    Morphological and mechanical stability of bladder cancer cells in response to substrate rigidity.
    Biochim Biophys Acta Gen Subj. 2019 Mar 13. pii: S0304-4165(19)30060.
    Abstract     Related articles   

  363. LARCHER A, Gandaglia G, Wiklund P, Mottrie A, et al
    Robot-assisted versus open cystectomy in the RAZOR trial.
    Lancet. 2019;393:645.
    Abstract     Related articles   

  364. PAREKH DJ, Venkatramani V
    Robot-assisted versus open cystectomy in the RAZOR trial - Authors' reply.
    Lancet. 2019;393:645-646.
    Abstract     Related articles   

  365. KHETRAPAL P, Catto JWF, Kelly JD
    Robot-assisted versus open cystectomy in the RAZOR trial.
    Lancet. 2019;393:644-645.
    Abstract     Related articles   

  366. DAL MORO F
    Tomorrow (and surgery) never dies.
    Lancet. 2019;393:642-644.
    Abstract     Related articles   

  367. ROCHEL N, Krucker C, Coutos-Thevenot L, Osz J, et al
    Recurrent activating mutations of PPARgamma associated with luminal bladder tumors.
    Nat Commun. 2019;10:253.
    Abstract     Related articles   

  368. ERBEN P, Sikic D, Wirtz RM, Martini T, et al
    Analysis of the prognostic relevance of sex-steroid hormonal receptor mRNA expression in muscle-invasive urothelial carcinoma of the urinary bladder.
    Virchows Arch. 2019;474:209-217.
    Abstract     Related articles   

  369. ALTUN E
    MR Imaging of the Urinary Bladder: Added Value of PET-MR Imaging.
    Magn Reson Imaging Clin N Am. 2019;27:105-115.
    Abstract     Related articles   

  370. CHEN YT, Yang CC, Shao PL, Huang CR, et al
    Melatonin-mediated downregulation of ZNF746 suppresses bladder tumorigenesis mainly through inhibiting the AKT-MMP-9 signaling pathway.
    J Pineal Res. 2019;66:e12536.
    Abstract     Related articles   

  371. HAN YS, Kim SM, Lee JH, Jung SK, et al
    Melatonin protects chronic kidney disease mesenchymal stem cells against senescence via PrP(C) -dependent enhancement of the mitochondrial function.
    J Pineal Res. 2019;66:e12535.
    Abstract     Related articles   

  372. AGGARWAL A, Agarwal S, Pandey S, Sankhwar S, et al
    Urachal adenocarcinoma.
    BMJ Case Rep. 2018;2018.
    Abstract     Related articles   

  373. HODGSON A, Liu SK, Vesprini D, Xu B, et al
    Basal-subtype bladder tumours show a 'hot' immunophenotype.
    Histopathology. 2018;73:748-757.
    Abstract     Related articles   

  374. ANDRES-LENCINA JJ, Burillo-Martinez S, Aragon-Miguel R, Calleja-Algarra A, et al
    Eosinophilic fasciitis and lichen sclerosus in a patient treated with nivolumab.
    Australas J Dermatol. 2018;59:e302-e304.
    Abstract     Related articles   

  375. BRIMO F, Downes MR, Jamaspishvili T, Berman D, et al
    Prognostic pathological factors in radical cystectomy after neoadjuvant chemotherapy.
    Histopathology. 2018;73:732-740.
    Abstract     Related articles   

  376. DELLABELLA M, Branchi A, Gasparri L, Claudini R, et al
    Oncological safety and quality of life in men undergoing simultaneous transurethral resection of bladder tumor and prostate: results from a randomized controlled trial.
    World J Urol. 2018;36:1629-1634.
    Abstract     Related articles   

  377. TAYLOR JM, McTyre ER, Tatter SB, Laxton AW, et al
    Gamma Knife Stereotactic Radiosurgery for the Treatment of Brain Metastases from Primary Tumors of the Urinary Bladder.
    Stereotact Funct Neurosurg. 2018;96:108-112.
    Abstract     Related articles   

  378. YU G, Zhou H, Yao W, Meng L, et al
    lncRNA TUG1 Promotes Cisplatin Resistance by Regulating CCND2 via Epigenetically Silencing miR-194-5p in Bladder Cancer.
    Mol Ther Nucleic Acids. 2019;16:257-271.
    Abstract     Related articles   

  379. HASSANIEN OA, Abouelkheir RT, Abou El-Ghar MI, Badawy ME, et al
    Dynamic Contrast-Enhanced Magnetic Resonance Imaging as a Diagnostic Tool in the Assessment of Tumour Angiogenesis in Urinary Bladder Cancer.
    Can Assoc Radiol J. 2019 Mar 25. pii: S0846-5371(18)30206.
    Abstract     Related articles   

  380. AMIN RW, Stafford B, Guttmann RP
    A spatial study of bladder cancer mortality and incidence in the contiguous US: 2000-2014.
    Sci Total Environ. 2019;670:806-813.
    Abstract     Related articles   

  381. HERNANDEZ P, Alem D, Nieves M, Cerecetto H, et al
    Chemosensitizer effect of cisplatin-treated bladder cancer cells by phenazine-5,10-dioxides.
    Environ Toxicol Pharmacol. 2019;69:9-15.
    Abstract     Related articles   

  382. WISSING MD, Santos F, Zakaria AS, O'Flaherty A, et al
    Short- and long-term survival has improved after radical cystectomy for bladder cancer in Quebec during the years 2000-2015.
    J Surg Oncol. 2019 Mar 28. doi: 10.1002/jso.25456.
    Abstract     Related articles   

  383. ZHANG L, Wu B, Zha Z, Zhao H, et al
    Concomitant carcinoma in situ may not be a prognostic factor for patients with bladder cancer following radical cystectomy: a PRISMA-compliant systematic review and meta-analysis.
    World J Urol. 2019 Mar 27. pii: 10.1007/s00345-019-02738.
    Abstract     Related articles   

  384. LUO H, Xu C, Le W, Ge B, et al
    lncRNA CASC11 promotes cancer cell proliferation in bladder cancer through miRNA-150.
    J Cell Biochem. 2019 Mar 27. doi: 10.1002/jcb.28622.
    Abstract     Related articles   

  385. ZHANG L, Yan R, Zhang SN, Zhang HZ, et al
    MicroRNA-338-3p inhibits the progression of bladder cancer through regulating ETS1 expression.
    Eur Rev Med Pharmacol Sci. 2019;23:1986-1995.
    Abstract     Related articles   

  386. BRIEU N, Gavriel CG, Nearchou IP, Harrison DJ, et al
    Automated tumour budding quantification by machine learning augments TNM staging in muscle-invasive bladder cancer prognosis.
    Sci Rep. 2019;9:5174.
    Abstract     Related articles   

  387. LI A, Zhu X, Wang C, Yang S, et al
    Upregulation of NDRG1 predicts poor outcome and facilitates disease progression by influencing the EMT process in bladder cancer.
    Sci Rep. 2019;9:5166.
    Abstract     Related articles   

  388. CHENG S, Qian K, Wang Y, Wang G, et al
    PPARgamma inhibition regulates the cell cycle, proliferation and motility of bladder cancer cells.
    J Cell Mol Med. 2019 Mar 25. doi: 10.1111/jcmm.14280.
    Abstract     Related articles   

  389. ZHANG G, Steinbach D, Grimm MO, Horstmann M, et al
    Utility of the EORTC risk tables and CUETO scoring model for predicting recurrence and progression in non-muscle-invasive bladder cancer patients treated with routine second transurethral resection.
    World J Urol. 2019 Mar 25. pii: 10.1007/s00345-019-02681.
    Abstract     Related articles   

  390. YOSHIKAWA Y, Taniguchi K, Tsujino T, Heishima K, et al
    Anti-cancer Effects of a Chemically Modified miR-143 on Bladder Cancer by Either Systemic or Intravesical Treatment.
    Mol Ther Methods Clin Dev. 2019;13:290-302.
    Abstract     Related articles   

  391. SUBIRA-RIOS D, Herranz-Amo F, Renedo-Villar T, Moralejo-Garate M, et al
    Influence of laparoscopic access in cancer-specific mortality of patients with pTa-2pN0R0 bladder cancer treated with radical cistectomy.
    Actas Urol Esp. 2019 Mar 22. pii: S0210-4806(19)30004.
    Abstract     Related articles   

  392. CAO W, Zhao Y, Wang L, Huang X, et al
    Circ0001429 regulates progression of bladder cancer through binding miR-205-5p and promoting VEGFA expression.
    Cancer Biomark. 2019 Mar 12. pii: CBM182380. doi: 10.3233/CBM-182380.
    Abstract     Related articles   

  393. SU H, Jiang H, Tao T, Kang X, et al
    Hope and challenge: Precision medicine in bladder cancer.
    Cancer Med. 2019 Mar 24. doi: 10.1002/cam4.1979.
    Abstract     Related articles   

  394. ROSSI M, Strikoudi P, Spei ME, Parpinel M, et al
    Flavonoids and bladder cancer risk.
    Cancer Causes Control. 2019 Mar 22. pii: 10.1007/s10552-019-01158.
    Abstract     Related articles   

  395. GUO X, Liu M, Hou H, Liu S, et al
    Impact of prostate cancer radiotherapy on the biological behavior and specific mortality of subsequent bladder cancer.
    Int J Clin Oncol. 2019 Mar 22. pii: 10.1007/s10147-019-01427.
    Abstract     Related articles   

  396. VAN OSCH FHM, Nekeman D, Aaronson NK, Billingham LJ, et al
    Patients choose certainty over burden in bladder cancer surveillance.
    World J Urol. 2019 Mar 23. pii: 10.1007/s00345-019-02728.
    Abstract     Related articles   

  397. ZHOU Q, Zhan H, Lin F, Liu Y, et al
    LincRNA-p21 suppresses glutamine catabolism and bladder cancer cell growth through inhibiting glutaminase (GLS) expression.
    Biosci Rep. 2019 Mar 22. pii: BSR20182372. doi: 10.1042/BSR20182372.
    Abstract     Related articles   

  398. OGAWA K, Shimizu Y, Tsuchihashi K, Kida K, et al
    [Two Cases of Inflammatory Myofibroblastic Tumor of the Urinary Bladder].
    Hinyokika Kiyo. 2018;64:445-450.
    Abstract     Related articles   

  399. CAO Q, Li P, Yang X, Qian J, et al
    Laparoscopic radical cystectomy with pelvic re-peritonealization: the technique and initial clinical outcomes.
    BMC Urol. 2018;18:113.
    Abstract     Related articles   

  400. OSMANOV YI, Gaibov ZA, Kogan EA, Radenska-Lopovok SG, et al
    [Comparative morphological characteristics and immunophenotype of urothelial carcinomas of the renal pelvis and bladder].
    Arkh Patol. 2018;80:23-32.
    Abstract     Related articles   

  401. MURAKAMI M, Kimura T, Iwamoto M, Honda M, et al
    [A Case of Metachronous Cancer Originating from Five Different Organs].
    Hinyokika Kiyo. 2018;64:231-234.
    Abstract     Related articles   

  402. KURAMOTO T, Nishikawa T, Nanpou Y
    [A Case Report of Granulomatous Renal Masses Following Intravesical Instillation of Bacillus Calmette-Guerin Therapy].
    Hinyokika Kiyo. 2018;64:225-230.
    Abstract     Related articles   

  403. SHI H, Yu H, Bellmunt J, Leow JJ, et al
    Comparison of health-related quality of life (HRQoL) between ileal conduit diversion and orthotopic neobladder based on validated questionnaires: a systematic review and meta-analysis.
    Qual Life Res. 2018;27:2759-2775.
    Abstract     Related articles   

  404. OKUMURA A, Morii A, Takagawa K, Kitamura H, et al
    [A Case of Metastasis of Cholangiocarcinoma to the Bladder].
    Hinyokika Kiyo. 2018;64:165-168.
    Abstract     Related articles   

  405. SHIMURA S, Matsumoto K, Tabata KI, Fujita T, et al
    [Recurrent Urothelial Carcinoma in the Uretero-Vesical Junction Treated with Partial Ureterectomy and Ureteroneocystostomy during Long-Term Follow-Up : A Case Report].
    Hinyokika Kiyo. 2018;64:157-160.
    Abstract     Related articles   

  406. MU XY, Wang RJ, Yao ZX, Zheng Z, et al
    RS 504393 inhibits M-MDSCs recruiting in immune microenvironment of bladder cancer after gemcitabine treatment.
    Mol Immunol. 2019;109:140-148.
    Abstract     Related articles   

  407. PRAKASH G, Pal M, Odaiyappan K, Shinde R, et al
    Bladder cancer demographics and outcome data from 2013 at a tertiary cancer hospital in India.
    Indian J Cancer. 2019;56:54-58.
    Abstract     Related articles   

  408. ZHU Q, Sheng Y, Li W, Wang J, et al
    Erianin, a novel dibenzyl compound in Dendrobium extract, inhibits bladder cancer cell growth via the mitochondrial apoptosis and JNK pathways.
    Toxicol Appl Pharmacol. 2019 Apr 1. pii: S0041-008X(19)30117.
    Abstract     Related articles   

  409. YU CC, Li CF, Chen IH, Lai MT, et al
    YWHAZ amplification/overexpression defines aggressive bladder cancer and contributes to chemo-/radio-resistance by suppressing caspase-mediated apoptosis.
    J Pathol. 2019 Apr 3. doi: 10.1002/path.5274.
    Abstract     Related articles   

  410. BOERI L, Montanari E, Karnes RJ
    Reply letter to: Peyton CC, Tang D, Reich RR, et al. Downstaging and survival outcomes associated with neoadjuvant chemotherapy regimens among patients treated with cystectomy for muscle-invasive bladder cancer. JAMA Oncol. 2018 Nov 1;4(11):1535-1542.
    World J Urol. 2019 Apr 3. pii: 10.1007/s00345-019-02751.
    Abstract     Related articles   

  411. NICOLAZZO C, Busetto GM, Gradilone A, Sperduti I, et al
    Circulating Tumor Cells Identify Patients with Super-High-Risk Non-Muscle-Invasive Bladder Cancer: Updated Outcome Analysis of a Prospective Single-Center Trial.
    Oncologist. 2019 Apr 3. pii: theoncologist.2018-0784.
    Abstract     Related articles   

  412. FLANNERY K, Boyd M, Black-Shinn J, Robert N, et al
    Outcomes in patients with metastatic bladder cancer in the USA: a retrospective electronic medical record study.
    Future Oncol. 2019 Apr 3. doi: 10.2217/fon-2018-0654.
    Abstract     Related articles   

  413. KACHRILAS S, Dellis A, Papatsoris A, Avgeris S, et al
    PI3K/AKT pathway genetic alterations and dysregulation of expression in bladder cancer.
    J BUON. 2019;24:329-337.
    Abstract     Related articles   

  414. LIANG T, Wang Y, Wang Y, Wang Y, et al
    Long noncoding RNA PEG10 facilitates bladder cancer cells proliferation, migration, and invasion via repressing microRNA-29b.
    J Cell Physiol. 2019 Apr 2. doi: 10.1002/jcp.28574.
    Abstract     Related articles   

  415. OH JJ, Byun SS, Jeong CW, Kwak C, et al
    Association Between Preoperative Hydronephrosis and Prognosis After Radical Cystectomy Among Patients With Bladder Cancer: A Systemic Review and Meta-Analysis.
    Front Oncol. 2019;9:158.
    Abstract     Related articles   

  416. BODGI L, Bahmad HF, Araji T, Al Choboq J, et al
    Assessing Radiosensitivity of Bladder Cancer in vitro: A 2D vs. 3D Approach.
    Front Oncol. 2019;9:153.
    Abstract     Related articles   

  417. MIAO L, Liu HY, Zhou C, He X, et al
    LINC00612 enhances the proliferation and invasion ability of bladder cancer cells as ceRNA by sponging miR-590 to elevate expression of PHF14.
    J Exp Clin Cancer Res. 2019;38:143.
    Abstract     Related articles   

  418. HAGGSTROM C, Garmo H, de Luna X, Van Hemelrijck M, et al
    Survival after radiotherapy versus radical cystectomy for primary muscle-invasive bladder cancer: A Swedish nationwide population-based cohort study.
    Cancer Med. 2019 Apr 1. doi: 10.1002/cam4.2126.
    Abstract     Related articles   

  419. XIE Q, Chen C, Li H, Xu J, et al
    miR-3687 Overexpression Promotes Bladder Cancer Cell Growth by Inhibiting the Negative Effect of FOXP1 on Cyclin E2 Transcription.
    Mol Ther. 2019 Mar 15. pii: S1525-0016(19)30092.
    Abstract     Related articles   

  420. SUBIRA-RIOS D, Herranz-Amo F, Moralejo-Garate M, Cano-Velasco J, et al
    Post-surgical complications in patients with bladder cancer treated with cystectomy: Differences between open and laparoscopic approach.
    Actas Urol Esp. 2019 Mar 29. pii: S0210-4806(19)30006.
    Abstract     Related articles   

  421. GAO H, Yu G, Zhang X, Yu S, et al
    BZW2 gene knockdown induces cell growth inhibition, G1 arrest and apoptosis in muscle-invasive bladder cancers: A microarray pathway analysis.
    J Cell Mol Med. 2019 Apr 1. doi: 10.1111/jcmm.14266.
    Abstract     Related articles   

  422. BEULENS AJW, van der Toorn PP, de Wildt MJ, Scheepens WA, et al
    High-precision Bladder Cancer Irradiation in the Elderly: Clinical Results for a Plan-of-the-day Integrated Boost Technique with Image Guidance Using Lipiodol Markers.
    Eur Urol Oncol. 2019;2:39-46.
    Abstract     Related articles   

  423. ZEKRI AN, Khaled HM, Mohammed MB, Diab FM, et al
    Microsatellite instability profiling in Egyptian bladder cancer patients: A pilot study.
    Curr Probl Cancer. 2019 Mar 26. pii: S0147-0272(18)30459.
    Abstract     Related articles   

  424. YAN X, Guo ZX, Liu XP, Feng YJ, et al
    Four novel biomarkers for bladder cancer identified by weighted gene coexpression network analysis.
    J Cell Physiol. 2019 Mar 29. doi: 10.1002/jcp.28546.
    Abstract     Related articles   

  425. MAIA MC, Hansen A, Alves C, Salah S, et al
    Biomarkers in Non-Schistosomiasis-related squamous cell carcinoma of the urinary bladder: A review.
    Crit Rev Oncol Hematol. 2019;135:76-84.
    Abstract     Related articles   

  426. IZUMI K, Iwamoto H, Yaegashi H, Shigehara K, et al
    Gemcitabine Plus Cisplatin Split Versus Gemcitabine Plus Carboplatin for Advanced Urothelial Cancer With Cisplatin-unfit Renal Function.
    In Vivo. 2019;33:167-172.
    Abstract     Related articles   

  427. GARG G, Sharma A, Sharma A, Sankhwar S, et al
    Metastatic adenocarcinoma of bladder presenting with skin and visceral metastasis.
    BMJ Case Rep. 2018;11.
    Abstract     Related articles   

  428. PARK S, Reuter VE, Hansel DE
    Non-urothelial carcinomas of the bladder.
    Histopathology. 2019;74:97-111.
    Abstract     Related articles   

    Precursor lesions of the urinary bladder.
    Histopathology. 2019;74:68-76.
    Abstract     Related articles   

  430. JAYARAJAH U, Fernando MH, Herath KB, Kuruppu SN, et al
    Clinico-pathological characteristics and outcome of upper urinary tract urothelial carcinoma presenting to a tertiary care urology unit in Sri Lanka
    Ceylon Med J. 2018;63:129-132.
    Abstract     Related articles   

  431. NILBERT M, Blackberg M, Ceberg J, Hagberg O, et al
    Diagnostic pathway efficacy for urinary tract cancer: population-based outcome of standardized evaluation for macroscopic haematuria.
    Scand J Urol. 2018;52:237-243.
    Abstract     Related articles   

  432. MINATO A, Noguchi H, Tomisaki I, Fukuda A, et al
    Clinical Significance of Squamous Differentiation in Urothelial Carcinoma of the Bladder.
    Cancer Control. 2018;25:1073274818800269.
    Abstract     Related articles   

  433. KARAOSMANOGLU AD, Onur MR, Karcaaltincaba M, Akata D, et al
    Secondary Tumors of the Urinary System: An Imaging Conundrum.
    Korean J Radiol. 2018;19:742-751.
    Abstract     Related articles   

  434. MORGANSTERN BA, Scaccia S, Wu W, Williamson AK, et al
    Synchronous, but separate, bladder and vaginal rhabdomyosarcoma: a novel genetic case report.
    Can J Urol. 2018;25:9357-9359.
    Abstract     Related articles   

  435. LEE AJ, Yabes JG, Hale N, Hrebinko RL, et al
    The comparative effectiveness of quadratus lumborum blocks and paravertebral blocks in radical cystectomy patients.
    Can J Urol. 2018;25:9255-9261.
    Abstract     Related articles   

  436. HAO YC, Xiao CL, Liu K, Liu YQ, et al
    [Application of narrow-band imaging flexible ureteroscopy in the diagnosis, treatment and follow-up of upper tract urothelial carcinomas].
    Zhonghua Wai Ke Za Zhi. 2018;56:222-226.
    Abstract     Related articles   

  437. MCARDLE BJ, Vidal P, Psutka SP, Hollowell CMP, et al
    T4 urothelial carcinoma in undiagnosed closed bladder exstrophy in a post-menopausal female.
    Can J Urol. 2018;25:9214-9216.
    Abstract     Related articles   

  438. PIERCONTI F, Rossi ED, Straccia P, Fadda G, et al
    The risk of malignancy of atypical urothelial cells of undetermined significance in patients treated with chemohyperthermia or electromotive drug administration.
    Cancer Cytopathol. 2018;126:200-206.
    Abstract     Related articles   

  439. WANG F, Zhang H, Ma AH, Yu W, et al
    COX-2/sEH Dual Inhibitor PTUPB Potentiates the Antitumor Efficacy of Cisplatin.
    Mol Cancer Ther. 2018;17:474-483.
    Abstract     Related articles   

  440. WANG Y, Auger M, Kanber Y, Caglar D, et al
    Implementing The Paris System for Reporting Urinary Cytology results in a decrease in the rate of the "atypical" category and an increase in its prediction of subsequent high-grade urothelial carcinoma.
    Cancer Cytopathol. 2018;126:207-214.
    Abstract     Related articles   

  441. TRETIAKOVA M, Fulton R, Kocherginsky M, Long T, et al
    Concordance study of PD-L1 expression in primary and metastatic bladder carcinomas: comparison of four commonly used antibodies and RNA expression.
    Mod Pathol. 2018;31:623-632.
    Abstract     Related articles   

  442. HINDY JR, Souaid T, Kourie HR, Kattan J, et al
    Targeted therapies in urothelial bladder cancer: a disappointing past preceding a bright future?
    Future Oncol. 2019 Apr 12. doi: 10.2217/fon-2018-0459.
    Abstract     Related articles   

  443. YE X, Guo J, Zhang H, Meng Q, et al
    The enhanced expression of estrogen-related receptor alpha in human bladder cancer tissues and the effects of estrogen-related receptor alpha knockdown on bladder cancer cells.
    J Cell Biochem. 2019 Apr 11. doi: 10.1002/jcb.28657.
    Abstract     Related articles   

  444. PANG KH, Noon AP
    Selection of patients and benefit of immediate radical cystectomy for non-muscle invasive bladder cancer.
    Transl Androl Urol. 2019;8:101-107.
    Abstract     Related articles   

    Device-assisted intravesical therapy for non-muscle invasive bladder cancer.
    Transl Androl Urol. 2019;8:94-100.
    Abstract     Related articles   

  446. D'ANDREA D, Gontero P, Shariat SF, Soria F, et al
    Intravesical bacillus Calmette-Guerin for bladder cancer: are all the strains equal?
    Transl Androl Urol. 2019;8:85-93.
    Abstract     Related articles   

  447. ZAMBONI S, Baumeister P, Mattei A, Mordasini L, et al
    Single postoperative instillation for non-muscle invasive bladder cancer: are there still any indication?
    Transl Androl Urol. 2019;8:76-84.
    Abstract     Related articles   

  448. RINK M, Schwarzenbach H, Vetterlein MW, Riethdorf S, et al
    The current role of circulating biomarkers in non-muscle invasive bladder cancer.
    Transl Androl Urol. 2019;8:61-75.
    Abstract     Related articles   

  449. MARCQ G, Henon F, Ouzaid I, Fantoni JC, et al
    Active surveillance for non-muscle invasive bladder cancer.
    Transl Androl Urol. 2019;8:54-60.
    Abstract     Related articles   

  450. SORIA F, Marra G, D'Andrea D, Gontero P, et al
    The rational and benefits of the second look transurethral resection of the bladder for T1 high grade bladder cancer.
    Transl Androl Urol. 2019;8:46-53.
    Abstract     Related articles   

  451. ZAMBONI S, Moschini M, Simeone C, Antonelli A, et al
    Prediction tools in non-muscle invasive bladder cancer.
    Transl Androl Urol. 2019;8:39-45.
    Abstract     Related articles   

  452. BAUMEISTER P, Zamboni S, Mattei A, Antonelli A, et al
    Histological variants in non-muscle invasive bladder cancer.
    Transl Androl Urol. 2019;8:34-38.
    Abstract     Related articles   

  453. BILSKI K, Zapala L, Skrzypczyk MA, Oszczudlowski M, et al
    Review on gender differences in non-muscle invasive bladder cancer.
    Transl Androl Urol. 2019;8:12-20.
    Abstract     Related articles   

    Epidemiology, aetiology and screening of bladder cancer.
    Transl Androl Urol. 2019;8:5-11.
    Abstract     Related articles   

  455. MOSCHINI M, Roghmann F, Xylinas E
    The present and future of non-muscle invasive bladder cancer.
    Transl Androl Urol. 2019;8:1.
    Abstract     Related articles   

  456. WISHAHI M, Ismail MA, Elganzoury H, Elkholy A, et al
    Genital-Sparing Cystectomy versus Standard Urethral-Sparing Cystectomy Followed with Orthotopic Neobladder in Women with Bladder Cancer: Incidence and Causes of Hypercontinence with an Ultrastructure Study of Urethral Smooth Muscles.
    Open Access Maced J Med Sci. 2019;7:978-981.
    Abstract     Related articles   

  457. LENFANT L, Roupret M
    [Immunotherapy and bladder cancer].
    Biol Aujourdhui. 2018;212.
    Abstract     Related articles   

  458. BUNCH BL, Ma Y, Attwood K, Amable L, et al
    Vitamin D3 enhances the response to cisplatin in bladder cancer through VDR and TAp73 signaling crosstalk.
    Cancer Med. 2019 Apr 10. doi: 10.1002/cam4.2119.
    Abstract     Related articles   

  459. MORTADA WI, Abdelghany AM
    Preconcentration of Lead in Blood and Urine Samples Among Bladder Cancer Patients Using Mesoporous Strontium Titanate Nanoparticles.
    Biol Trace Elem Res. 2019 Apr 10. pii: 10.1007/s12011-019-01704.
    Abstract     Related articles   

  460. JIANG Y, Wei T, Li W, Zhang R, et al
    Circular RNA hsa_circ_0002024 suppresses cell proliferation, migration, and invasion in bladder cancer by sponging miR-197-3p.
    Am J Transl Res. 2019;11:1644-1652.
    Abstract     Related articles   

  461. BAYKAN O, Akgul M, Uren N, Yaman A, et al
    The Relationship Between Urothelial Type Bladder Cancer, Plasma 25-Hydroxyvitamin D Levels, and Vitamin D Receptor ApaI BsmI FokI, and TaqI Polymorphisms.
    Clin Lab. 2019;65.
    Abstract     Related articles   

  462. SUN J, Zhang H, Tao D, Xie F, et al
    CircCDYL inhibits the expression of C-MYC to suppress cell growth and migration in bladder cancer.
    Artif Cells Nanomed Biotechnol. 2019;47:1349-1356.
    Abstract     Related articles   

  463. CHENG XZ, Zhou HL, Tang SX, Jiang T, et al
    Intercellular transfer of P-glycoprotein mediates the formation of stable multidrug resistance in human bladder cancer BIU-87 cells.
    Biol Open. 2019 Apr 9. pii: bio.041889. doi: 10.1242/bio.041889.
    Abstract     Related articles   

  464. ERMAN A, Veranic P
    The Use of Polymer Chitosan in Intravesical Treatment of Urinary Bladder Cancer and Infections.
    Polymers (Basel). 2018;10.
    Abstract     Related articles   

  465. SHIVAPPA N, Hebert JR, Mirsafa F, Rashidkhani B, et al
    Increased Inflammatory Potential of Diet Is Associated with Increased Risk of Bladder Cancer in an Iranian Case-Control Study.
    Nutr Cancer. 2019 Apr 9:1-8. doi: 10.1080/01635581.2019.1597902.
    Abstract     Related articles   

  466. LIU XK, Chen D, Li X
    MiR-335 suppresses cell proliferation and migration by upregulating CRKL in bladder cancer.
    Eur Rev Med Pharmacol Sci. 2019;23:2399-2408.
    Abstract     Related articles   

  467. TYAGI S, Nelivigi G, Bhagat S
    Management of Bladder Cancer in the Second Trimester of Pregnancy.
    J Obstet Gynaecol India. 2019;69.
    Abstract     Related articles   

  468. MIYAKE M, Owari T, Tomizawa M, Matsui M, et al
    Long-term Changes in Renal Function, Blood Electrolyte Levels, and Nutritional Indices after Radical Cystectomy and Ileal Conduit in Patients with Bladder Cancer.
    Urol J. 2019 Apr 7. pii: 4531/1360. doi: 10.22037/uj.v0i0.4531.
    Abstract     Related articles   

  469. JIANG F, Qi W, Wang Y, Wang W, et al
    lncRNA PEG10 promotes cell survival, invasion and migration by sponging miR-134 in human bladder cancer.
    Biomed Pharmacother. 2019;114:108814.
    Abstract     Related articles   

  470. YANG Z, Liu A, Xiong Q, Xue Y, et al
    Prognostic value of differentially methylated gene profiles in bladder cancer.
    J Cell Physiol. 2019 Apr 5. doi: 10.1002/jcp.28515.
    Abstract     Related articles   

  471. PEARCE S, Daneshmand S
    Correction to: Enhanced Endoscopy in Bladder Cancer.
    Curr Urol Rep. 2019;20:25.
    Abstract     Related articles   

  472. DI MARTINO E, Alder O, Hurst CD, Knowles MA, et al
    ETV5 links the FGFR3 and Hippo signalling pathways in bladder cancer.
    Sci Rep. 2019;9:5740.
    Abstract     Related articles   

  473. WANG J, Li J, Yan G, Gao M, et al
    Preparation of a thickness-controlled Mg-MOFs-based magnetic graphene composite as a novel hydrophilic matrix for the effective identification of the glycopeptide in the human urine.
    Nanoscale. 2019;11:3701-3709.
    Abstract     Related articles   

  474. OKAMOTO M, Soeda T, Asamura A, Tanaka K, et al
    Functional comparison of the human epidermal growth factor receptor and telomerase reverse transcriptase promoters in canine tumor cells.
    J Vet Med Sci. 2019;81:397-400.
    Abstract     Related articles   

  475. WANG G, Zhou C, Conklin C, Hayes MM, et al
    Metastatic breast carcinoma to the urinary bladder-a report of 11 cases including a tumor to tumor metastasis.
    Virchows Arch. 2019;474:333-339.
    Abstract     Related articles   

  476. FERREIRA R, Neuparth MJ, Nogueira-Ferreira R, Magalhaes S, et al
    Exercise Training Impacts Cardiac Mitochondrial Proteome Remodeling in Murine Urothelial Carcinoma.
    Int J Mol Sci. 2018;20.
    Abstract     Related articles   

  477. TANAKA Y, Okamura T, Chaya R, Nagai T, et al
    Outcomes and Complications of Simultaneous Laparoscopic Cystectomy and Laparoscopic Nephroureterectomy with Umbilical Reduced Port Surgery
    Asian Pac J Cancer Prev. 2018;19:3495-3500.
    Abstract     Related articles   

  478. MATHES J, Todenhofer T
    Managing Toxicity of Intravesical Therapy.
    Eur Urol Focus. 2018;4:464-467.
    Abstract     Related articles   

  479. MOSCHINI M, Zamboni S, Mattei A, Amparore D, et al
    Bacillus Calmette-Guerin unresponsiveness in non-muscle-invasive bladder cancer patients: what the urologists should know.
    Minerva Urol Nefrol. 2019;71:17-30.
    Abstract     Related articles   

  480. RENTSCH CA, Derre L, Dugas SG, Wetterauer C, et al
    Building on a Solid Foundation: Enhancing Bacillus Calmette-Guerin Therapy.
    Eur Urol Focus. 2018;4:485-493.
    Abstract     Related articles   

  481. ERMAN A, Kapun G, Novak S, Pavlin M, et al
    How cancer cells attach to urinary bladder epithelium in vivo: study of the early stages of tumorigenesis in an orthotopic mouse bladder tumor model.
    Histochem Cell Biol. 2019;151:263-273.
    Abstract     Related articles   

  482. KIM TN, Chung MK, Nam JK, Lee JZ, et al
    Effectiveness of hyaluronic acid/carboxymethylcellulose in preventing adhesive bowel obstruction after laparoscopic radical cystectomy.
    Asian J Surg. 2019;42:394-400.
    Abstract     Related articles   

  483. O'BRIEN T
    The Case for Photodynamic Diagnosis-assisted Resection Without Intravesical Single-shot Chemotherapy.
    Eur Urol Focus. 2018;4:470-471.
    Abstract     Related articles   

  484. GOEL R, Westblade LF, Kessler DA, Sfeir M, et al
    Death from Transfusion-Transmitted Anaplasmosis, New York, USA, 2017.
    Emerg Infect Dis. 2018;24:1548-1550.
    Abstract     Related articles   

  485. BANDARI J, Maganty A, MacLeod LC, Davies BJ, et al
    Manufacturing and the Market: Rationalizing the Shortage of Bacillus Calmette-Guerin.
    Eur Urol Focus. 2018;4:481-484.
    Abstract     Related articles   

  486. BURGER M
    Hexvix plus Chemo.
    Eur Urol Focus. 2018;4:468-469.
    Abstract     Related articles   

  487. CIMADAMORE A, Gasparrini S, Santoni M, Cheng L, et al
    Biomarkers of aggressiveness in genitourinary tumors with emphasis on kidney, bladder, and prostate cancer.
    Expert Rev Mol Diagn. 2018;18:645-655.
    Abstract     Related articles   

  488. ST BLANC A, Crossland NA, DiGeronimo PM, Cianciolo RE, et al
    Pathology in Practice.
    J Am Vet Med Assoc. 2018;253:53-56.
    Abstract     Related articles   

  489. ISHARWAL S, Huang H, Nanjangud G, Audenet F, et al
    Intratumoral heterogeneity of ERBB2 amplification and HER2 expression in micropapillary urothelial carcinoma.
    Hum Pathol. 2018;77:63-69.
    Abstract     Related articles   

  490. ZHANG Q, Mao Z, Sun J
    NF-kappaB inhibitor, BAY11-7082, suppresses M2 tumor-associated macrophage induced EMT potential via miR-30a/NF-kappaB/Snail signaling in bladder cancer cells.
    Gene. 2019 Apr 16. pii: S0378-1119(19)30392-0. doi: 10.1016/j.gene.2019.
    Abstract     Related articles   

  491. ZHUO D, Wu Y, Luo J, Deng L, et al
    CSTP1 inhibits IL-6 expression through targeting Akt/FoxO3a signaling pathway in bladder cancer cells.
    Exp Cell Res. 2019 Apr 16. pii: S0014-4827(19)30193.
    Abstract     Related articles   

  492. LI Z, Liu Z, Yao K, Qin Z, et al
    An improved ileal conduit surgery for bladder cancer with fewer complications.
    Cancer Commun (Lond). 2019;39:19.
    Abstract     Related articles   

  493. MAO W, Huang X, Wang L, Zhang Z, et al
    Circular RNA hsa_circ_0068871 regulates FGFR3 expression and activates STAT3 by targeting miR-181a-5p to promote bladder cancer progression.
    J Exp Clin Cancer Res. 2019;38:169.
    Abstract     Related articles   

  494. NGUYEN MH, Giordani MM, Thompson GR 3rd
    The double-edged sword - prosthetic joint infection following BCG treatment for bladder cancer: a case report.
    BMC Infect Dis. 2019;19:331.
    Abstract     Related articles   

  495. WANG Q, Zhang T, Wu J, Wen J, et al
    Prognosis and risk factors of patients with upper urinary tract urothelial carcinoma and postoperative recurrence of bladder cancer in central China.
    BMC Urol. 2019;19:24.
    Abstract     Related articles   

  496. SZARVAS T, Jardin-Watelet B, Bourgoin N, Hoffmann MJ, et al
    High soluble CGA levels are associated with poor survival in bladder cancer.
    Endocr Connect. 2019 Apr 1. pii: EC-19-0068.R1. doi: 10.1530/EC-19-0068.
    Abstract     Related articles   

  497. ZACHOS I, Zachou K, Dalekos GN, Tzortzis V, et al
    Management of Patients with Liver Cirrhosis and Invasive Bladder Cancer: A Case-series.
    J Transl Int Med. 2019;7:29-33.
    Abstract     Related articles   

  498. FERRO M, Di Lorenzo G, Vartolomei MD, Bruzzese D, et al
    Absolute basophil count is associated with time to recurrence in patients with high-grade T1 bladder cancer receiving bacillus Calmette-Guerin after transurethral resection of the bladder tumor.
    World J Urol. 2019 Apr 16. pii: 10.1007/s00345-019-02754.
    Abstract     Related articles   

  499. XIANG M, Yuan W, Zhang W, Huang J, et al
    Expression of miR-490-5p, miR-148a-3p and miR-608 in bladder cancer and their effects on the biological characteristics of bladder cancer cells.
    Oncol Lett. 2019;17:4437-4442.
    Abstract     Related articles   

  500. WU X, Chen B, Shi H, Zhou J, et al
    miR-758-3p suppresses human bladder cancer cell proliferation, migration and invasion by targeting NOTCH2.
    Exp Ther Med. 2019;17:4273-4278.
    Abstract     Related articles   

  501. HSIAO CH, Yao CJ, Lai GM, Lee LM, et al
    Honokiol induces apoptotic cell death by oxidative burst and mitochondrial hyperpolarization of bladder cancer cells.
    Exp Ther Med. 2019;17:4213-4222.
    Abstract     Related articles   

  502. PFANNSTIEL C, Strissel PL, Chiappinelli KB, Sikic D, et al
    The tumor immune microenvironment drives a prognostic relevance that correlates with bladder cancer subtypes.
    Cancer Immunol Res. 2019 Apr 15. pii: 2326-6066.CIR-18-0758.
    Abstract     Related articles   

  503. CHEN YT, Huang HC, Hsieh YJ, Fu SH, et al
    Targeting amine- and phenol-containing metabolites in urine by dansylation isotope labeling and liquid chromatography mass spectrometry for evaluation of bladder cancer biomarkers.
    J Food Drug Anal. 2019;27:460-474.
    Abstract     Related articles   

  504. HUANG Y, Cen J, Liu Z, Wei J, et al
    A Comparison of Different Prophylactic Intravesical Chemotherapy Regimens for Bladder Cancer Recurrence After Nephroureterectomy for Primary Upper Tract Urothelial Carcinomas: A Retrospective 2-center Study.
    Technol Cancer Res Treat. 2019;18:1533033819844483.
    Abstract     Related articles   

  505. LI M, Wang Y, Liu Y, Zhang X, et al
    Low Expression of hsa_circ_0018069 in Human Bladder Cancer and Its Clinical Significance.
    Biomed Res Int. 2019;2019:9681863.
    Abstract     Related articles   

  506. DING B, Yan L, Zhang Y, Wang Z, et al
    Analysis of the role of mutations in the KMT2D histone lysine methyltransferase in bladder cancer.
    FEBS Open Bio. 2019;9:693-706.
    Abstract     Related articles   

  507. YANG L, Li YL, Li XQ, Zhang Z, et al
    High Apelin Level Indicates a Poor Prognostic Factor in Muscle-Invasive Bladder Cancer.
    Dis Markers. 2019;2019:4586405.
    Abstract     Related articles   

  508. LIU Y, Lu J, Huang Y, Ma L, et al
    Clinical Spectrum of Complications Induced by Intravesical Immunotherapy of Bacillus Calmette-Guerin for Bladder Cancer.
    J Oncol. 2019;2019:6230409.
    Abstract     Related articles   

  509. LI Y, Shi B, Dong F, Zhu X, et al
    Long Non-coding RNA DLEU1 Promotes Cell Proliferation, Invasion, and Confers Cisplatin Resistance in Bladder Cancer by Regulating the miR-99b/HS3ST3B1 Axis.
    Front Genet. 2019;10:280.
    Abstract     Related articles   

  510. YANG FY, Wang WK, Liu S, Song LM, et al
    [Clinical experiences of laparoscopic radical cystectomy and urinary diversion in the elderly patients with bladder cancer].
    Zhonghua Yi Xue Za Zhi. 2019;99:1101-1105.
    Abstract     Related articles   

  511. HOUEDE N, Milano G
    [Care of advanced or metastatic bladder cancer in second line: A specific place for vinflunine].
    Bull Cancer. 2019 Apr 10. pii: S0007-4551(19)30146.
    Abstract     Related articles   

  512. XU X, Wang H, Du P, Zhang F, et al
    A predictive nomogram for individualized recurrence stratification of bladder cancer using multiparametric MRI and clinical risk factors.
    J Magn Reson Imaging. 2019 Apr 13. doi: 10.1002/jmri.26749.
    Abstract     Related articles   

  513. ROUVINOV K, Plimack ER, Zibelman M, Ghatalia P, et al
    Update on perioperative systemic therapy for urothelial carcinoma.
    Clin Adv Hematol Oncol. 2019;17:176-183.
    Abstract     Related articles   

  514. HANNA KS
    Updates and novel treatments in urothelial carcinoma.
    J Oncol Pharm Pract. 2019;25:648-656.
    Abstract     Related articles   

  515. PENG H, Li H
    The encouraging role of long noncoding RNA small nuclear RNA host gene 16 in epithelial-mesenchymal transition of bladder cancer via directly acting on miR-17-5p/metalloproteinases 3 axis.
    Mol Carcinog. 2019 Apr 26. doi: 10.1002/mc.23028.
    Abstract     Related articles   

  516. BUSS JH, Begnini KR, Bruinsmann FA, Ceolin T, et al
    Lapatinib-Loaded Nanocapsules Enhances Antitumoral Effect in Human Bladder Cancer Cell.
    Front Oncol. 2019;9:203.
    Abstract     Related articles   

  517. XU Z, Wang C, Xiang X, Li J, et al
    Characterization of mRNA Expression and Endogenous RNA Profiles in Bladder Cancer Based on The Cancer Genome Atlas (TCGA) Database.
    Med Sci Monit. 2019;25:3041-3060.
    Abstract     Related articles   

  518. JERLSTROM T, Chen R, Liedberg F, Andren O, et al
    No increased risk of short-term complications after radical cystectomy for muscle-invasive bladder cancer among patients treated with preoperative chemotherapy: a nation-wide register-based study.
    World J Urol. 2019 Apr 24. pii: 10.1007/s00345-019-02770.
    Abstract     Related articles   

  519. LOTAN Y, Bivalacqua TJ, Downs T, Huang W, et al
    Blue light flexible cystoscopy with hexaminolevulinate in non-muscle-invasive bladder cancer: review of the clinical evidence and consensus statement on optimal use in the USA - update 2018.
    Nat Rev Urol. 2019 Apr 24. pii: 10.1038/s41585-019-0184.
    Abstract     Related articles   

  520. GANDAGLIA G, Larcher A, Gallina A, Fossati N, et al
    Requiem for Open Radical Cystectomy in Bladder Cancer Patients.
    Eur Urol Oncol. 2019;2:196-197.
    Abstract     Related articles   

  521. WILLIAMS SB, Hudgins HK, Ray-Zack MD, Chamie K, et al
    Systematic Review of Factors Associated with the Utilization of Radical Cystectomy for Bladder Cancer.
    Eur Urol Oncol. 2019;2:119-125.
    Abstract     Related articles   

  522. RAI BP, Bondad J, Vasdev N, Adshead J, et al
    Robotic versus open radical cystectomy for bladder cancer in adults.
    Cochrane Database Syst Rev. 2019;4:CD011903.
    Abstract     Related articles   

  523. WANG H, Hu D, Yao H, Chen M, et al
    Radiomics analysis of multiparametric MRI for the preoperative evaluation of pathological grade in bladder cancer tumors.
    Eur Radiol. 2019 Apr 23. pii: 10.1007/s00330-019-06222.
    Abstract     Related articles   

  524. ZHU J, Tian Z, Li Y, Hua X, et al
    ATG7 Promotes Bladder Cancer Invasion via Autophagy-Mediated Increased ARHGDIB mRNA Stability.
    Adv Sci (Weinh). 2019;6:1801927.
    Abstract     Related articles   

  525. MARTINEZ-BOSCH N, Rodriguez-Vida A, Juanpere N, Lloreta J, et al
    Galectins in prostate and bladder cancer: tumorigenic roles and clinical opportunities.
    Nat Rev Urol. 2019 Apr 23. pii: 10.1038/s41585-019-0183.
    Abstract     Related articles   

  526. AYOUB M, Shinde-Jadhav S, Mansure JJ, Alvarez F, et al
    The immune mediated role of extracellular HMGB1 in a heterotopic model of bladder cancer radioresistance.
    Sci Rep. 2019;9:6348.
    Abstract     Related articles   

    Vying for Standardization of Bladder Cancer MRI Interpretation and Reporting: VI-RADS.
    Radiology. 2019 Apr 23:190648. doi: 10.1148/radiol.2019190648.
    Abstract     Related articles   

  528. WANG H, Luo C, Zhang F, Guan J, et al
    Multiparametric MRI for Bladder Cancer: Validation of VI-RADS for the Detection of Detrusor Muscle Invasion.
    Radiology. 2019 Apr 23:182506. doi: 10.1148/radiol.2019182506.
    Abstract     Related articles   

  529. RAVEN PA, Lysakowski S, Tan Z, D'Costa NM, et al
    Inhibition of GLI2 with antisense-oligonucleotides: A potential therapy for the treatment of bladder cancer.
    J Cell Physiol. 2019 Apr 22. doi: 10.1002/jcp.28669.
    Abstract     Related articles   

  530. FLORES-MARTIN JF, Perea F, Exposito-Ruiz M, Carretero FJ, et al
    A Combination of Positive Tumor HLA-I and Negative PD-L1 Expression Provides an Immune Rejection Mechanism in Bladder Cancer.
    Ann Surg Oncol. 2019 Apr 22. pii: 10.1245/s10434-019-07371.
    Abstract     Related articles   

  531. KRAJEWSKI W, Poletajew S
    The TaHG bladder cancer - the devil is as black as he is painted.
    Cent European J Urol. 2019;72:76-77.
    Abstract     Related articles   

  532. MORTAZAVI N, Asadikaram G, Ebadzadeh MR, Kamalati A, et al
    Organochlorine and organophosphorus pesticides and bladder cancer: A case-control study.
    J Cell Biochem. 2019 Apr 22. doi: 10.1002/jcb.28746.
    Abstract     Related articles   

  533. DENG S, Ren ZJ, Jin T, Yang B, et al
    Contribution of prostate stem cell antigen variation rs2294008 to the risk of bladder cancer.
    Medicine (Baltimore). 2019;98:e15179.
    Abstract     Related articles   

  534. UMEZAWA Y, Shirotake S, Kaneko G, Nishimoto K, et al
    Meningeal carcinomatosis from bladder cancer: A case report and review of the literature.
    Mol Clin Oncol. 2019;10:506-510.
    Abstract     Related articles   

  535. OURFALI S, Ohannessian R, Fassi-Fehri H, Pages A, et al
    Recurrence Rate and Cost Consequence of the Shortage of Bacillus Calmette-Guerin Connaught Strain for Bladder Cancer Patients.
    Eur Urol Focus. 2019 Apr 17. pii: S2405-4569(19)30109.
    Abstract     Related articles   

  536. LI T, Zou L, Zhang J, Li G, et al
    Non-invasive diagnosis of bladder cancer by detecting telomerase activity in human urine using hybridization chain reaction and dynamic light scattering.
    Anal Chim Acta. 2019;1065:90-97.
    Abstract     Related articles   

  537. HOU G, Jiang Y, Jian S, Niu Y, et al
    Hemolymphangioma involving bones and bladder detected on 68Ga-NEB PET/CT: A rare case report.
    Medicine (Baltimore). 2019;98:e15213.
    Abstract     Related articles   

  538. LIN Z, Hu WM, Li YH, Jiang LJ, et al
    [Surgical treatment for inflammatory myofibroblastic tumor in genito-urinary system: a study of 15 cases].
    Zhonghua Yi Xue Za Zhi. 2019;99:947-949.
    Abstract     Related articles   

  539. LEE HY, Chen YJ, Li CC, Li WM, et al
    Deduction of Novel Genes Potentially Involved in Upper Tract Urothelial Carcinoma Using Next-Generation Sequencing and Bioinformatics Approaches.
    Int J Med Sci. 2019;16:93-105.
    Abstract     Related articles   

  540. KUMAR P, Nayyar R, Seth A, Gupta D, et al
    Management of cavernous abdominal wall defects post radical cystectomy in adult exstrophy complex.
    BMJ Case Rep. 2019;12.
    Abstract     Related articles   

  541. CRONISE KE, Hernandez BG, Gustafson DL, Duval DL, et al
    Identifying the ErbB/MAPK Signaling Cascade as a Therapeutic Target in Canine Bladder Cancer.
    Mol Pharmacol. 2019 May 2. pii: mol.119.115808. doi: 10.1124/mol.119.115808.
    Abstract     Related articles   

  542. LI Y, Tindle HA, Hendryx MS, Xun P, et al
    Smoking Cessation and the Risk of Bladder Cancer among Postmenopausal Women.
    Cancer Prev Res (Phila). 2019;12:305-314.
    Abstract     Related articles   

  543. XIAN-LI T, Hong L, Hong Z, Yuan L, et al
    Higher Expression of Linc00152 Promotes Bladder Cancer Proliferation and Metastasis by Activating the Wnt/beta-Catenin Signaling Pathway.
    Med Sci Monit. 2019;25:3221-3230.
    Abstract     Related articles   

  544. YANG Y, Cheng Z, Jia X, Shi N, et al
    Mortality trends of bladder cancer in China from 1991 to 2015: an age-period-cohort analysis.
    Cancer Manag Res. 2019;11:3043-3051.
    Abstract     Related articles   

  545. ZHANG C, Wang W, Lin J, Xiao J, et al
    lncRNA CCAT1 promotes bladder cancer cell proliferation, migration and invasion.
    Int Braz J Urol. 2019;45.
    Abstract     Related articles   

  546. LEKO V, McDuffie LA, Zheng Z, Gartner JJ, et al
    Identification of Neoantigen-Reactive Tumor-Infiltrating Lymphocytes in Primary Bladder Cancer.
    J Immunol. 2019 Apr 29. pii: jimmunol.1801022. doi: 10.4049/jimmunol.1801022.
    Abstract     Related articles   

  547. KIM S, Kim Y, Kong J, Kim E, et al
    Epigenetic regulation of mammalian Hedgehog signaling to the stroma determines the molecular subtype of bladder cancer.
    Elife. 2019;8.
    Abstract     Related articles   

  548. Erratum to "Re: Elevated Bladder Cancer in Northern New England: The Role of Drinking Water and Arsenic".
    J Natl Cancer Inst. 2019 Apr 29. pii: 5481408. doi: 10.1093.
    Abstract     Related articles   

  549. HECK CL, Schwartzbauer GT
    BCG-induced discitis and osteomyelitis in a patient with a history of bladder cancer.
    JAAPA. 2019;32:1-4.
    Abstract     Related articles   

  550. HEYES SM, Prior KN, Whitehead D, Bond MJ, et al
    Toward an Understanding of Patients' and Their Partners' Experiences of Bladder Cancer.
    Cancer Nurs. 2019 Apr 25. doi: 10.1097/NCC.0000000000000718.
    Abstract     Related articles   

  551. FAN L, Wang Y, Wang W, Wei X, et al
    Carcinogenic role of K-Ras-ERK1/2 signaling in bladder cancer via inhibition of H1.2 phosphorylation at T146.
    J Cell Physiol. 2019 Apr 29. doi: 10.1002/jcp.28716.
    Abstract     Related articles   

  552. CHEN W, Jiang T, Mao H, Gao R, et al
    Nodal Promotes the Migration and Invasion of Bladder Cancer Cells via Regulation of Snail.
    J Cancer. 2019;10:1511-1519.
    Abstract     Related articles   

  553. NAGAI T, Okamura T, Yanase T, Chaya R, et al
    Examination of Diagnostic Accuracy of UroVysion Fluorescence In Situ Hybridization for Bladder Cancer in a Single Community of Japanese Hospital Patients
    Asian Pac J Cancer Prev. 2019;20:1271-1273.
    Abstract     Related articles   

  554. RENNINGER M, Fahmy O, Schubert T, Schmid MA, et al
    The prognostic impact of hexaminolevulinate-based bladder tumor resection in patients with primary non-muscle invasive bladder cancer treated with radical cystectomy.
    World J Urol. 2019 Apr 27. pii: 10.1007/s00345-019-02780.
    Abstract     Related articles   

  555. NADAL R, Bellmunt J
    Management of metastatic bladder cancer.
    Cancer Treat Rev. 2019;76:10-21.
    Abstract     Related articles   

  556. PALMISANO F, Boeri L, Montanari E
    Reply letter to: Loh-Doyle JC, Ashrafi A, Nazemi A, et al. Dual Prosthetic Implantation After Radical Cystoprostatectomy and Neobladder: Outcomes of the Inflatable Penile Prosthesis and Artificial Urinary Sphincter in Bladder Cancer Survivors.
    J Sex Med. 2019;16:760-761.
    Abstract     Related articles   

  557. GARCIA-PERDOMO HA, Usubillaga-Velasquez JP, Zapata-Copete JA, Reis LO, et al
    Mutations in CDKN2A and the FGFR3 genes on bladder cancer diagnosis: a systematic review and meta-analysis.
    World J Urol. 2019 Apr 27. pii: 10.1007/s00345-019-02779.
    Abstract     Related articles   

  558. STONE L
    Budding prognostic technique for muscle-invasive bladder cancer.
    Nat Rev Urol. 2019 Apr 26. pii: 10.1038/s41585-019-0187.
    Abstract     Related articles   

  559. JHA S, Mitra S, Adhya AK, Nayak P, et al
    Urothelial carcinoma with villoglandular differentiation (UCVGD) with small cell neuroendocrine carcinoma of urinary bladder.
    BMJ Case Rep. 2019;12.
    Abstract     Related articles   

  560. NGWESO S, Mukhtar S, Forrest C, Mander J, et al
    Rare case of bladder chondroma causing lower urinary tract symptoms.
    BMJ Case Rep. 2019;12.
    Abstract     Related articles   

  561. LI G, Lei Q, Wang F, Deng D, et al
    Fluorinated Polymer Mediated Transmucosal Peptide Delivery for Intravesical Instillation Therapy of Bladder Cancer.
    Small. 2019 May 10:e1900936. doi: 10.1002/smll.201900936.
    Abstract     Related articles   

  562. NUMMI A, Jarvinen R, Sairanen J, Huotari K, et al
    A retrospective study on tolerability and complications of bacillus Calmette-Guerin (BCG) instillations for non-muscle-invasive bladder cancer.
    Scand J Urol. 2019 May 10:1-7. doi: 10.1080/21681805.2019.1609080.
    Abstract     Related articles   

  563. ZHUANG C, Huang X, Yu J, Gui Y, et al
    Circular RNA hsa_circ_0075828 promotes bladder cancer cell proliferation through activation of CREB1.
    BMB Rep. 2019 May 10. pii: 4552.
    Abstract     Related articles   

  564. ZHU J, Xu C, Ruan L, Wu J, et al
    MicroRNA-146b Overexpression Promotes Human Bladder Cancer Invasion via Enhancing ETS2-Mediated mmp2 mRNA Transcription.
    Mol Ther Nucleic Acids. 2019;16:531-542.
    Abstract     Related articles   

  565. SUN W, Li S, Yu Y, Jin H, et al
    MicroRNA-3648 Is Upregulated to Suppress TCF21, Resulting in Promotion of Invasion and Metastasis of Human Bladder Cancer.
    Mol Ther Nucleic Acids. 2019;16:519-530.
    Abstract     Related articles   

  566. CONG L, Yang Q, Hu C, Yu Q, et al
    Current Status of Functional Studies on Circular RNAs in Bladder Cancer and their Potential Role as Diagnostic and Prognostic Biomarkers: A Review.
    Med Sci Monit. 2019;25:3425-3434.
    Abstract     Related articles   

  567. ZHANG Z, Qin H, Jiang B, Chen W, et al
    miR-30e-5p suppresses cell proliferation and migration in bladder cancer through regulating metadherin.
    J Cell Biochem. 2019 May 8. doi: 10.1002/jcb.28866.
    Abstract     Related articles   

  568. BORCOMAN E, De La Rochere P, Richer W, Vacher S, et al
    Inhibition of PI3K pathway increases immune infiltrate in muscle-invasive bladder cancer.
    Oncoimmunology. 2019;8:e1581556.
    Abstract     Related articles   

  569. ZHAOJIE L, Yuchen L, Miao C, Yacun C, et al
    Gelsolin-like actin-capping protein has prognostic value and promotes tumorigenesis and epithelial-mesenchymal transition via the Hippo signaling pathway in human bladder cancer.
    Ther Adv Med Oncol. 2019;11:1758835919841235.
    Abstract     Related articles   

  570. GUO CC, Majewski T, Zhang L, Yao H, et al
    Dysregulation of EMT Drives the Progression to Clinically Aggressive Sarcomatoid Bladder Cancer.
    Cell Rep. 2019;27:1781-1793.
    Abstract     Related articles   

  571. CLERIGO V, Castro A, Mourato T, Gomes C, et al
    A Rare Case of Granulomatous Pneumonitis Due to Intravesical BCG for Bladder Cancer.
    Acta Med Port. 2019;32:316-320.
    Abstract     Related articles   

  572. TSUJINO T, Sugito N, Taniguchi K, Honda R, et al
    MiR-143/MSI2/KRAS Cascade Contributes Positively to Carcinogenesis in Human Bladder Cancer.
    Cancer Sci. 2019 May 7. doi: 10.1111/cas.14035.
    Abstract     Related articles   

  573. ZHU W, Liu H, Wang X, Lu J, et al
    Long noncoding RNAs in bladder cancer prognosis: A meta-analysis.
    Pathol Res Pract. 2019 Apr 29:152429. doi: 10.1016/j.prp.2019.
    Abstract     Related articles   

  574. SORENBY A, Baseckas G, Bendahl PO, Brandstedt J, et al
    Reducing recurrence in non-muscle-invasive bladder cancer by systematically implementing guideline-based recommendations: effect of a prospective intervention in primary bladder cancer patients.
    Scand J Urol. 2019 May 8:1-7. doi: 10.1080/21681805.2019.1604568.
    Abstract     Related articles   

    Gall bladder cancer in Delhi - some thoughts.
    Indian J Cancer. 2019;56:182.
    Abstract     Related articles   

  576. FARHOOD B, Raei B, Ameri H, Shirvani M, et al
    A review of incidence and mortality of colorectal, lung, liver, thyroid, and bladder cancers in Iran and compared to other countries.
    Contemp Oncol (Pozn). 2019;23:7-15.
    Abstract     Related articles   

  577. LYON TD, Frank I, Takahashi N, Boorjian SA, et al
    Sarcopenia and Response to Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer.
    Clin Genitourin Cancer. 2019 Mar 25. pii: S1558-7673(19)30102.
    Abstract     Related articles   

  578. HU X, Guo Z, Xu J, Mei X, et al
    Role of feline sarcomarelated protein in the viability and apoptosis of bladder cancer cells.
    Mol Med Rep. 2019 Apr 30. doi: 10.3892/mmr.2019.10204.
    Abstract     Related articles   

  579. BEN FRADJ MK, Mrad Dali K, Kallel A, Bibi M, et al
    Interaction Effects of Plasma Vitamins A, E, D, B9, and B12 and Tobacco Exposure in Urothelial Bladder Cancer: A Multifactor Dimensionality Reduction Analysis.
    Nutr Cancer. 2019 May 6:1-8. doi: 10.1080/01635581.2019.1609531.
    Abstract     Related articles   

  580. ABBAS W, Goel V, Verma A, Gupta VG, et al
    Harnessing the Immunomodulatory Effects of Radiation in Urinary Bladder Cancer.
    Cureus. 2019;11:e4108.
    Abstract     Related articles   

  581. ABDOLMALEKI F, Ghafoui-Fard S, Taheri M, Mordadi A, et al
    Expression analysis of a panel of long non-coding RNAs (lncRNAs) revealed their potential as diagnostic biomarkers in bladder cancer.
    Genomics. 2019 May 2. pii: S0888-7543(19)30012.
    Abstract     Related articles   

  582. MACLEOD LC, Yabes JG, Yu M, Fam MM, et al
    Trends and appropriateness of perioperative chemotherapy for muscle-invasive bladder cancer.
    Urol Oncol. 2019 Apr 30. pii: S1078-1439(19)30139.
    Abstract     Related articles   

  583. KRAFFT U, Tschirdewahn S, Hess J, Harke NN, et al
    Validation of survivin and HMGA2 as biomarkers for cisplatin resistance in bladder cancer.
    Urol Oncol. 2019 Apr 30. pii: S1078-1439(19)30148.
    Abstract     Related articles   

  584. RUI X, Gu TT, Pan HF, Zhang HZ, et al
    Evaluation of PD-L1 biomarker for immune checkpoint inhibitor (PD-1/PD-L1 inhibitors) treatments for urothelial carcinoma patients: A meta-analysis.
    Int Immunopharmacol. 2019;67:378-385.
    Abstract     Related articles   

  585. SUN P, Wu T, Sun X, Cui Z, et al
    KMT2D inhibits the growth and metastasis of bladder Cancer cells by maintaining the tumor suppressor genes.
    Biomed Pharmacother. 2019;115:108924.
    Abstract     Related articles   

  586. AKAND M, Muilwijk T, Raskin Y, De Vrieze M, et al
    Quality Control Indicators for Transurethral Resection of Non-Muscle-Invasive Bladder Cancer.
    Clin Genitourin Cancer. 2019 Apr 19. pii: S1558-7673(19)30140.
    Abstract     Related articles   

  587. AGREDA CASTANEDA F, Raventos Busquets CX, Morote Robles J
    Urinary markers in the surveillance of non-muscle invasive bladder cancer. A literature review.
    Actas Urol Esp. 2019 May 13. pii: S0210-4806(19)30041.
    Abstract     Related articles   

  588. ALMEIDA TC, Guerra CCC, Assis BLG, Soares RDOA, et al
    Antiproliferative and toxicogenomic effects of resveratrol in bladder cancer cells with different TP53 status.
    Environ Mol Mutagen. 2019 May 16. doi: 10.1002/em.22297.
    Abstract     Related articles   

  589. SHEN T, Yang L, Zhang Z, Yu J, et al
    KIF20A Affects the Prognosis of Bladder Cancer by Promoting the Proliferation and Metastasis of Bladder Cancer Cells.
    Dis Markers. 2019;2019:4863182.
    Abstract     Related articles   

  590. WASHINGTON SL, Neuhaus J, Meng MV, Porten SP, et al
    Social Determinants of Appropriate Treatment for Muscle-Invasive Bladder Cancer.
    Cancer Epidemiol Biomarkers Prev. 2019 May 15. pii: 1055-9965.EPI-18-1280.
    Abstract     Related articles   

  591. BOLENZ C, Hautmann RE
    [Surgical treatment of bladder cancer: advances made in the past 50 years].
    Aktuelle Urol. 2019 May 15. doi: 10.1055/a-0884-2792.
    Abstract     Related articles   

  592. ZHU Z, Wang X, Wang J, Wang S, et al
    Preoperative predictors of early death risk in bladder cancer patients treated with robot-assisted radical cystectomy.
    Cancer Med. 2019 May 15. doi: 10.1002/cam4.2237.
    Abstract     Related articles   

  593. LEE YH, Tuyet PT
    Synthesis and biological evaluation of quercetin-zinc (II) complex for anti-cancer and anti-metastasis of human bladder cancer cells.
    In Vitro Cell Dev Biol Anim. 2019 May 14. pii: 10.1007/s11626-019-00363.
    Abstract     Related articles   

  594. MA JY, Hu G, Liu Q
    Prognostic Significance of the Lymphocyte-to-Monocyte Ratio in Bladder Cancer Undergoing Radical Cystectomy: A Meta-Analysis of 5638 Individuals.
    Dis Markers. 2019;2019:7593560.
    Abstract     Related articles   

  595. XU Y, Kim YH, Jeong P, Piao XM, et al
    Urinary Cell-Free DNA IQGAP3/BMP4 Ratio as a Prognostic Marker for Non-Muscle-Invasive Bladder Cancer.
    Clin Genitourin Cancer. 2019 Apr 9. pii: S1558-7673(19)30012.
    Abstract     Related articles   

  596. GARRY EM, Buse JB, Gokhale M, Lund JL, et al
    Study Design Choices for Evaluating Comparative Safety of Diabetic Medications: An Evaluation of Pioglitazone and Bladder Cancer Risk Among Older US Adults with Type-2 Diabetes.
    Diabetes Obes Metab. 2019 May 14. doi: 10.1111/dom.13774.
    Abstract     Related articles   

  597. TYRITZIS SI, Gaya JM, Wallestedt-Lantz A, Pini G, et al
    Current role of robotic bladder cancer surgery.
    Minerva Urol Nefrol. 2019 May 7. pii: S0393-2249.19.03435.
    Abstract     Related articles   

  598. WU YJ, Su TR, Dai GF, Su JH, et al
    Flaccidoxide-13-Acetate-Induced Apoptosis in Human Bladder Cancer Cells is through Activation of p38/JNK, Mitochondrial Dysfunction, and Endoplasmic Reticulum Stress Regulated Pathway.
    Mar Drugs. 2019;17.
    Abstract     Related articles   

  599. LUO F, Ma C, Wu J, Li J, et al
    Prognostic Value of the Neutrophil-to-Lymphocyte Ratio in Nonmuscle-Invasive Bladder Cancer Treated with GreenLight Laser Vaporization.
    Photobiomodul Photomed Laser Surg. 2019;37:312-317.
    Abstract     Related articles   

  600. LI J, Wang F, Gao H, Huang S, et al
    ALDOLASE A regulates invasion of bladder cancer cells via E-cadherin-EGFR signaling.
    J Cell Biochem. 2019 May 13. doi: 10.1002/jcb.28642.
    Abstract     Related articles   

  601. SORIA F, Mosca A, Gontero P
    Drug strategies for bladder cancer in the elderly: is there promise for the future?
    Expert Opin Pharmacother. 2019 May 13:1-10. doi: 10.1080/14656566.2019.1615055.
    Abstract     Related articles   

  602. MELEIS L, Moore R, Inman BA, Harrison MR, et al
    Retrospective analysis of the efficacy and safety of neoadjuvant gemcitabine and cisplatin in muscle-invasive bladder cancer.
    J Oncol Pharm Pract. 2019 May 12:1078155219845434. doi: 10.1177/1078155219845434
    Abstract     Related articles   

  603. CHEN J, Miranda G, Cai J, Daneshmand S, et al
    Preoperative chemotherapy for prostatic stromal invasive urothelial bladder cancer: comparison of oncological outcomes of male patients with cT4a disease undergoing radical cystectomy with or without preoperative chemotherapy.
    Scand J Urol. 2019 May 13:1-6. doi: 10.1080/21681805.2019.1613445.
    Abstract     Related articles   

  604. XIE Y, Li P, Gao Y, Gu L, et al
    Correction: Reduced E-cadherin expression is correlated with poor prognosis in patients with bladder cancer: a systematic review and meta-analysis.
    Oncotarget. 2019;10:2657.
    Abstract     Related articles   

  605. PANDEY S, Garg RK, Malhotra HS, Uniyal R, et al
    Atypical frontal lobe seizure as the first manifestation of gall-bladder cancer: a case report.
    BMC Neurol. 2019;19:95.
    Abstract     Related articles   

  606. LONG X, Xiong W, Zeng X, Qi L, et al
    Cancer-associated fibroblasts promote cisplatin resistance in bladder cancer cells by increasing IGF-1/ERbeta/Bcl-2 signalling.
    Cell Death Dis. 2019;10:375.
    Abstract     Related articles   

  607. WESTHOFF E, Kampman E, Aben KK, Hendriks IG, et al
    Low awareness, adherence, and practice but positive attitudes regarding lifestyle recommendations among non-muscle-invasive bladder cancer patients.
    Urol Oncol. 2019 May 8. pii: S1078-1439(19)30149.
    Abstract     Related articles   

  608. NAZEMI A, Ghodoussipour S, Pearce S, Bhanvadia S, et al
    Socioeconomic and insurance status are independent prognostic indicators of higher disease stage and worse prognosis in bladder cancer.
    Urol Oncol. 2019 May 8. pii: S1078-1439(19)30154.
    Abstract     Related articles   

  609. HAYASHI Y, Fujita K, Matsuzaki K, Matsushita M, et al
    Diagnostic potential of TERT promoter and FGFR3 mutations in urinary cell-free DNA in upper tract urothelial carcinoma.
    Cancer Sci. 2019;110:1771-1779.
    Abstract     Related articles   

  610. KOGUCHI D, Matsumoto K, Ikeda M, Taoka Y, et al
    Histologic variants associated with biological aggressiveness and poor prognosis in patients treated with radical cystectomy.
    Jpn J Clin Oncol. 2019;49:373-378.
    Abstract     Related articles   

  611. ANWAR T, Malm-Buatsi E
    Propranolol as an effective therapy for infantile haemangioma of the urinary bladder.
    BMJ Case Rep. 2019;12.
    Abstract     Related articles   

  612. JUNG M, Lee JH, Kim B, Park JH, et al
    Transcriptional Analysis of Immunohistochemically Defined Subgroups of Non-Muscle-Invasive Papillary High-Grade Upper Tract Urothelial Carcinoma.
    Int J Mol Sci. 2019;20.
    Abstract     Related articles   

  613. PEREIRA R, McGeorge S, Perera M, Vela I, et al
    Urachal Mucinous Cystadenocarcinoma.
    BMJ Case Rep. 2019;12.
    Abstract     Related articles   

  614. BAGHDADI A, Hussein AA, Ahmed Y, Cavuoto LA, et al
    A computer vision technique for automated assessment of surgical performance using surgeons' console-feed videos.
    Int J Comput Assist Radiol Surg. 2019;14:697-707.
    Abstract     Related articles   

  615. LI JR, Chiu KY, Ou YC, Wang SS, et al
    Alteration in serum concentrations of FGF19, FGF21, and FGF23 in patients with urothelial carcinoma.
    Biofactors. 2019;45:62-68.
    Abstract     Related articles   

  616. FISCHER-VALUCK BW, Michalski JM, Mitra N, Christodouleas JP, et al
    Effectiveness of postoperative radiotherapy after radical cystectomy for locally advanced bladder cancer.
    Cancer Med. 2019 May 22. doi: 10.1002/cam4.2102.
    Abstract     Related articles   

  617. GIL D, Zarzycka M, Dulinska-Litewka J, Ciolczyk-Wierzbicka D, et al
    Dihydrotestosterone increases the risk of bladder cancer in men.
    Hum Cell. 2019 May 22. pii: 10.1007/s13577-019-00255.
    Abstract     Related articles   

  618. WANG C, Zhu X, Li A, Yang S, et al
    S100A16 regulated by Snail promotes the chemoresistance of nonmuscle invasive bladder cancer through the AKT/Bcl-2 pathway.
    Cancer Manag Res. 2019;11:2449-2456.
    Abstract     Related articles   

  619. FLAIG TW
    NCCN Guidelines Updates: Management of Muscle-Invasive Bladder Cancer.
    J Natl Compr Canc Netw. 2019;17.
    Abstract     Related articles   

  620. LI B, Xie D, Zhang H
    Long non-coding RNA GHET1 contributes to chemotherapeutic resistance to Gemcitabine in bladder cancer.
    Cancer Chemother Pharmacol. 2019 May 21. pii: 10.1007/s00280-019-03873.
    Abstract     Related articles   

  621. ZHAO X, Wang D, Ding Y, Zhou J, et al
    lncRNA ZEB1-AS1 promotes migration and metastasis of bladder cancer cells by post-transcriptional activation of ZEB1.
    Int J Mol Med. 2019 May 8. doi: 10.3892/ijmm.2019.4187.
    Abstract     Related articles   

  622. NAKAHARA K, Yamasaki K, Nagai T, Fujii M, et al
    Expression of protease activating receptor-2 (PAR-2) is positively correlated with the recurrence of non-muscle invasive bladder cancer: an immunohistochemical analysis.
    Res Rep Urol. 2019;11:97-104.
    Abstract     Related articles   

  623. MAURYA N, Singh R, Goel A, Singhai A, et al
    Clinicohistopathological implications of phosphoserine 9 glycogen synthase kinase-3beta/ beta-catenin in urinary bladder cancer patients.
    World J Clin Oncol. 2019;10:166-182.
    Abstract     Related articles   

  624. SHI MJ, Meng XY, Wu QJ, Zhou XH, et al
    High CD3D/CD4 ratio predicts better survival in muscle-invasive bladder cancer.
    Cancer Manag Res. 2019;11:2987-2995.
    Abstract     Related articles   

  625. HAN C, Ma T, Lei D, Xie S, et al
    Effect of ultrasound-guided proximal and distal approach for obturator nerve block in transurethral resection of bladder cancer under spinal anesthesia.
    Cancer Manag Res. 2019;11:2499-2505.
    Abstract     Related articles   

  626. XU X, Zhang G, He L, Zhu Y, et al
    Clinicopathological impacts of c-Met overexpression in bladder cancer: evidence from 1,336 cases.
    Onco Targets Ther. 2019;12:2695-2702.
    Abstract     Related articles   

  627. KROCHMAL M, van Kessel KEM, Zwarthoff EC, Belczacka I, et al
    Urinary peptide panel for prognostic assessment of bladder cancer relapse.
    Sci Rep. 2019;9:7635.
    Abstract     Related articles   

  628. SANCAR F
    Precision Approach to Bladder Cancer.
    JAMA. 2019;321:1862.
    Abstract     Related articles   

  629. KONG J, Diao X, Diao F, Fan X, et al
    Causes of death in long-term bladder cancer survivors: A population-based study.
    Asia Pac J Clin Oncol. 2019 May 20. doi: 10.1111/ajco.13156.
    Abstract     Related articles   

  630. WAINGANKAR N, Jia R, Marqueen KE, Audenet F, et al
    The impact of pathologic response to neoadjuvant chemotherapy on conditional survival among patients with muscle-invasive bladder cancer.
    Urol Oncol. 2019 May 18. pii: S1078-1439(19)30160.
    Abstract     Related articles   

  631. BURDEN S, Billson HA, Lal S, Owen KA, et al
    Perioperative nutrition for the treatment of bladder cancer by radical cystectomy.
    Cochrane Database Syst Rev. 2019;5:CD010127.
    Abstract     Related articles   

  632. HUANG J, Shiao SL, Furuya H, Rosser CJ, et al
    Immunogenomic Analysis of Exceptional Responder to ALT-803 (IL-15 Analogue) in BCG Unresponsive Nonmuscle Invasive Bladder Cancer: A Case Series and Review of the Literature.
    J Immunother. 2019 May 15. doi: 10.1097/CJI.0000000000000269.
    Abstract     Related articles   

  633. WU SC, Kwon D, Jue JS, Chen FV, et al
    Androgen Suppression Therapy Is Associated with Lower Recurrence of Non-muscle-invasive Bladder Cancer.
    Eur Urol Focus. 2019 May 15. pii: S2405-4569(19)30141.
    Abstract     Related articles   

  634. SANKIN A, Chand D, Schoenberg M, Zang X, et al
    Human urothelial bladder cancer generates a clonal immune response: The results of T-cell receptor sequencing.
    Urol Oncol. 2019 May 15. pii: S1078-1439(19)30144.
    Abstract     Related articles   

  635. SONG D, Powles T, Shi L, Zhang L, et al
    Bladder cancer, a unique model to understand cancer immunity and develop immunotherapy approaches.
    J Pathol. 2019 May 18. doi: 10.1002/path.5306.
    Abstract     Related articles   

  636. STANIK M, Poprach A, Zapletalova M, Krejci D, et al
    Comparison of Different Treatment Modalities Outcomes in Clinically Node-positive Bladder Cancer: Analysis of a Population-based Cancer Registry.
    Clin Genitourin Cancer. 2019 Apr 16. pii: S1558-7673(19)30133.
    Abstract     Related articles   

  637. DONG W, Bi J, Liu H, Yan D, et al
    Circular RNA ACVR2A suppresses bladder cancer cells proliferation and metastasis through miR-626/EYA4 axis.
    Mol Cancer. 2019;18:95.
    Abstract     Related articles   

  638. LORAS A, Suarez-Cabrera C, Martinez-Bisbal MC, Quintas G, et al
    Integrative Metabolomic and Transcriptomic Analysis for the Study of Bladder Cancer.
    Cancers (Basel). 2019;11.
    Abstract     Related articles   

  639. BERMEJO LM, Lopez-Plaza B, Santurino C, Cavero-Redondo I, et al
    Milk and Dairy Product Consumption and Bladder Cancer Risk: A Systematic Review and Meta-Analysis of Observational Studies.
    Adv Nutr. 2019;10.
    Abstract     Related articles   

  640. FLAUS A, Longo MG, Dematons M, Granjon D, et al
    18F-FDG PET/CT in Urachal Abscess.
    Clin Nucl Med. 2019 Mar 1. doi: 10.1097/RLU.0000000000002524.
    Abstract     Related articles   

  641. BILLGER M, Kirk J, Chang J, Bedard A, et al
    A study in a rat initiation-promotion bladder tumour model demonstrated no promoter/progressor potential of dapagliflozin.
    Regul Toxicol Pharmacol. 2019;103:166-173.
    Abstract     Related articles   

  642. JOHANSSON VR, von Vogelsang AC
    Patient-reported extremity symptoms after robot-assisted laparoscopic cystectomy.
    J Clin Nurs. 2019;28.
    Abstract     Related articles   

  643. EL RASSY E, Assi T, Bakouny Z, Pavlidis N, et al
    Beyond first-line systemic treatment for metastatic urothelial carcinoma of the bladder.
    Clin Transl Oncol. 2019;21:280-288.
    Abstract     Related articles   

  644. YU EY, Wesselius A, van Osch F, Stern MC, et al
    The association between coffee consumption and bladder cancer in the bladder cancer epidemiology and nutritional determinants (BLEND) international pooled study.
    Cancer Causes Control. 2019 May 30. pii: 10.1007/s10552-019-01191.
    Abstract     Related articles   

  645. TIAN H, Wang X, Lu J, Tian W, et al
    MicroRNA-621 inhibits cell proliferation and metastasis in bladder cancer by suppressing Wnt/beta-catenin signaling.
    Chem Biol Interact. 2019 May 27. pii: S0009-2797(19)30587.
    Abstract     Related articles   

  646. JAHNSON S, Gardmark T, Hosseini A, Jerlstrom T, et al
    Management and outcome of TaG3 tumours of the urinary bladder in the nationwide, population-based bladder cancer database Sweden (BladderBaSe).
    Scand J Urol. 2019 May 30:1-6. doi: 10.1080/21681805.2019.1621377.
    Abstract     Related articles   

  647. POLI G, Egidi MG, Cochetti G, Brancorsini S, et al
    Relationship between cellular and exosomal miRNAs targeting NOD-like receptors in bladder cancer: preliminary results.
    Minerva Urol Nefrol. 2019 May 28. pii: S0393-2249.19.03297.
    Abstract     Related articles   

  648. DUMONT C, Gauthier H, Bonnet C, Culine S, et al
    Understanding chemotherapy-induced changes in bladder cancer biology: a necessary step towards tailored treatment in cisplatin-refractory disease.
    Transl Androl Urol. 2019;8.
    Abstract     Related articles   

  649. JOSHI M, Warrick JI, Yin M, Holder SL, et al
    Need for a personalized approach for muscle invasive bladder cancer: role of tumor biology in response to neoadjuvant chemotherapy.
    Transl Androl Urol. 2019;8.
    Abstract     Related articles   

  650. VANDERWEELE DJ, Meeks JJ, Hussain M
    Can post-neoadjuvant therapy molecular classification guide future treatment selection for muscle-invasive bladder cancer?
    Transl Androl Urol. 2019;8.
    Abstract     Related articles   

  651. LI Q, Zhang P, Wang Y, Zhang Y, et al
    Association between AXIN1 Gene Polymorphisms and Bladder Cancer in Chinese Han Population.
    Dis Markers. 2019;2019:3949343.
    Abstract     Related articles   

  652. ZHOU ZF, Fang JB, Chen L, Wang HF, et al
    Effects of intraoperative PEEP on postoperative pulmonary complications in patients undergoing robot-assisted laparoscopic radical resection for bladder cancer or prostate cancer: study protocol for a randomized controlled trial.
    Trials. 2019;20:304.
    Abstract     Related articles   

  653. YOSHIDA K, Tsuda M, Matsumoto R, Semba S, et al
    Exosomes containing ErbB2/CRK induce vascular growth in premetastatic niches and promote metastasis of bladder cancer.
    Cancer Sci. 2019 May 29. doi: 10.1111/cas.14080.
    Abstract     Related articles   

  654. BUCKWALTER JM, Chan W, Shuman L, Wildermuth T, et al
    Characterization of Histone Deacetylase Expression Within In Vitro and In Vivo Bladder Cancer Model Systems.
    Int J Mol Sci. 2019;20.
    Abstract     Related articles   

  655. GARG M, Singh R
    Epithelial-to-mesenchymal transition: Event and core associates in bladder cancer.
    Front Biosci (Elite Ed). 2019;11:150-165.
    Abstract     Related articles   

  656. YAN X, Liu XP, Guo ZX, Liu TZ, et al
    Identification of Hub Genes Associated With Progression and Prognosis in Patients With Bladder Cancer.
    Front Genet. 2019;10:408.
    Abstract     Related articles   

  657. WANG Y, Chang A, Tan WP, Fantony JJ, et al
    Diet and Exercise Are not Associated with Skeletal Muscle Mass and Sarcopenia in Patients with Bladder Cancer.
    Eur Urol Oncol. 2019 May 25. pii: S2588-9311(19)30061.
    Abstract     Related articles   

  658. YUAN W, Zhou R, Wang J, Han J, et al
    Circular RNA Cdr1as sensitizes bladder cancer to cisplatin by upregulating APAF1 expression through miR-1270 inhibition.
    Mol Oncol. 2019 May 26. doi: 10.1002/1878-0261.12523.
    Abstract     Related articles   

  659. CHEN L, Xiong W, Guo W, Su S, et al
    Significance of CLASP2 expression in prognosis for muscle-invasive bladder cancer patients: A propensity score-based analysis.
    Urol Oncol. 2019 May 23. pii: S1078-1439(19)30189.
    Abstract     Related articles   

  660. LI Z, Li Y, Wang Y
    miR-19a promotes invasion and epithelial to mesenchymal transition of bladder cancer cells by targeting RhoB.
    J BUON. 2019;24:797-804.
    Abstract     Related articles   

  661. LIU X, Zhao W, Wang X, Zhu Y, et al
    Expression of mir-143 in serum of bladder cancer patients and its correlation with clinical features and prognosis.
    J BUON. 2019;24:791-796.
    Abstract     Related articles   

  662. LV WL, Liu Q, An JH, Song XY, et al
    Scutellarin inhibits hypoxia-induced epithelial-mesenchymal transition in bladder cancer cells.
    J Cell Physiol. 2019 May 24. doi: 10.1002/jcp.28883.
    Abstract     Related articles   

  663. DI MAIDA F, Mari A, Scalici Gesolfo C, Cangemi A, et al
    Epidermal Growth Factor Receptor (EGFR) Cell Expression During Adjuvant Treatment After Transurethral Resection for Non-Muscle-Invasive Bladder Cancer: A New Potential Tool to Identify Patients at Higher Risk of Disease Progression.
    Clin Genitourin Cancer. 2019 Apr 26. pii: S1558-7673(19)30134.
    Abstract     Related articles   

  664. WANG X, Lyu J, Ji A, Zhang Q, et al
    Jarid2 enhances the progression of bladder cancer through regulating PTEN/AKT signaling.
    Life Sci. 2019 May 21. pii: S0024-3205(19)30409.
    Abstract     Related articles   

  665. ZHU H, Chen H, Wang J, Zhou L, et al
    Collagen stiffness promoted non-muscle-invasive bladder cancer progression to muscle-invasive bladder cancer.
    Onco Targets Ther. 2019;12:3441-3457.
    Abstract     Related articles   

  666. VARUGHESE M, Treece S, Drinkwater KJ
    Radiotherapy Management of Muscle Invasive Bladder Cancer: Evaluation of a National Cohort.
    Clin Oncol (R Coll Radiol). 2019 May 20. pii: S0936-6555(19)30184.
    Abstract     Related articles   

  667. SHI G, Liu Q, Chen H, Feng F, et al
    Percutaneous osteoplasty for the management of a humeral head metastasis: Two case reports.
    Medicine (Baltimore). 2019;98:e15727.
    Abstract     Related articles   

  668. KOYANAGI Y, Kubo C, Nagata S, Ryu A, et al
    Detection of pagetoid urothelial intraepithelial neoplasia extending to the vagina by cervical screening cytology: a case report with renewed immunochemical summary.
    Diagn Pathol. 2019;14:9.
    Abstract     Related articles   

  669. GOFRIT ON, Bercovier H, Klein BY, Cohen IR, et al
    Can immunization with Bacillus Calmette-Guerin (BCG) protect against Alzheimer's disease?
    Med Hypotheses. 2019;123:95-97.
    Abstract     Related articles   

  670. ITANO N
    Implications of altered O-glycosylation in tumour immune evasion.
    J Biochem. 2019;165:387-390.
    Abstract     Related articles   

  671. FILICE FP, Ding Z
    Analysing single live cells by scanning electrochemical microscopy.
    Analyst. 2019;144:738-752.
    Abstract     Related articles   

  672. MATSUURA H, Arase S, Hori Y
    Ureteral stents for malignant extrinsic ureteral obstruction: outcomes and factors predicting stent failure.
    Int J Clin Oncol. 2019;24:306-312.
    Abstract     Related articles   

  673. KOO CH, Chung SH, Kim BG, Min BH, et al
    Comparison between the effects of deep and moderate neuromuscular blockade during transurethral resection of bladder tumor on endoscopic surgical condition and recovery profile: a prospective, randomized, and controlled trial.
    World J Urol. 2019;37:359-365.
    Abstract     Related articles   

  674. VARTOLOMEI MD, Iwata T, Roth B, Kimura S, et al
    Impact of alcohol consumption on the risk of developing bladder cancer: a systematic review and meta-analysis.
    World J Urol. 2019 Jun 6. pii: 10.1007/s00345-019-02825.
    Abstract     Related articles   

  675. JACYNA J, Wawrzyniak R, Balayssac S, Gilard V, et al
    Urinary metabolomic signature of muscle-invasive bladder cancer: A multiplatform approach.
    Talanta. 2019;202:572-579.
    Abstract     Related articles   

  676. RYBICKI F JR, Glanc P
    Patient-Friendly Summary of the ACR Appropriateness Criteria: Pretreatment Staging of Muscle-Invasive Bladder Cancer.
    J Am Coll Radiol. 2019;16:e25.
    Abstract     Related articles   

  677. LIU L, Wu SQ, Zhu X, Xu R, et al
    Analysis of ceRNA network identifies prognostic circRNA biomarkers in bladder cancer.
    Neoplasma. 2019;2019.
    Abstract     Related articles   

  678. LIU L, Wu SQ, Zhu X, Xu R, et al
    Analysis of ceRNA network identifies prognostic circRNA biomarkers in bladder cancer.
    Neoplasma. 2019;2019.
    Abstract     Related articles   

  679. JUENGEL E, Natsheh I, Najafi R, Rutz J, et al
    Mechanisms behind Temsirolimus Resistance Causing Reactivated Growth and Invasive Behavior of Bladder Cancer Cells In Vitro.
    Cancers (Basel). 2019;11.
    Abstract     Related articles   

  680. TIAN Z, Luo Y, Zhu J, Hua X, et al
    Transcriptionally elevation of miR-494 by new ChlA-F compound via a HuR/JunB axis inhibits human bladder cancer cell invasion.
    Biochim Biophys Acta Gene Regul Mech. 2019 Jun 2. pii: S1874-9399(19)30018.
    Abstract     Related articles   

  681. WILLIAMS SB, Shan Y, Ray-Zack MD, Hudgins HK, et al
    Comparison of Costs of Radical Cystectomy vs Trimodal Therapy for Patients With Localized Muscle-Invasive Bladder Cancer.
    JAMA Surg. 2019 Jun 5:e191629. doi: 10.1001/jamasurg.2019.1629.
    Abstract     Related articles   

  682. COLE AP, Trinh QD
    Trimodal Therapy for Bladder Cancer: You Get What You Don't Pay for.
    JAMA Surg. 2019 Jun 5:e191637. doi: 10.1001/jamasurg.2019.1637.
    Abstract     Related articles   

  683. PAK S, You D, Jeong IG, Song C, et al
    Adjuvant chemotherapy versus observation after radical cystectomy in patients with node-positive bladder cancer.
    Sci Rep. 2019;9:8305.
    Abstract     Related articles   

  684. LU BS, Yin YW, Zhang YP, Guo PY, et al
    Upregulation of NPL4 promotes bladder cancer cell proliferation by inhibiting DXO destabilization of cyclin D1 mRNA.
    Cancer Cell Int. 2019;19:149.
    Abstract     Related articles   

  685. KORPAL M, Puyang X, Wu ZJ, Seiler R, et al
    Author Correction: Evasion of immunosurveillance by genomic alterations of PPARgamma/RXRalpha in bladder cancer.
    Nat Commun. 2019;10:2527.
    Abstract     Related articles   

  686. HUANG J, Lo UG, Wu S, Wang B, et al
    The roles and mechanism of IFIT5 in bladder cancer epithelial-mesenchymal transition and progression.
    Cell Death Dis. 2019;10:437.
    Abstract     Related articles   

  687. AYDIN M, Bitkin A, Kadihasanoglu M, Irkilata L, et al
    Correlation of neutrophil-lymphocyte ratio and risk scores in non-muscle invasive bladder cancer.
    Actas Urol Esp. 2019 Jun 1. pii: S0210-4806(19)30073.
    Abstract     Related articles   

  688. DUPLISEA JJ, Dinney CPN
    Should chemotherapy still be used to treat all muscle invasive bladder cancer in the "era of immunotherapy"?
    Expert Rev Anticancer Ther. 2019 Jun 5:1-3. doi: 10.1080/14737140.2019.1625773.
    Abstract     Related articles   

  689. SHIGEMATSU Y, Oue N, Sekino Y, Sakamoto N, et al
    SEC11A Expression Is Associated with Basal-Like Bladder Cancer and Predicts Patient Survival.
    Pathobiology. 2019 Jun 4:1-9. doi: 10.1159/000497206.
    Abstract     Related articles   

  690. LI G, Zhang Y, Mao J, Hu P, et al
    lncRNA TUC338 is a potential diagnostic biomarker for bladder cancer.
    J Cell Biochem. 2019 Jun 4. doi: 10.1002/jcb.29104.
    Abstract     Related articles   

  691. HERNANDEZ-PRAT A, Rodriguez-Vida A, Juanpere-Rodero N, Arpi O, et al
    Novel oral mTORC1/2 inhibitor TAK-228 has synergistic antitumor effects when combined with paclitaxel or PI3Kalpha inhibitor TAK-117 in preclinical bladder cancer models.
    Mol Cancer Res. 2019 Jun 3. pii: 1541-7786.MCR-18-0923.
    Abstract     Related articles   

  692. MAEDA S, Murakami K, Inoue A, Yonezawa T, et al
    CCR4 Blockade Depletes Regulatory T Cells and Prolongs Survival in a Canine Model of Bladder Cancer.
    Cancer Immunol Res. 2019 Jun 3. pii: 2326-6066.CIR-18-0751.
    Abstract     Related articles   

  693. CARNEIRO BDB, Sanches BCF, Andrade DL, Voris BRI, et al
    Moreau Strain Bacillus Calmette-Guerin Low Versus Standard Dose in the Treatment of High-Grade T1 Bladder Cancer: A Retrospective Observational Cohort Study.
    Clin Genitourin Cancer. 2019 Apr 16. pii: S1558-7673(19)30129.
    Abstract     Related articles   

  694. BLINOVA E, Roshchin D, Kogan E, Samishina E, et al
    Patient-Derived Non-Muscular Invasive Bladder Cancer Xenografts of Main Molecular Subtypes of the Tumor for Anti-Pd-l1 Treatment Assessment.
    Cells. 2019;8.
    Abstract     Related articles   

  695. TRENTI E, D'Elia C, Mian C, Schwienbacher C, et al
    Diagnostic predictive value of the Bladder EpiCheck test in the follow-up of patients with non-muscle-invasive bladder cancer.
    Cancer Cytopathol. 2019 Jun 2. doi: 10.1002/cncy.22152.
    Abstract     Related articles   

  696. BOCHENEK K, Aebisher D, Miedzybrodzka A, Cieslar G, et al
    Methods of bladder cancer diagnostics - the role of autofluorescence and photodynamic diagnosis.
    Photodiagnosis Photodyn Ther. 2019 May 29. pii: S1572-1000(19)30126.
    Abstract     Related articles   

    Urologic Malignancies.
    Prim Care. 2019;46:275-285.
    Abstract     Related articles   

  698. HOLLAND BC, Sood A, Delfino K, Dynda DI, et al
    Age and sex have no impact on expression levels of markers of immune cell infiltration and immune checkpoint pathways in patients with muscle-invasive urothelial carcinoma of the bladder treated with radical cystectomy.
    Cancer Immunol Immunother. 2019;68:991-997.
    Abstract     Related articles   

  699. TSUI KH, Hou CP, Chang KS, Lin YH, et al
    Metallothionein 3 Is a Hypoxia-Upregulated Oncogene Enhancing Cell Invasion and Tumorigenesis in Human Bladder Carcinoma Cells.
    Int J Mol Sci. 2019;20.
    Abstract     Related articles   

  700. TSE J, Ghandour R, Singla N, Lotan Y, et al
    Molecular Predictors of Complete Response Following Neoadjuvant Chemotherapy in Urothelial Carcinoma of the Bladder and Upper Tracts.
    Int J Mol Sci. 2019;20.
    Abstract     Related articles   

  701. RADES D, Sondermann L, Motisi L, Janssen S, et al
    Prognostic Factors and a Survival Score in Patients Irradiated for Metastatic Epidural Spinal Cord Compression from Urothelial Carcinoma Cancer of the Bladder.
    Anticancer Res. 2018;38:6841-6846.
    Abstract     Related articles   

  702. KUSUHARA Y, Daizumoto K, Kawai K, Hirayama K, et al
    Low Expression of Toll-like Receptor 4 Is Associated With Poor Prognosis in Bladder Cancer.
    Anticancer Res. 2019;39:703-711.
    Abstract     Related articles   

  703. VASYUTIN I, Zerihun L, Ivan C, Atala A, et al
    Bladder Organoids and Spheroids: Potential Tools for Normal and Diseased Tissue Modelling.
    Anticancer Res. 2019;39:1105-1118.
    Abstract     Related articles   

  704. KUMAGAI-TOGASHI A, Uozaki H, Kikuchi Y, Watabe S, et al
    Tumorous CD10 Is More Strongly Related to the Progression of Urothelial Carcinoma than Stromal CD10.
    Anticancer Res. 2019;39:635-640.
    Abstract     Related articles   

  705. HANADA E, Kageyama S, Murai R, Kubota S, et al
    Pro-GA, a Novel Inhibitor of gamma-Glutamylcyclotransferase, Suppresses Human Bladder Cancer Cell Growth.
    Anticancer Res. 2019;39:1893-1898.
    Abstract     Related articles   

  706. HUANG AC, Cheng YD, Huang LH, Hsiao YT, et al
    Casticin Induces DNA Damage and Impairs DNA Repair in Human Bladder Cancer TSGH-8301 Cells.
    Anticancer Res. 2019;39:1839-1847.
    Abstract     Related articles   

  707. NAKAMURA Y, Miyata Y, Takehara K, Asai A, et al
    The Pathological Significance and Prognostic Roles of Thrombospondin-1, and -2, and 4N1K-peptide in Bladder Cancer.
    Anticancer Res. 2019;39:2317-2324.
    Abstract     Related articles   

  708. BOERI L, Soligo M, Frank I, Boorjian SA, et al
    Cigarette smoking is associated with adverse pathological response and increased disease recurrence amongst patients with muscle-invasive bladder cancer treated with cisplatin-based neoadjuvant chemotherapy and radical cystectomy: a single-centre expe
    BJU Int. 2019 Jan 8. doi: 10.1111/bju.14612.
    Abstract     Related articles   

  709. BAJIC P, Wolfe AJ, Gupta GN
    Old Instillations and New Implications in Bladder Cancer: The Urinary Microbiome and Intravesical BCG.
    BJU Int. 2019 Jan 21. doi: 10.1111/bju.14683.
    Abstract     Related articles   

  710. D'ANDREA D, Soria F, Zehetmayer S, Gust KM, et al
    Diagnostic accuracy, clinical utility and influence on decision making of a methylation urine biomarker test in the surveillance of non-muscle-invasive bladder cancer.
    BJU Int. 2019 Jan 17. doi: 10.1111/bju.14673.
    Abstract     Related articles   

  711. TAN WS, Teo CH, Chan D, Heinrich M, et al
    Mix methods approach to explore patients' perspectives on the acceptability of a urinary biomarker test in replacement of cystoscopy in bladder cancer surveillance.
    BJU Int. 2019 Jan 29. doi: 10.1111/bju.14690.
    Abstract     Related articles   

  712. MMEJE CO, Benson CR, Nogueras-Gonzalez GM, Jayaratna IS, et al
    Determining the optimal time for radical cystectomy after neoadjuvant chemotherapy.
    BJU Int. 2018;122:89-98.
    Abstract     Related articles   

  713. JEFFERIES ER, Cresswell J, McGrath JS, Miller C, et al
    Open radical cystectomy in England: the current standard of care - an analysis of the British Association of Urological Surgeons (BAUS) cystectomy audit and Hospital Episodes Statistics (HES) data.
    BJU Int. 2018;121:880-885.
    Abstract     Related articles   

  714. HUGAR LA, Lopa SH, Yabes JG, Yu JA, et al
    Palliative Care Use Among Patients with Bladder Cancer.
    BJU Int. 2019 Feb 13. doi: 10.1111/bju.14708.
    Abstract     Related articles   

  715. BRASSETTI A, Moller A, Laurin O, Hoijer J, et al
    Evolution of cystectomy care over an 11-year period in a high-volume tertiary referral centre.
    BJU Int. 2018;121:752-757.
    Abstract     Related articles   

  716. KIJIMA T, Tanaka H, Koga F, Masuda H, et al
    Selective Tetramodal Bladder Preservation Therapy Incorporating Induction Chemoradiotherapy and Consolidative Partial Cystectomy with Pelvic Lymph Node Dissection for Muscle-Invasive Bladder Cancer: Oncological and Functional Outcomes of 107 Patients.
    BJU Int. 2019 Feb 27. doi: 10.1111/bju.14736.
    Abstract     Related articles   

  717. TARIQ A, Khan SR, Vela I, Williams ED, et al
    Assessment of bladder cancer patients and carers use of internet, social media and quality of available patient centric online resources: A systematic review.
    BJU Int. 2019 Feb 24. doi: 10.1111/bju.14720.
    Abstract     Related articles   

    Postoperative intravesical chemotherapy has an important role in reducing subsequent bladder tumours - why is it not routine?
    BJU Int. 2018;122:525-526.
    Abstract     Related articles   

  719. GROSS T, Furrer M, Schorno P, Wuethrich PY, et al
    Reproductive organ-sparing cystectomy significantly improves continence in women after orthotopic bladder substitution without affecting oncological outcome.
    BJU Int. 2018;122:227-235.
    Abstract     Related articles   

  720. MOSSANEN M, Kibel AS
    The bladder cancer conundrum: how do we treat the right tumour with the right treatment, at the right time?
    BJU Int. 2019;123:748-749.
    Abstract     Related articles   

  721. SEILER R, Wyatt AW, Black PC
    Molecular landscape of muscle-invasive bladder cancer: Patient age matter?
    BJU Int. 2019 May 9. doi: 10.1111/bju.14802.
    Abstract     Related articles   

  722. WARD DG, Gordon NS, Boucher RH, Pirrie SJ, et al
    Targeted deep sequencing of urothelial bladder cancers and associated urinary DNA: a 23-gene panel with utility for non-invasive diagnosis and risk stratification.
    BJU Int. 2019 May 11. doi: 10.1111/bju.14808.
    Abstract     Related articles   

  723. YU EY, Nekeman D, Aaronson NK, Billingham LJ, et al
    Health-Related Quality of Life in Bladder Cancer Patients around the Time of Diagnosis.
    BJU Int. 2019 May 11. doi: 10.1111/bju.14804.
    Abstract     Related articles   

    Palliative care in patients with bladder cancer: an opportunity for value improvement?
    BJU Int. 2019;123:913-914.
    Abstract     Related articles   

  725. DUFOUR F, Silina L, Neyret-Kahn H, Moreno-Vega A, et al
    TYRO3 as a molecular target for growth inhibition and apoptosis induction in bladder cancer.
    Br J Cancer. 2019 Feb 15. pii: 10.1038/s41416-019-0397.
    Abstract     Related articles   

  726. VANTAKU V, Donepudi SR, Piyarathna DWB, Sekhar Amara C, et al
    Large-scale profiling of serum metabolites in African American and European American patients with bladder cancer reveals metabolic pathways associated with patient survival.
    Cancer. 2019 Jan 2. doi: 10.1002/cncr.31890.
    Abstract     Related articles   

  727. COLE AP, Fletcher SA, Berg S, Nabi J, et al
    Impact of tumor, treatment, and access on outcomes in bladder cancer: Can equal access overcome race-based differences in survival?
    Cancer. 2019 Jan 11. doi: 10.1002/cncr.31926.
    Abstract     Related articles   

  728. CHU AT, Holt SK, Wright JL, Ramos JD, et al
    Delays in radical cystectomy for muscle-invasive bladder cancer.
    Cancer. 2019 Mar 6. doi: 10.1002/cncr.32048.
    Abstract     Related articles   

  729. MASIC S, Smaldone MC
    Treatment delays for muscle-invasive bladder cancer.
    Cancer. 2019 Mar 6. doi: 10.1002/cncr.32047.
    Abstract     Related articles   

  730. SCHROECK FR, Lynch KE, Li Z, MacKenzie TA, et al
    The impact of frequent cystoscopy on surgical care and cancer outcomes among patients with low-risk, non-muscle-invasive bladder cancer.
    Cancer. 2019 May 23. doi: 10.1002/cncr.32185.
    Abstract     Related articles   

  731. MARTINI A, Jia R, Ferket BS, Waingankar N, et al
    Tumor downstaging as an intermediate endpoint to assess the activity of neoadjuvant systemic therapy in patients with muscle-invasive bladder cancer.
    Cancer. 2019 May 31. doi: 10.1002/cncr.32169.
    Abstract     Related articles   

  732. YU C, Liu Z, Chen Q, Li Y, et al
    Nkx2.8 Inhibits Epithelial-Mesenchymal Transition in Bladder Urothelial Carcinoma via Transcriptional Repression of Twist1.
    Cancer Res. 2018;78:1241-1252.
    Abstract     Related articles   

  733. WANG Z, Cao D, Qi Z, Pang Y, et al
    Retinoic acid-related orphan receptor C regulates proliferation, glycolysis, and chemoresistance via the PD-L1/ITGB6/STAT3 signaling axis in bladder cancer.
    Cancer Res. 2019 Feb 26. pii: 0008-5472.CAN-18-3842.
    Abstract     Related articles   

  734. AVGERIS M, Tsilimantou A, Levis PK, Rampias T, et al
    Unraveling UCA1 lncRNA prognostic utility in urothelial bladder cancer.
    Carcinogenesis. 2019 Feb 27. pii: 5366409. doi: 10.1093.
    Abstract     Related articles   

  735. VANTAKU V, Dong J, Ambati CR, Perera D, et al
    sMulti-omics integration analysis robustly predicts high-grade patient survival and identifies CPT1B effect on fatty acid metabolism in Bladder Cancer.
    Clin Cancer Res. 2019 Mar 7. pii: 1078-0432.CCR-18-1515.
    Abstract     Related articles   

  736. KISS B, van den Berg NS, Ertsey R, McKenna K, et al
    CD47-targeted Near-Infrared Photoimmunotherapy for Human Bladder Cancer.
    Clin Cancer Res. 2019 Mar 19. pii: 1078-0432.CCR-18-3267.
    Abstract     Related articles   

  737. BATISTA DA COSTA J, Gibb EA, Bivalacqua TJ, Liu Y, et al
    Molecular characterization of neuroendocrine-like bladder cancer.
    Clin Cancer Res. 2019 Apr 5. pii: 1078-0432.CCR-18-3558.
    Abstract     Related articles   

  738. CHENG THT, Jiang P, Teoh JYC, Heung MMS, et al
    Noninvasive Detection of Bladder Cancer by Shallow-Depth Genome-Wide Bisulfite Sequencing of Urinary Cell-Free DNA for Methylation and Copy Number Profiling.
    Clin Chem. 2019 Apr 15. pii: clinchem.2018.301341.
    Abstract     Related articles   

  739. NASER-TAVAKOLIAN A, Ghodoussipour S, Djaladat H
    Upper urinary tract recurrence following bladder cancer therapy: a review of surveillance and management.
    Curr Opin Urol. 2019 Feb 11. doi: 10.1097/MOU.0000000000000598.
    Abstract     Related articles   

  740. MUKHERJEE N, Wheeler KM, Svatek RS
    Bacillus Calmette-Guerin treatment of bladder cancer: a systematic review and commentary on recent publications.
    Curr Opin Urol. 2019 Feb 11. doi: 10.1097/MOU.0000000000000595.
    Abstract     Related articles   

  741. MUN DH, Kimura S, Shariat SF, Abufaraj M, et al
    The impact of gender on oncologic outcomes of bladder cancer.
    Curr Opin Urol. 2019 Mar 6. doi: 10.1097/MOU.0000000000000606.
    Abstract     Related articles   

  742. EULITT PJ, Bjurlin MA, Milowsky MI
    Perioperative systemic therapy for bladder cancer.
    Curr Opin Urol. 2019 Mar 6. doi: 10.1097/MOU.0000000000000600.
    Abstract     Related articles   

  743. SMELSER WW, Woolbright BL, Taylor JA 3rd
    Molecular subtyping of bladder cancer: current trends and future directions in 2019.
    Curr Opin Urol. 2019 Mar 6. doi: 10.1097/MOU.0000000000000599.
    Abstract     Related articles   

  744. PHAM A, Ballas LK
    Trimodality therapy for bladder cancer: modern management and future directions.
    Curr Opin Urol. 2019 Mar 6. doi: 10.1097/MOU.0000000000000601.
    Abstract     Related articles   

  745. BHAT A, Ritch CR
    Urinary biomarkers in bladder cancer: where do we stand?
    Curr Opin Urol. 2019 Mar 6. doi: 10.1097/MOU.0000000000000605.
    Abstract     Related articles   

  746. JANISCH F, Shariat SF, Schernhammer E, Rink M, et al
    The interaction of gender and smoking on bladder cancer risks.
    Curr Opin Urol. 2019 Mar 14. doi: 10.1097/MOU.0000000000000602.
    Abstract     Related articles   

  747. DASON S, Goh AC
    Contemporary techniques and outcomes of robotic cystectomy and intracorporeal urinary diversions.
    Curr Opin Urol. 2018;28:115-122.
    Abstract     Related articles   

  748. SATYAL U, Sikder RK, McConkey D, Plimack ER, et al
    Clinical implications of molecular subtyping in bladder cancer.
    Curr Opin Urol. 2019;29:350-356.
    Abstract     Related articles   

  749. CAPURSO G, Archibugi L, Tessieri L, Petrone MC, et al
    Focal immune-related pancreatitis occurring after treatment with programmed cell death 1 inhibitors: a distinct form of autoimmune pancreatitis?
    Eur J Cancer. 2018;95:123-126.
    Abstract     Related articles   

  750. ROUANNE M, Betari R, Radulescu C, Goubar A, et al
    Stromal lymphocyte infiltration is associated with tumour invasion depth but is not prognostic in high-grade T1 bladder cancer.
    Eur J Cancer. 2019;108:111-119.
    Abstract     Related articles   

  751. NECCHI A, Raggi D, Giannatempo P, Alessi A, et al
    Exceptional response to olaparib in BRCA2-altered urothelial carcinoma after PD-L1 inhibitor and chemotherapy failure.
    Eur J Cancer. 2018;96:128-130.
    Abstract     Related articles   

  752. GIANNARINI G, Crestani A, Ficarra V
    Re: Stenting Prior to Cystectomy Is an Independent Risk Factor for Upper Urinary Tract Recurrence.
    Eur Urol. 2018;74:395-396.
    Abstract     Related articles   

  753. SZABADOS B, van Dijk N, Tang YZ, van der Heijden MS, et al
    Response Rate to Chemotherapy After Immune Checkpoint Inhibition in Metastatic Urothelial Cancer.
    Eur Urol. 2018;73:149-152.
    Abstract     Related articles   

  754. YUH B, Chan K, Wilson T
    Robotic Cystectomy-Moving from Innovation to Measurable Impact.
    Eur Urol. 2018;74:472-473.
    Abstract     Related articles   

  755. ZUIVERLOON TCM, Theodorescu D
    Re: Genomic Differences Between "Primary" and "Secondary" Muscle-invasive Bladder Cancer as a Basis for Disparate Outcomes to Cisplatin-based Neoadjuvant Chemotherapy.
    Eur Urol. 2019 Jan 17. pii: S0302-2838(18)31024.
    Abstract     Related articles   

  756. CHOUDHURY A, Hoskin PJ
    Predictive Biomarkers for Muscle-invasive Bladder Cancer: The Search for the Holy Grail Continues.
    Eur Urol. 2019 Feb 4. pii: S0302-2838(19)30086.
    Abstract     Related articles   

  757. EFSTATHIOU JA, Mouw KW, Gibb EA, Liu Y, et al
    Impact of Immune and Stromal Infiltration on Outcomes Following Bladder-sparing Trimodality Therapy for Muscle-invasive Bladder Cancer.
    Eur Urol. 2019 Jan 31. pii: S0302-2838(19)30012.
    Abstract     Related articles   

  758. BESSA A, Maclennan S, Enting D, Bryan R, et al
    Consensus in Bladder Cancer Research Priorities Between Patients and Healthcare Professionals Using a Four-stage Modified Delphi Method.
    Eur Urol. 2019 Jan 31. pii: S0302-2838(19)30075.
    Abstract     Related articles   

  759. RADZISZEWSKI P, Poletajew S
    Re: Radiofrequency-induced Thermo-chemotherapy Effect Versus a Second Course of Bacillus Calmette-Guerin or Institutional Standard in Patients with Recurrence of Non-muscle-invasive Bladder Cancer Following Induction or Maintenance Bacillus Calmette-G
    Eur Urol. 2019 Jan 31. pii: S0302-2838(19)30074.
    Abstract     Related articles   

    Bladder Tumors with Mixed Histology: What Is the Basis for the Heterogeneity?
    Eur Urol. 2018;74:754-755.
    Abstract     Related articles   

  761. GOLDSTEIN MR, Mascitelli L
    Re: John L. Gore, Jonathan L. Wright. Can We Prevent Bladder Cancer Recurrences? Eur Urol. In press. https://doi.org/10.1016/j.eururo.2018.10.008.
    Eur Urol. 2019 Feb 11. pii: S0302-2838(19)30093.
    Abstract     Related articles   

  762. KAMAT AM, Li R, O'Donnell MA, Black PC, et al
    Predicting Response to Intravesical Bacillus Calmette-Guerin Immunotherapy: Are We There Yet? A Systematic Review.
    Eur Urol. 2018;73:738-748.
    Abstract     Related articles   

  763. WITJES JA
    Re: Bladder Preservation with Twice-a-day Radiation plus Fluorouracil/Cisplatin or Once Daily Radiation plus Gemcitabine for Muscle-invasive Bladder Cancer: NRG/RTOG 0712-A Randomized Phase II Trial.
    Eur Urol. 2019 Feb 25. pii: S0302-2838(19)30163.
    Abstract     Related articles   

  764. PICHLER R, Heidegger I
    Re: F. Johannes P. van Valenberg, Andrew M. Hiar, Ellen Wallace, et al. Prospective Validation of an mRNA-based Urine Test for Surveillance of Patients with Bladder Cancer. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2018.11.055.
    Eur Urol. 2019 Feb 22. pii: S0302-2838(19)30159.
    Abstract     Related articles   

  765. LI R, Spiess PE, Gilbert SM, Necchi A, et al
    Towards Personalized Neoadjuvant Therapy for Muscle-invasive Bladder Cancer.
    Eur Urol. 2019 Mar 1. pii: S0302-2838(19)30174.
    Abstract     Related articles   

  766. NARAYAN VM, Lim AH, Dinney CPN
    Re: Impact of Immune and Stromal Infiltration on Outcomes Following Bladder-sparing Trimodality Therapy for Muscle-invasive Bladder Cancer.
    Eur Urol. 2019 Mar 1. pii: S0302-2838(19)30165.
    Abstract     Related articles   

  767. MONTORSI F, Gandaglia G
    Re: Georg Jancke, Firas Aljabery, Sigurdur Gudjonsson, et al. Port-site Metastases After Robot-assisted Radical Cystectomy: Is There a Publication Bias? Eur Urol 2018;73:641-2.
    Eur Urol. 2019;75:e31.
    Abstract     Related articles   

  768. CAMPI R, Roupret M
    Re: Conservative Management Following Complete Clinical Response to Neoadjuvant Chemotherapy of Muscle Invasive Bladder Cancer: Contemporary Outcomes of a Multi-institutional Cohort Study.
    Eur Urol. 2019 Mar 14. pii: S0302-2838(19)30187.
    Abstract     Related articles   

  769. GAKIS G
    Re: Extended Versus Limited Lymph Node Dissection in Bladder Cancer Patients Undergoing Radical Cystectomy: Survival Results from a Prospective, Randomized Trial.
    Eur Urol. 2019 Mar 13. pii: S0302-2838(19)30181.
    Abstract     Related articles   

  770. UENO Y, Takeuchi M, Tamada T, Sofue K, et al
    Diagnostic Accuracy and Interobserver Agreement for the Vesical Imaging-Reporting and Data System for Muscle-invasive Bladder Cancer: A Multireader Validation Study.
    Eur Urol. 2019 Mar 25. pii: S0302-2838(19)30198.
    Abstract     Related articles   

  771. MOUW KW, Miyamoto DT, Efstathiou JA
    Reply from Authors re: Ananya Choudhury, Peter J. Hoskin. Predictive Biomarkers for Muscle-invasive Bladder Cancer: The Search for the Holy Grail Continues. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2019.01.040: Towards Biomarker-Informed M
    Eur Urol. 2019 Mar 22. pii: S0302-2838(19)30195.
    Abstract     Related articles   

  772. SHI MJ, Meng XY, Lamy P, Banday AR, et al
    APOBEC-mediated Mutagenesis as a Likely Cause of FGFR3 S249C Mutation Over-representation in Bladder Cancer.
    Eur Urol. 2019 Apr 8. pii: S0302-2838(19)30261.
    Abstract     Related articles   

  773. GUST KM, Shariat SF
    Re: Pembrolizumab as Neoadjuvant Therapy Before Radical Cystectomy in Patients with Muscle-invasive Urothelial Bladder Carcinoma (PURE-01): An Open-label, Single-arm, Phase II Study.
    Eur Urol. 2019;75:695-696.
    Abstract     Related articles   

  774. LERNER SP, Svatek RS
    What is the Standard of Care for Pelvic Lymphadenectomy Performed at the Time of Radical Cystectomy?
    Eur Urol. 2019;75:612-614.
    Abstract     Related articles   

  775. SORIA F, Gontero P
    Re: Extended Versus Limited Lymph Node Dissection in Bladder Cancer Patients Undergoing Radical Cystectomy: Survival Results from a Prospective, Randomized Trial.
    Eur Urol. 2019 Apr 12. pii: S0302-2838(19)30275.
    Abstract     Related articles   

  776. SAITA A, Lughezzani G, Buffi NM, Hurle R, et al
    Assessing the Feasibility and Accuracy of High-resolution Microultrasound Imaging for Bladder Cancer Detection and Staging.
    Eur Urol. 2019 Apr 10. pii: S0302-2838(19)30277.
    Abstract     Related articles   

  777. DIJKSTRA S, Wijburg CJ
    Re: Bernard H. Bochner, Guido Dalbagni, Karim H. Marzouk, et al. Randomized Trial Comparing Open Radical Cystectomy and Robot-assisted Laparoscopic Radical Cystectomy: Oncologic Outcomes. Eur Urol 2018;74:465-71: Can the Pattern of Cancer Recurrence T
    Eur Urol. 2019;75:e137.
    Abstract     Related articles   

  778. BOCHNER BH, Dalbagni G
    Reply to Siebren Dijkstra and Carl J. Wijburg's Letter to the Editor re: Bernard H. Bochner, Guido Dalbagni, Karim H. Marzouk, et al. Randomized Trial Comparing Open Radical Cystectomy and Robot-assisted Laparoscopic Radical Cystectomy: Oncologic Outc
    Eur Urol. 2019;75:e138-e139.
    Abstract     Related articles   

  779. GSCHWEND JE, Heck M
    Reply to Satoru Taguchi, Tohru Nakagawa, and Hiroshi Fukuhara's Letter to the Editor re: Jurgen E. Gschwend, Matthias M. Heck, Jan Lehmann, et al. Extended Versus Limited Lymph Node Dissection in Bladder Cancer Patients Undergoing Radical Cystectomy:
    Eur Urol. 2019 May 2. pii: S0302-2838(19)30346.
    Abstract     Related articles   

  780. LI R, Spiess PE, Gilbert SM, Necchi A, et al
    Reply to Yubo Yang, Xin Wei, and Ping Han's Letter to the Editor re: Roger Li, Philippe E. Spiess, Scott M. Gilbert, Andrea Necchi. Towards Personalized Neoadjuvant Therapy for Muscle-invasive Bladder Cancer. Eur Urol. In press. https://doi.org/10.101
    Eur Urol. 2019 May 2. pii: S0302-2838(19)30344.
    Abstract     Related articles   

  781. YANG Y, Wei X, Han P
    Re: Roger Li, Philippe E. Spiess, Scott M. Gilbert, Andrea Necchi. Towards Personalized Neoadjuvant Therapy for Muscle-invasive Bladder Cancer. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2019.02.027.
    Eur Urol. 2019 May 1. pii: S0302-2838(19)30343.
    Abstract     Related articles   

  782. TAGUCHI S, Nakagawa T, Fukuhara H
    Re: Jurgen E. Gschwend, Matthias M. Heck, Jan Lehmann, et al. Extended Versus Limited Lymph Node Dissection in Bladder Cancer Patients Undergoing Radical Cystectomy: Survival Results from a Prospective, Randomized Trial. Eur Urol 2019;75:604-11.
    Eur Urol. 2019 May 1. pii: S0302-2838(19)30345.
    Abstract     Related articles   

  783. CAO L, Yang Z, Wang B
    Re: F. Johannes P. van Valenberg, Andrew M. Hiar, Ellen Wallace, et al. Prospective Validation of an mRNA-based Urine Test for Surveillance of Patients with Bladder Cancer. Eur Urol. 2019; 75,5: 853-860.
    Eur Urol. 2019 May 10. pii: S0302-2838(19)30364.
    Abstract     Related articles   

  784. VARMA M, Delahunt B, van der Kwast T
    Grading Noninvasive Bladder Cancer: World Health Organisation 1973 or 2004 May Be the Wrong Question.
    Eur Urol. 2019 May 10. pii: S0302-2838(19)30362.
    Abstract     Related articles   

  785. BESSA A, Maclennan S, Enting D, Bryan R, et al
    Reply to Jon Mikel Inarritu, Daniele Castellani, and Jeremy Y.C. Teoh's Letter to the Editor re: Agustina Bessa, Steven Maclennan, Deborah Enting, et al. Consensus in Bladder Cancer Research Priorities Between Patients and Healthcare Professionals Usi
    Eur Urol. 2019 May 17. pii: S0302-2838(19)30379.
    Abstract     Related articles   

  786. INARRITU JM, Castellani D, Teoh JYC
    Re: Agustina Bessa, Steven Maclennan, Deborah Enting, et al. Consensus in Bladder Cancer Research Priorities Between Patients and Healthcare Professionals Using a Four-stage Modified Delphi Method. Eur Urol. In press. https://doi.org/10.1016/j.eururo.
    Eur Urol. 2019 May 15. pii: S0302-2838(19)30378.
    Abstract     Related articles   

  787. LI R, Tabayoyong WB, Guo CC, Gonzalez GMN, et al
    Prognostic Implication of the United States Food and Drug Administration-defined BCG-unresponsive Disease.
    Eur Urol. 2019;75:8-10.
    Abstract     Related articles   

  788. DUGUE PA, Brinkman MT, Hodge AM, Bassett JK, et al
    Dietary intake of nutrients involved in one-carbon metabolism and risk of urothelial cell carcinoma: A prospective cohort study.
    Int J Cancer. 2018;143:298-306.
    Abstract     Related articles   

  789. TURNER MC, Gracia-Lavedan E, Cirac M, Castano-Vinyals G, et al
    Ambient air pollution and incident bladder cancer risk: updated analysis of the Spanish Bladder Cancer Study.
    Int J Cancer. 2019 Jan 17. doi: 10.1002/ijc.32136.
    Abstract     Related articles   

  790. SUN M, Zhao W, Chen Z, Li M, et al
    Circular RNA CEP128 Promotes Bladder Cancer Progression by Regulating Mir-145-5p/Myd88 Via Mapk Signaling Pathway.
    Int J Cancer. 2019 Apr 2. doi: 10.1002/ijc.32311.
    Abstract     Related articles   

  791. WU Q, Fu C, Li M, Li J, et al
    CINP is a novel cofactor of KLF5 required for its role in the promotion of cell proliferation, survival and tumor growth.
    Int J Cancer. 2019;144:582-594.
    Abstract     Related articles   

  792. LAAKSONEN MA, MacInnis RJ, Canfell K, Giles GG, et al
    The future burden of kidney and bladder cancers preventable by behaviour modification in Australia: a pooled cohort study.
    Int J Cancer. 2019 May 20. doi: 10.1002/ijc.32420.
    Abstract     Related articles   

  793. HUANG Z, Zhang M, Chen G, Wang W, et al
    Bladder cancer cells interact with vascular endothelial cells triggering EGFR signals to promote tumor progression.
    Int J Oncol. 2019 Feb 27. doi: 10.3892/ijo.2019.4729.
    Abstract     Related articles   

  794. SUGITA S, Yoshino H, Yonemori M, Miyamoto K, et al
    Tumorsuppressive microRNA223 targets WDR62 directly in bladder cancer.
    Int J Oncol. 2019 Mar 22. doi: 10.3892/ijo.2019.4762.
    Abstract     Related articles   

  795. LIN JF, Tsai TF, Lin YC, Chen HE, et al
    Benzyl isothiocyanate suppresses IGF1R, FGFR3 and mTOR expression by upregulation of miR-99a-5p in human bladder cancer cells.
    Int J Oncol. 2019 Mar 26. doi: 10.3892/ijo.2019.4763.
    Abstract     Related articles   

  796. HORI S, Miyake M, Onishi S, Morizawa Y, et al
    Evaluation of pro and antitumor effects induced by three colonystimulating factors, GCSF, GMCSF and MCSF, in bladder cancer cells: Is GCSF a friend of bladder cancer cells?
    Int J Oncol. 2019;54:2237-2249.
    Abstract     Related articles   

  797. MIYATA Y, Matsuo T, Sakai H
    Editorial Comment from Dr Miyata et al. to Impact of serum sodium concentration on survival outcomes in patients with invasive bladder cancer without metastasis treated by cystectomy.
    Int J Urol. 2019 Jan 22. doi: 10.1111/iju.13893.
    Abstract     Related articles   

  798. KOIE T, Ohyama C, Makiyama K, Shimazui T, et al
    Utility of robot-assisted radical cystectomy with intracorporeal urinary diversion for muscle-invasive bladder cancer.
    Int J Urol. 2019 Jan 28. doi: 10.1111/iju.13900.
    Abstract     Related articles   

  799. TEISHIMA J, Matsubara A
    Editorial Comment to Utility of robot-assisted radical cystectomy with intracorporeal urinary diversion for muscle-invasive bladder cancer.
    Int J Urol. 2019 Jan 28. doi: 10.1111/iju.13906.
    Abstract     Related articles   

  800. LEE A, Lee HJ, Huang HH, Ho H, et al
    Low-risk non-muscle-invasive bladder cancer: Further prognostic stratification into the "very-low-risk" group based on tumor size.
    Int J Urol. 2019 Mar 4. doi: 10.1111/iju.13913.
    Abstract     Related articles   

  801. ZACHOS I
    Editorial Comment to Low-risk non-muscle-invasive bladder cancer: Further prognostic stratification into the "very-low-risk" group based on tumor size.
    Int J Urol. 2019 Mar 4. doi: 10.1111/iju.13929.
    Abstract     Related articles   

  802. NAKAYAMA M, Ito Y, Hatano K, Nakai Y, et al
    Impact of sex difference on survival of bladder cancer: A population-based registry data in Japan.
    Int J Urol. 2019 Mar 27. doi: 10.1111/iju.13955.
    Abstract     Related articles   

  803. YANG J, Zhang P, Zhou H, Feng S, et al
    Prospective, randomized controlled study of the preventive effect of fosfomycin tromethamine on post-transurethral resection of bladder tumor urinary tract infection.
    Int J Urol. 2018 Jul 12. doi: 10.1111/iju.13719.
    Abstract     Related articles   

  804. AMINI E, Ahmadi N, Clifford TG, Hugen CM, et al
    Long term oncologic outcome in patients with bladder cancer after radical cystectomy: Impact of carcinoma in situ in the era of neoadjuvant chemotherapy.
    Int Urol Nephrol. 2019 Jan 31. pii: 10.1007/s11255-019-02087.
    Abstract     Related articles   

  805. TEKE K, Yilmaz H, Uslubas AK, Akpinar G, et al
    Histopathologic and molecular comparative analyses of intravesical Aurora kinase-A inhibitor Alisertib with bacillus Calmette-Guerin on precancerous lesions of bladder in a rat model.
    Int Urol Nephrol. 2018;50:1417-1425.
    Abstract     Related articles   

  806. ZEWIN TS, El-Assmy A, Harraz AM, Bazeed M, et al
    Efficacy and safety of low-intensity shock wave therapy in penile rehabilitation post nerve-sparing radical cystoprostatectomy: a randomized controlled trial.
    Int Urol Nephrol. 2018;50:2007-2014.
    Abstract     Related articles   

  807. MAO W, Ma B, Huang X, Gu S, et al
    Which treatment is best for patients with AJCC stage IV bladder cancer?
    Int Urol Nephrol. 2019 Apr 4. pii: 10.1007/s11255-019-02105.
    Abstract     Related articles   

  808. MILOJEVIC B, Dzamic Z, Bojanic N, Durutovic O, et al
    Urothelial carcinoma of the upper urinary tract: preoperative pyuria is not correlated with bladder cancer recurrence and survival.
    Int Urol Nephrol. 2019 Apr 1. pii: 10.1007/s11255-019-02133.
    Abstract     Related articles   

  809. TSENG WH, Liu CL, Huang SK, Liao AC, et al
    Therapeutic benefit of second-look transurethral resection of bladder tumors for newly diagnosed T1 bladder cancer: a single-center experience.
    Int Urol Nephrol. 2019 May 25. pii: 10.1007/s11255-019-02172.
    Abstract     Related articles   

  810. SLUSARCZYK A, Zapala P, Zapala L, Piecha T, et al
    Prediction of BCG responses in non-muscle-invasive bladder cancer in the era of novel immunotherapeutics.
    Int Urol Nephrol. 2019 Jun 1. pii: 10.1007/s11255-019-02183.
    Abstract     Related articles   

  811. ZHANG S
    Neoadjuvant Immunotherapy in Muscle-Invasive Bladder Cancer: Time to Change Clinical Practice?
    J Clin Oncol. 2019 Feb 27:JCO1801864. doi: 10.1200/JCO.18.01864.
    Abstract     Related articles   

  812. ATALA A
    Re: Identification of MicroR-106b as a Prognostic Biomarker of p53-Like Bladder Cancers by ActMiR.
    J Urol. 2019;201:231.
    Abstract     Related articles   

  813. CHANG SS
    Re: Analysis of T1 Bladder Cancer on Biopsy and Transurethral Resection Specimens: .
    J Urol. 2019;201:225-226.
    Abstract     Related articles   

  814. EBRAHIMI H, Amini E, Pishgar F, Moghaddam SS, et al
    Global, Regional, and National Burden of Bladder Cancer, 1990 - 2016: Results from the Global Burden of Disease Study 2016.
    J Urol. 2019 Jan 25. doi: 10.1097/JU.0000000000000025.
    Abstract     Related articles   

  815. CHANG SS
    Re: Long-Term Survival Outcomes with Intravesical Nanoparticle Albumin-Bound Paclitaxel for Recurrent Non-Muscle-Invasive Bladder Cancer after Previous Bacillus Calmette-Guerin Therapy.
    J Urol. 2019 Jan 15. doi: 10.1097/JU.0000000000000097.
    Abstract     Related articles   

  816. CHANG SS
    Re: Next-Generation Sequencing of Nonmuscle Invasive Bladder Cancer Reveals Potential Biomarkers and Rational Therapeutic Targets.
    J Urol. 2019 Jan 15. doi: 10.1097/01.JU.0000553308.83315.
    Abstract     Related articles   

  817. ATALA A
    Re: LNMAT1 Promotes Lymphatic Metastasis of Bladder Cancer via CCL2 Dependent Macrophage Recruitment.
    J Urol. 2019 Jan 15. doi: 10.1097/01.JU.0000553307.75692.
    Abstract     Related articles   

  818. HAIFLER M
    Editorial Comment.
    J Urol. 2018;200:59-60.
    Abstract     Related articles   

  819. FILSON CP
    Editorial Comment.
    J Urol. 2018;200:59.
    Abstract     Related articles   

  820. MEEKS JJ, Glaser AP
    Editorial Comment.
    J Urol. 2018;200:60.
    Abstract     Related articles   

  821. WANG DS
    Re: A Prospective Randomized Pilot Study Evaluating an ERAS Protocol versus a Standard Protocol for Patients Treated with Radical Cystectomy and Urinary Diversion for Bladder Cancer.
    J Urol. 2019 Feb 1. doi: 10.1097/JU.0000000000000154.
    Abstract     Related articles   

  822. CHANG SS
    Re: Effect of Intravesical Instillation of Gemcitabine vs Saline Immediately following Resection of Suspected Low-Grade Non-Muscle-Invasive Bladder Cancer on Tumor Recurrence: .
    J Urol. 2019;201:442.
    Abstract     Related articles   

  823. CHANG SS
    Re: Human Epidermal Growth Factor Receptor 2 Expression is More Important than bacillus Calmette Guerin Treatment in Predicting the Outcome of T1G3 Bladder Cancer.
    J Urol. 2019;201:441-442.
    Abstract     Related articles   

  824. CHANG SS
    Re: Assessing Cancer Progression and Stable Disease after Neoadjuvant Chemotherapy for Organ-Confined Muscle-Invasive Bladder Cancer.
    J Urol. 2019;201:441.
    Abstract     Related articles   

    Re: Impact of Psychiatric Illness on Decreased Survival in Elderly Patients with Bladder Cancer in the United States.
    J Urol. 2019 Feb 7. doi: 10.1097/JU.0000000000000162.
    Abstract     Related articles   

    Re: Comparing Survival Outcomes and Costs Associated with Radical Cystectomy and Trimodal Therapy for Older Adults with Muscle-Invasive Bladder Cancer.
    J Urol. 2019 Feb 7. doi: 10.1097/01.JU.0000553996.66966.
    Abstract     Related articles   

    Re: The Challenges of Bacillus of Calmette-Guerin (BCG) Therapy for High Risk Non Muscle Invasive Bladder Cancer Treatment in Older Patients.
    J Urol. 2019 Feb 7. doi: 10.1097/01.JU.0000553995.59343.
    Abstract     Related articles   

  828. CHANG SS
    Re: Predicting Local Failure after Radical Cystectomy in Patients with Bladder Cancer: .
    J Urol. 2019 Feb 8. doi: 10.1097/JU.0000000000000166.
    Abstract     Related articles   

  829. CHANG SS
    Re: National Comprehensive Cancer Network Recommendations on Molecular Profiling of Advanced Bladder Cancer.
    J Urol. 2019 Feb 8. doi: 10.1097/01.JU.0000554054.35801.
    Abstract     Related articles   

  830. CHANG SS
    Re: Preclinical Evaluation of Intravesical Cisplatin Nanoparticles for Non-Muscle-Invasive Bladder Cancer.
    J Urol. 2019 Feb 8. doi: 10.1097/01.JU.0000554055.35801.
    Abstract     Related articles   

  831. KIMURA S, Mari A, Foerster B, Abufaraj M, et al
    Prognostic Value of Concomitant Carcinoma In Situ in the Radical Cystectomy Specimen: A Systematic Review and Meta-Analysis.
    J Urol. 2019;201:46-53.
    Abstract     Related articles   

  832. WINTERS BR, Wen L, Holt SK, Dash A, et al
    Does the diagnosis of bladder cancer lead to higher rates of smoking cessation? Findings from the Medicare Health Outcomes Survey.
    J Urol. 2019 Mar 5:101097JU0000000000000206. doi: 10.1097/JU.0000000000000206.
    Abstract     Related articles   

  833. LEO MC, Gilbert SM, Wendel CS, Krouse RS, et al
    Development of a goal elicitation measure to support bladder cancer patients' choice about urinary diversion.
    J Urol. 2019 Mar 5:101097JU0000000000000203. doi: 10.1097/JU.0000000000000203.
    Abstract     Related articles   

  834. CHANG SS
    Re: Safety and Efficacy of Temsirolimus as Second Line Treatment for Patients with Recurrent Bladder Cancer.
    J Urol. 2019 Mar 13:10109701JU000055464194059.
    Abstract     Related articles   

  835. CHANG SS
    Re: Partial Bladder Boost Using Lipiodol Marking during Image-Guided Radiotherapy for Bladder Cancer.
    J Urol. 2019 Mar 13:101097JU0000000000000218. doi: 10.1097/JU.0000000000000218.
    Abstract     Related articles   

    Re: Comparative Safety of Pioglitazone versus Clinically Meaningful Treatment Alternatives Concerning the Risk of Bladder Cancer in Older US Adults with Type 2 Diabetes.
    J Urol. 2019 Mar 13:10109701JU00005546361960937.
    Abstract     Related articles   

    Re: Outcomes of Radiosensitisation in Elderly Patients with Advanced Bladder Cancer.
    J Urol. 2019 Mar 13:10109701JU00005546347386712.
    Abstract     Related articles   

    Re: Real-World Effectiveness of Chemotherapy in Elderly Patients with Metastatic Bladder Cancer in the United States.
    J Urol. 2019 Mar 13:10109701JU0000554635814908.
    Abstract     Related articles   

    Editorial Comment.
    J Urol. 2018;200:290.
    Abstract     Related articles   

  840. PATEL S, Cookson MS
    Editorial Comment.
    J Urol. 2018;200:290-291.
    Abstract     Related articles   

    Re: Stenting Prior to Cystectomy is an Independent Risk Factor for Upper Urinary Tract Recurrence: B. Kiss, M. A. Furrer, P. Y. Wuethrich, F. C. Burkhard, G. N. Thalmann and B. Roth J Urol 2017;198:1263-1268.
    J Urol. 2018;200:457-458.
    Abstract     Related articles   

  842. CHANG SS
    Re: Genomic Differences between "Primary" and "Secondary" Muscle-Invasive Bladder Cancer as a Basis for Disparate Outcomes to Cisplatin-Based Neoadjuvant Chemotherapy.
    J Urol. 2019 Mar 29:10109701JU0000557728168538.
    Abstract     Related articles   

  843. CHANG SS
    Re: Contemporary Treatment Patterns and Outcomes of Sarcomatoid Bladder Cancer.
    J Urol. 2019 Mar 29:101097JU0000000000000252. doi: 10.1097/JU.0000000000000252.
    Abstract     Related articles   

  844. CHANG SS
    Re: Mutational Patterns in Chemotherapy Resistant Muscle-Invasive Bladder Cancer.
    J Urol. 2019 Mar 29:10109701JU000055772739723.
    Abstract     Related articles   

  845. PARKER DC, Abboud MA, Patel SG
    Is Routine Removal of the Ovaries Advisable during Radical Cystectomy?
    J Urol. 2019;201:455-456.
    Abstract     Related articles   

  846. XUE W, Yang L, Wei Q
    Re: Comparison of Pathological Stage in Patients Treated with and without Neoadjuvant Chemotherapy for High Risk Upper Tract Urothelial Carcinoma: R. S. Liao, M. Gupta, Z. R. Schwen, H. D. Patel, M. Kates, M. H. Johnson, N. M. Hahn, D. McConkey, T. J.
    J Urol. 2018;200:1378-1379.
    Abstract     Related articles   

    Editorial Comment.
    J Urol. 2018;200:539-540.
    Abstract     Related articles   

  848. HAMILTON-REEVES JM, Stanley A, Bechtel MD, Yankee TM, et al
    Perioperative Immunonutrition Modulates Inflammatory Response after Radical Cystectomy: Results of a Pilot Randomized Controlled Clinical Trial.
    J Urol. 2018;200:292-301.
    Abstract     Related articles   

  849. ABUFARAJ M, Tabung FK, Shariat SF, Moschini M, et al
    Association between inflammatory potential of diet and bladder cancer risk:Results from three US prospective cohort studies.
    J Urol. 2019 Apr 22:101097JU0000000000000279. doi: 10.1097/JU.0000000000000279.
    Abstract     Related articles   

  850. MENG MV, Gschwend JE, Shore N, Grossfeld GD, et al
    Emerging Immunotherapy Options for BCG-unresponsive Non-muscle-invasive Bladder Cancer.
    J Urol. 2019 May 1:101097JU0000000000000297. doi: 10.1097/JU.0000000000000297.
    Abstract     Related articles   

  851. CHANG SS
    Re: Discrepancies in Staging, Treatment, and Delays to Treatment May Explain Disparities in Bladder Cancer Outcomes: An Update from the National Cancer Data Base (2004-2013).
    J Urol. 2019 May 8:10109701JU000055962335906.
    Abstract     Related articles   

  852. CHANG SS
    Re: Characterization of Late Recurrence after Radical Cystectomy in a Large Multicenter Cohort of Bladder Cancer Patients.
    J Urol. 2019 May 8:10109701JU00005596222828385.
    Abstract     Related articles   

  853. CHANG SS
    Re: Extended versus Limited Lymph Node Dissection in Bladder Cancer Patients Undergoing Radical Cystectomy: Survival Results from a Prospective, Randomized Trial.
    J Urol. 2019 May 8:101097JU0000000000000332. doi: 10.1097/JU.0000000000000332.
    Abstract     Related articles   

  854. WOLDU SL
    Editorial Comment.
    J Urol. 2019;201:901.
    Abstract     Related articles   

  855. LOTAN Y, Inman BA, Davis LG, Kassouf W, et al
    Evaluation of the UroVysion Test to Predict Recurrence and/or Progression of Disease After BCG for Primary High Grade Non-Muscle Invasive Bladder Cancer: Results from a Prospective Multicenter Trial.
    J Urol. 2019 May 23:101097JU0000000000000355. doi: 10.1097/JU.0000000000000355.
    Abstract     Related articles   

  856. MORERA DS, Lahorewala SS, Belew D, Ghosh S, et al
    Clinical parameters outperform molecular subtypes for predicting outcome in bladder cancer: Results from multiple cohorts including TCGA.
    J Urol. 2019 May 21:101097JU0000000000000351. doi: 10.1097/JU.0000000000000351.
    Abstract     Related articles   

  857. WESTERGREN DO, Gardmark T, Lindhagen L, Chau A, et al
    A Nationwide Population Based Analysis of Organ-Confined Muscle-Invasive Bladder Cancer Patients Not Receiving Curative Intent Therapy in Sweden from 1997 to 2014.
    J Urol. 2019 May 30:101097JU0000000000000350. doi: 10.1097/JU.0000000000000350.
    Abstract     Related articles   

  858. METCALF M, Glazyrine V, Glavin K, Dahlgren A, et al
    The Feasibility of a Health Care Application in the Treatment of Patients Undergoing Radical Cystectomy.
    J Urol. 2019;201:902-908.
    Abstract     Related articles   

  859. ROTH B, Furrer MA, Giannakis I, Vartolomei MD, et al
    Positive Pre-cystectomy Biopsies of the Prostatic Urethra or Bladder Neck Do Not Necessarily Preclude Orthotopic Bladder Substitution.
    J Urol. 2019;201:909-915.
    Abstract     Related articles   

  860. ZHU J, Huang G, Hua X, Li Y, et al
    CD44s is a crucial ATG7 downstream regulator for stem-like property, invasion, and lung metastasis of human bladder cancer (BC) cells.
    Oncogene. 2019 Jan 11. pii: 10.1038/s41388-018-0664.
    Abstract     Related articles   

  861. CHENG M, Sheng L, Gao Q, Xiong Q, et al
    The m(6)A methyltransferase METTL3 promotes bladder cancer progression via AFF4/NF-kappaB/MYC signaling network.
    Oncogene. 2019 Jan 18. pii: 10.1038/s41388-019-0683.
    Abstract     Related articles   

  862. ROUDNICKY F, Yoon SY, Poghosyan S, Schwager S, et al
    Alternative transcription of a shorter, non-anti-angiogenic thrombospondin-2 variant in cancer-associated blood vessels.
    Oncogene. 2018;37:2573-2585.
    Abstract     Related articles   

  863. LIU JY, Zeng QH, Cao PG, Xie D, et al
    SPAG5 promotes proliferation and suppresses apoptosis in bladder urothelial carcinoma by upregulating Wnt3 via activating the AKT/mTOR pathway and predicts poorer survival.
    Oncogene. 2018;37:3937-3952.
    Abstract     Related articles   

  864. LIU Q, Gheorghiu L, Drumm M, Clayman R, et al
    PARP-1 inhibition with or without ionizing radiation confers reactive oxygen species-mediated cytotoxicity preferentially to cancer cells with mutant TP53.
    Oncogene. 2018;37:2793-2805.
    Abstract     Related articles   

  865. WU M, Sheng L, Cheng M, Zhang H, et al
    Low doses of decitabine improve the chemotherapy efficacy against basal-like bladder cancer by targeting cancer stem cells.
    Oncogene. 2019 Mar 27. pii: 10.1038/s41388-019-0799.
    Abstract     Related articles   

  866. PALMBOS PL, Wang Y, Bankhead Iii A, Kelleher AJ, et al
    ATDC mediates a TP63-regulated basal cancer invasive program.
    Oncogene. 2019;38:3340-3354.
    Abstract     Related articles   

  867. ZHUO Z, Song Z, Ma Z, Zhang Y, et al
    Chlorophyllin e6mediated photodynamic therapy inhibits proliferation and induces apoptosis in human bladder cancer cells.
    Oncol Rep. 2019 Feb 14. doi: 10.3892/or.2019.7013.
    Abstract     Related articles   

  868. HO JN, Byun SS, Lee SE, Youn JI, et al
    Multikinase inhibitor motesanib enhances the antitumor effect of cisplatin in cisplatinresistant human bladder cancer cells via apoptosis and the PI3K/Akt pathway.
    Oncol Rep. 2019 Feb 11. doi: 10.3892/or.2019.7005.
    Abstract     Related articles   

  869. CHENG H, Hao Y, Gao Y, He Y, et al
    PLCepsilon promotes urinary bladder cancer cells proliferation through STAT3/LDHA pathwaymediated glycolysis.
    Oncol Rep. 2019 Mar 13. doi: 10.3892/or.2019.7056.
    Abstract     Related articles   

  870. SEKINO Y, Sakamoto N, Ishikawa A, Honma R, et al
    Transcribed ultraconserved region Uc.63+ promotes resistance to cisplatin through regulation of androgen receptor signaling in bladder cancer.
    Oncol Rep. 2019 Feb 28. doi: 10.3892/or.2019.7039.
    Abstract     Related articles   

  871. HORI S, Miyake M, Tatsumi Y, Morizawa Y, et al
    Intravesical treatment of chemotherapeutic agents sensitizes bacillus CalmetteGuerin by the modulation of the tumor immune environment.
    Oncol Rep. 2019;41:1863-1874.
    Abstract     Related articles   

  872. MARTIN T, Mantey K, Boissier R, Albert P, et al
    [The REVELA13 observatory to study new cases of bladder tumor among women living in Bouches-du-Rhone county].
    Prog Urol. 2018;28:935-941.
    Abstract     Related articles   

  873. BALDINI A, Fassi Fehri H, Cerantola Y, Bayle F, et al
    [Do initial experience with an enhanced recovery program after surgery (ERAS) improve postoperative outcomes after cystectomy?]
    Prog Urol. 2018;28:351-358.
    Abstract     Related articles   

  874. ALBISINNI S, Moussa I, Aoun F, Quackels T, et al
    The impact of postoperative inflammatory biomarkers on oncologic outcomes of bladder cancer.
    Prog Urol. 2019 Apr 3. pii: S1166-7087(19)30043.
    Abstract     Related articles   

  875. MOUDOUNI SM, Latabi A, Mouaad A, Lakmichi MA, et al
    [Evaluation of the learning curve of laparoscopic radical cystectomy for cancer: Morbidity and oncological results].
    Prog Urol. 2019;29:50-62.
    Abstract     Related articles   

  876. FERRO M, Vartolomei MD, Cantiello F, Lucarelli G, et al
    High-Grade T1 on Re-Transurethral Resection after Initial High-Grade T1 Confers Worse Oncological Outcomes: Results of a Multi-Institutional Study.
    Urol Int. 2018;101:7-15.
    Abstract     Related articles   

  877. BEN BAHRIA-SEDIKI I, Chebil M, Sampaio C, Martel-Frachet V, et al
    Prognostic Value of Soluble Death Receptor Ligands in Patients with Transitional Cell Carcinoma of Bladder.
    Urol Int. 2018;100:476-484.
    Abstract     Related articles   

  878. GIERTH M, Zeman F, Denzinger S, Vetterlein MW, et al
    Influence of Body Mass Index on Clinical Outcome Parameters, Complication Rate and Survival after Radical Cystectomy: Evidence from a Prospective European Multicentre Study.
    Urol Int. 2018;101:16-24.
    Abstract     Related articles   

  879. GROEBEN C, Koch R, Baunacke M, Borkowetz A, et al
    In-Hospital Outcomes after Radical Cystectomy for Bladder Cancer: Comparing National Trends in the United States and Germany from 2006 to 2014.
    Urol Int. 2019 Jan 30:1-9. doi: 10.1159/000496347.
    Abstract     Related articles   

  880. MOSCHINI M, Zamboni S, Mattei A, Baumeister P, et al
    Radical Cystectomy in Pathological T4a and T4b Bladder Cancer Patients: Is There Any Space for Sub Stratification?
    Urol Int. 2019 Jan 29:1-8. doi: 10.1159/000493899.
    Abstract     Related articles   

  881. CARRION A, Diaz F, Raventos C, Lozano F, et al
    Comparison of Outcomes between Standard and Palliative Management for High Grade Non-Muscle Invasive Bladder Cancer in Patients Older than 85 Years.
    Urol Int. 2019 Mar 7:1-7. doi: 10.1159/000496802.
    Abstract     Related articles   

  882. ZIESCHANG H, Koch R, Wirth MP, Froehner M, et al
    Leiomyosarcoma of the Urinary Bladder in Adult Patients: A Systematic Review of the Literature and Meta-Analysis.
    Urol Int. 2019;102:96-101.
    Abstract     Related articles   

  883. TAE BS, Ku JH, Kwak C, Kim HH, et al
    Comparison of Renal Function after Radical Surgery for Upper Tract Urothelial Carcinoma versus Renal Cell Carcinoma: Propensity Score Matching.
    Urol Int. 2018;101:400-408.
    Abstract     Related articles   

  884. LI A, Zhang P, Zhang M, Yang T, et al
    Transurethral Enucleation of Bladder Leiomyoma: A Series of Six Cases and Review of the Literature.
    Urol Int. 2019;102:102-108.
    Abstract     Related articles   

  885. BO S, Donghao S, Guangqi K, Ye T, et al
    CC Chemokine Ligand 18 Promotes Cell Proliferation and Metastasis of Urothelial Carcinoma via Activating PI3K/mTOR Signaling in Patient with Renal Transplantation.
    Urol Int. 2018;101:450-458.
    Abstract     Related articles   

  886. RAYN KN, Ritchie C, Folio LR, Stamatakis L, et al
    Bilateral Ureteroenteric Strictures: A Case of the "Reverse 7".
    Urology. 2018;118:e3-e4.
    Abstract     Related articles   

  887. BAJIC P, Wolfe AJ, Gupta GN
    The Urinary Microbiome: Implications in Bladder Cancer Pathogenesis and Therapeutics.
    Urology. 2019 Jan 4. pii: S0090-4295(19)30006.
    Abstract     Related articles   

  888. GONZALEZ AN, Lipsky MJ, Li G, Rutman MP, et al
    The prevalence of bladder cancer during cystoscopy for asymptomatic microscopic hematuria.
    Urology. 2019 Jan 21. pii: S0090-4295(19)30073.
    Abstract     Related articles   

  889. LOH-DOYLE JC, Ashrafi A, Nazemi A, Ghodoussipour S, et al
    Dual Prosthetic Implantation After Radical Cystoprostatectomy and Neobladder: Outcomes of the Inflatable Penile Prosthesis and Artificial Urinary Sphincter in Bladder Cancer Survivors.
    Urology. 2019 Jan 18. pii: S0090-4295(19)30065.
    Abstract     Related articles   

  890. LORENZO SORIANO L, Ordaz Jurado G, Pontones Moreno JL, Villarroya Castillo S, et al
    Urology. 2019 Apr 12. pii: S0090-4295(19)30344.
    Abstract     Related articles   

  891. MAGANTY A, Turner RM 2nd, Yabes JG, Davies BJ, et al
    Downstream Studies Following the Use of Bone Scan in the Staging of Muscle-invasive Bladder Cancer.
    Urology. 2019 Apr 18. pii: S0090-4295(19)30353.
    Abstract     Related articles   

  892. HERR H
    Preventable Cancer Deaths associated with Bladder-Preservation for Muscle Invasive Bladder Cancer.
    Urology. 2019 May 6. pii: S0090-4295(19)30425.
    Abstract     Related articles   

  893. BAT T, Buck DA, Nathan R, Cinquino J, et al
    Advanced Bladder Cancer Rechallenged With an Immune Checkpoint Inhibitor: A Case Report.
    Urology. 2019 May 3. pii: S0090-4295(19)30421.
    Abstract     Related articles   

  894. ROYCE TJ, Efstathiou JA
    Editorial comment.
    Urology. 2019;124:189-190.
    Abstract     Related articles   

  895. BANDARI J, Maganty A, Davies BJ
    Editorial Comment.
    Urology. 2019;124:125-126.
    Abstract     Related articles   

  896. HONG P, Ding GP, Hao H, Yang KL, et al
    Laparoscopic Radical Cystectomy With Extracorporeal Neobladder: Our Initial Experience.
    Urology. 2019;124:286-291.
    Abstract     Related articles   

  897. RAGUE JT, Lee RS
    Management of High-grade, Nonmuscle Invasive Urothelial Carcinoma in a Prepubertal Patient With TURBT and Intravesical BCG.
    Urology. 2019;124:257-259.
    Abstract     Related articles   

  898. HERR H, Donat M
    Reduced Recurrence of Low-grade Papillary Bladder Tumors Associated With Asymptomatic Bacteriuria.
    Urology. 2019;124:179-182.
    Abstract     Related articles   

  899. HOARE D, Kiddoo D, Stryker T
    An Antenatally Detected Pure Malignant Rhabdoid Tumor of the Bladder.
    Urology. 2019;123:221-223.
    Abstract     Related articles   

  900. SYU SH, Chan KS, Hsiao CH, Chen WY, et al
    A Large Urinary Bladder Hemangioma Mimicking Urachal Cancer: A Case Report and Literature Review.
    Urology. 2019;123:224-226.
    Abstract     Related articles   

  901. KAYE DR, Ye Z, Li J, Herrel LA, et al
    The Stability of Physician-Specific Episode Costs for Urologic Cancer Surgery: Implications for Urologists Under the Merit-Based Incentive Program.
    Urology. 2019;123:114-119.
    Abstract     Related articles   

  902. HAN DS, Lynch KE, Chang JW, Sirovich B, et al
    Overuse of Cystoscopic Surveillance among Patients with Low-Risk Non-Muscle-Invasive Bladder Cancer - A National Study of Patient, Provider, and Facility Factors.
    Urology. 2019 May 27. pii: S0090-4295(19)30448.
    Abstract     Related articles   

  903. DANFORTH KN, Sidell MA, Luong TQ, Yi DK, et al
    Care Quality and Variability in the Use of Intravesical Therapy for Initial Treatment of Non-Muscle Invasive Bladder Cancer within a Large, Diverse Integrated Delivery System.
    Urology. 2019 May 24. pii: S0090-4295(19)30442.
    Abstract     Related articles   

  904. MAY D, Canter DJ
    Urology. 2019;125:228-229.
    Abstract     Related articles   

    Urology. 2019;125:152-153.
    Abstract     Related articles   

  906. PEREIRA JF, Pareek G, Mueller-Leonhard C, Zhang Z, et al
    The Perioperative Morbidity of Transurethral Resection of Bladder Tumor: Implications for Quality Improvement.
    Urology. 2019;125:131-137.
    Abstract     Related articles   

  907. MODI PK, Hollenbeck BK, Oerline M, Weizer AZ, et al
    Real-World Impact of Minimally Invasive Versus Open Radical Cystectomy on Perioperative Outcomes and Spending.
    Urology. 2019;125:86-91.
    Abstract     Related articles   

  908. GOULET CR, Champagne A, Bernard G, Vandal D, et al
    Cancer-associated fibroblasts induce epithelial-mesenchymal transition of bladder cancer cells through paracrine IL-6 signalling.
    BMC Cancer. 2019;19:137.
    Abstract     Related articles   

  909. LV S, Wang W, Wang H, Zhu Y, et al
    PPARgamma activation serves as therapeutic strategy against bladder cancer via inhibiting PI3K-Akt signaling pathway.
    BMC Cancer. 2019;19:204.
    Abstract     Related articles   

  910. PANG K, Zhang Z, Hao L, Shi Z, et al
    The ERH gene regulates migration and invasion in 5637 and T24 bladder cancer cells.
    BMC Cancer. 2019;19:225.
    Abstract     Related articles   

  911. YASUI M, Kawahara T, Izumi K, Yao M, et al
    Androgen receptor mRNA expression is a predictor for recurrence-free survival in non-muscle invasive bladder cancer.
    BMC Cancer. 2019;19:331.
    Abstract     Related articles   

  912. AL-HUSSEINI MJ, Kunbaz A, Saad AM, Santos JV, et al
    Trends in the incidence and mortality of transitional cell carcinoma of the bladder for the last four decades in the USA: a SEER-based analysis.
    BMC Cancer. 2019;19:46.
    Abstract     Related articles   

  913. YOSHINO T, Miyazaki J, Kojima T, Kandori S, et al
    Cationized liposomal keto-mycolic acids isolated from Mycobacterium bovis bacillus Calmette-Guerin induce antitumor immunity in a syngeneic murine bladder cancer model.
    PLoS One. 2019;14:e0209196.
    Abstract     Related articles   

  914. APOLLO A, Ortenzi V, Scatena C, Zavaglia K, et al
    Molecular characterization of low grade and high grade bladder cancer.
    PLoS One. 2019;14:e0210635.
    Abstract     Related articles   

  915. BYUN SJ, Park W, Cho KH, Cho J, et al
    A multi-institutional study of bladder-preserving therapy for stage II-IV bladder cancer: A Korean Radiation Oncology Group Study (KROG 14-16).
    PLoS One. 2019;14:e0209998.
    Abstract     Related articles   

  916. BOSSCHIETER J, Bach S, Bijnsdorp IV, Segerink LI, et al
    A protocol for urine collection and storage prior to DNA methylation analysis.
    PLoS One. 2018;13:e0200906.
    Abstract     Related articles   

  917. HASNAIN Z, Mason J, Gill K, Miranda G, et al
    Machine learning models for predicting post-cystectomy recurrence and survival in bladder cancer patients.
    PLoS One. 2019;14:e0210976.
    Abstract     Related articles   

  918. SIMON M, Bosset PO, Rouanne M, Benhamou S, et al
    Multiple recurrences and risk of disease progression in patients with primary low-grade (TaG1) non-muscle-invasive bladder cancer and with low and intermediate EORTC-risk score.
    PLoS One. 2019;14:e0211721.
    Abstract     Related articles   

  919. BAUSCH K, Roth E, Heinz S, Horst D, et al
    Urinary Calprotectin loses specificity as tumour marker due to sterile leukocyturia associated with bladder cancer.
    PLoS One. 2019;14:e0213549.
    Abstract     Related articles   

  920. LU DL, Ren ZJ, Zhang Q, Ren PW, et al
    Meta-analysis of the association between the inflammatory potential of diet and urologic cancer risk.
    PLoS One. 2018;13:e0204845.
    Abstract     Related articles   

  921. YU A, Mansure JJ, Solanki S, Siemens DR, et al
    Presence of lymphocytic infiltrate cytotoxic T lymphocyte CD3+, CD8+, and immunoscore as prognostic marker in patients after radical cystectomy.
    PLoS One. 2018;13:e0205746.
    Abstract     Related articles   

  922. WETTSTEIN MS, Rooprai JK, Pazhepurackel C, Wallis CJD, et al
    Systematic review and meta-analysis on trimodal therapy versus radical cystectomy for muscle-invasive bladder cancer: Does the current quality of evidence justify definitive conclusions?
    PLoS One. 2019;14:e0216255.
    Abstract     Related articles   

  923. LIM YW, Chen-Harris H, Mayba O, Lianoglou S, et al
    Germline genetic polymorphisms influence tumor gene expression and immune cell infiltration.
    Proc Natl Acad Sci U S A. 2018;115:E11701-E11710.
    Abstract     Related articles   

  924. MULLENDERS J, de Jongh E, Brousali A, Roosen M, et al
    Mouse and human urothelial cancer organoids: A tool for bladder cancer research.
    Proc Natl Acad Sci U S A. 2019 Feb 20. pii: 1803595116.
    Abstract     Related articles   

Thank you for your interest in scientific medicine.

AMEDEO Bladder Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.